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Novel intracellular signalling regulators of cartilage progenitor cell populations. 
 
Cartilage is a viscoelastic tissue that absorbs shocks and facilitates low friction of the 
joint. Adult articular cartilage is limited in its ability to self-repair. Lesions or gradual 
wear-and-tear affect cartilage integrity and lead to damage that, when untreated, can 
ultimately develop to osteoarthritis. Osteoarthritis is a considerable health burden and 
is a leading cause of disability worldwide. In order to address this burdensome 
condition, several treatments have been developed. In particular, therapies that allow 
delivery of bone marrow and its constituent cell populations to the site of cartilage 
damage to form a regenerative clot have proved promising in repairing joint cartilage 
defects. In order to improve such regenerative technique, further research is required 
to provide a deeper understanding of the mechanisms underlying cartilage 
regeneration. One of the critical players are the cells that originally reside in the 
cartilage surrounding the damage. How these resident cells contribute to the activity of 
cells within the repair tissue at the site of cartilage damage is largely undescribed. 
 
In this thesis chondrocytes from three different cartilage areas were compared: 
chondrocytes from 1) the superficial (SZ) and 2) the middle-deep (MDZ) zone of non-
weight bearing femoral condyles, and from 3) the osteoarthritic zone (OAZ) of patients 
undergoing knee replacement. More inflammatory factors and cytokines are present in 
MSCs co-culture with OA cartilage chips, and with MDZ cartilage chips. To assess how 
chondrocyte-MSC crosstalk would affect MSCs chondrogenesis, cartilage chips from 
the three different zones were co-cultured with BMSC pellets. Results indicated that 
the SZ induce chondrogenic differentiation of BMSCs, whereas MDZ and OAZ have a 
negative effect, compared to control conditions. The findings suggest that the presence 
of SZ, which has been reported to reduce with age, is important to direct BMSCs 
differentiation towards the chondrogenic fate. 
In order to better understand the molecular mechanism that differentiate SZ from MDZ 
and OA chondrocytes, DACTs (Dapper antagonist of catenin) were studied. DACT1 
and DACT2 are known to be Wnt and TGFβ pathways regulators, but their role in 
chondrocytes and MSCs has not been described before. Both proteins are present in 
chondrocytes throughout the osteoarthritic human tissue, including in chondrocytes 
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forming cell clusters. On the non-weight bearing and visually undamaged cartilage, 
DACT1 and DACT2 expression is localised to the articular surface. In mouse embryos 
(E.15.5), DACT2 is expressed at the interzone, site of developing synovial joint, 
indicating that DACT2 is expressed in cells that give rise to the articular joint. 
Subsequently the expression of DACT1 and DACT2 was analysed in MSCs: both are 
expressed in synovial and bone marrow-derived MSCs. Following this observation an 
RNAi knockdown experiment showed that DACT1 knockdown in both chondrocyte and 
MSCs causes the cells to undergo apoptosis within 24 hours. To understand the 
pathway regulated by DACT1, next generation sequencing gene expression analysis 
was performed on BMSCs where DACT1 had been reduced by RNAi. The study 
showed that loss of DACT1 influences the expression (p<0.05) of genes involved in 
both TGFβ and Wnt pathways and putative link to relevant cell regulatory pathways 
(Ingenuity® Pathway Analysis). SMURF2 and other genes involved in protein 
phosphorylation and degradation are downregulated following DACT1 knockdown. 
This suggests that DACT1 is an upstream regulator of SMAD protein phosphorylation 
affecting proliferation and survival of MSCs.  
 
The data presented in this thesis has indicated that different types of chondrocytes are 
present within human articular cartilage and that they cross talk with MSCs differently 
according to their regional origin. This information offers a new level of complexity to 
consider to improve regenerative techniques. In addition, this work describes for the 
first time, the presence and biological relevance of DACT1 and DACT2 in chondrocytes 
and MSCs. DACT1 is involved in MSCs survival and is downregulated in OA which 
suggest that this is an important regulatory protein. Further studies of DACT1 could 
help elucidate mechanisms involved in OA, but also uncover the relevance of cartilage 
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Adult joints are anatomical parts of the human body where different types of tissues 
come together to allow movement. Diseases that affect these articulations and 
consequently mobility are a major cause of pain and disability. Cartilage is a connective 
tissue present at the articulating end of each bone that makes up a synovial joint. 
Cartilage is composed of specialised cells called chondrocytes that are surrounded by 
matrix, and it act to absorbs mechanical shocks and to facilitates smooth, low friction 
movement of the joint. Adult articular cartilage is limited in its ability to self-repair. 
Lesions sustained after sports or the result of a chronic disease and age-related 
breakdown affect cartilage integrity and lead to damage that, when untreated, can 
ultimately develop to osteoarthritis. Osteoarthritis (OA) is a joint disease that affects 
millions of people and is a leading cause of disability worldwide. End stage OA can be 
effectively treated by surgical operation to replace the joint, but other surgical and non-
surgical treatments have been developed to address early stage OA. Therapies that 
recruit bone marrow to the site of cartilage damage to form a regenerative clot have 
proved promising in repairing small joint cartilage defects. One approach called 
microfracture consists of drilling holes into the underlying subchondral bone to recruit 
a number of resident cell type including mesenchymal stromal cells (MSC).  However, 
fibrotic features of the regenerated cartilage may affect its mechanical properties and 
therefore the longevity of such treatments. In order to improve this regenerative 
technique, as well as other similar treatments, further research is required to provide a 
deeper understanding of the mechanisms underlying cartilage regeneration. One of 
the critical players are the cells that originally reside in the cartilage surrounding the 
damage. How these resident cells contribute to the activity of cells within the repair 
tissue at the site of cartilage damage is largely undescribed. Despite recent progress 
in determining the origin and process of cartilage development by chondrocytes 
progenitors in mouse, which cells and mechanism are involved in cartilage repair in 
human are still elusive. In this chapter, a literature review will illustrate the current 
understanding of the synovial joint and specifically cartilage development and repair 
from a cell and molecular point of view. Tissue engineering and cell-based strategies 
that have recently been developed for the repair of early cartilage damage will be 




focus on proteins that might be important chondrocytes and cartilage progenitor 
regulators. 
 
1.1 The social impact of musculoskeletal disorders 
Among the newest challenges faced by our society, the UK government policy makers 
have identified ageing as one of the main 5 to address in 2019. Elderly population is 
set to become a large part of the UK population in the coming years and a large amount 
of resources have been allocated to improve their lives. 98£ millions in investments 
have been destined to Healthy Ageing Industrial Strategy Fund to stimulate innovative 
solutions to ensure that older people can lead an active and independent life for longer 
(UK government, 2019b).  An extra £130 million of investment is specifically being 
allocated towards the development of healthcare innovation and new treatment to 
enable people to live longer and healthier lives (UK government, 2019b). Specific focus 
on the quality of life of older people seems a strong and leading target for these national 
investments. 
Another main concern to improve national health is to promote adult engagement in 
physical activity, because of the many associated health benefits including reduction 
of the incidence of life-threatening diseases such as cardiovascular disease, diabetes, 
cancer, and general mortality (fig. 1). Engaging is regular physical activity is also 
critically increasing quality of live by improving mental health, ensuring that we can 
enjoy living longer.  
 
Figure 1 Health benefits of physical activity.  
Exercising every day has been associated with overall increase of life span by reducing 
the incidence of many diseases. Being physically active also increase quality of life by 





Both challenges of providing the elderly with better healthcare solutions and making 
the general population more active and consequently healthier, can be addressed by 
treating musculoskeletal disorders. In the past three decades, health concerns 
involving joints, bones and muscle have been the main cause of disability in the UK, 
affecting about 30% of the adult population (fig.2). Disability can severely affect mental 
health, ability to perform physical activity and being independent, which have a large 
impact not only on the self but also on society. Several risk factors can increase the 
incidence of musculoskeletal conditions, including physical inactivity, being overweight 
or obesity, older age and genetic predisposition (Palazzo, Ravaud, Papelard, Ravaud, 
& Poiraudeau, 2014). About 1 in 5 people seek doctor help about musculoskeletal 
problems, which spans from inflammatory conditions, for example, rheumatoid arthritis, 
to conditions that result in chronic pain such as OA and back pain (UK government, 
2019a). Developing therapies that target musculoskeletal disorder, such as OA, is 
imperative to tackle the societal challenges outlined above.  In addition, this disorder 
category affects today about 18 million people in the UK only and accounts for one of 
the largest expenditure areas for the National Health Service (fig. 2). 
 
 
Figure 2 Musculoskeletal disease in the UK. 
“Global Burden of Disease Study 2016 (GBD 2016) Results”. Institute for Health 






1.2 The knee joint 
Articulations can be described by a number of different classifications, depending on 
anatomy and biomechanics (depending on how many articular surfaces they connect), 
the movements they perform, and the type of connective tissue which binds the 
articular bones. This work will focus on the knee joint, an articular synovial joint that 
allows a hinge type of movement. 
The knee is the largest joint system in the body and connects the femur, the thigh bone, 
with the tibia, the shin bone, and with the patella, or “knee cap” (Flandry & Hommel, 
2011). This structure is made of articular cartilage at the end of the long bones, the 
synovial fluid produced by the synovium, ligaments and tendons to hold the structure 
together and connected to muscles and bones (fig. 3). Together, they permit and 
transmit biomechanical loads during skeletal movement. 
 
Cartilage is a connective tissue that provides support and flexibility to the other joint 
tissues. It is found in the knee in two main forms: 
• Articular cartilage, that covers the ends of the bones and allows for the bones 
to slide and glide on each other with limited friction (Flandry & Hommel, 2011). 
• Menisci, two C-shaped pieces of cartilage that are placed medially and laterally 
between the femur and tibia. The role of the meniscus is thought to be for shock 
absorption and to stabilize joint (Flandry & Hommel, 2011). 
 
The layer of bone underlying articular cartilage is called subchondral bone. The role of 
this structure is to help distribute the mechanical loads across the joint. Alteration in 
the subchondral bone, therefore, has an effect on cartilage and could cause cartilage 
degeneration (Imhof et al., 2000). Cartilage and subchondral bone can communicate 
thanks to the presence of channels between the two structures (Imhof et al., 2000). 
The biochemical communication between the two and their exact relationship affecting 
the physiological and diseased state of the knee is still largely undefined. 
 
The synovium, a smooth and thin membranous tissue produces a fluid that helps the 
lubrication of the healthy knee, reduces friction, and provides a mean of contact 
between the knee tissues. Synovium is also proposed to be the stem cell niche that 




synovium is made up of predominantly synovial fibroblasts, but also immune cells, and 
is highly vascularised. The synovium is responsible for the maintenance of synovial 
fluid volume and composition. Synovial fluid is secreted by the synovium into the 
synovial cavity and contains products derived from blood plasma and proteins 
produced by the cells from both cartilage and synovium. The synovial fluid contains 
hyaluronan, lubricin, and waste products produced by the chondrocytes, like CO2 and 
metabolic waste. Because of its highly vascularised nature, the synovium, via synovial 
fluid, supports articular chondrocytes by supplying oxygen and nutrients and removing 
waste products. 
Other components of the knee joints are ligaments and tendons (Flandry & Hommel, 
2011). Ligaments are made of strong connective tissue that is responsible for giving 
the knee stability from front to back by directly connecting the different bones. 
Ligaments support the joint by holding the bones together and resisting excess or 
abnormal joint motions. Tendons are also responsible for stabilizing the different joint 
parts by connecting bones to the muscles that move the knee.  
 
 
Figure 3 Anatomy of the human knee and articular cartilage. 
The human knee is a synovial joint that connects the femoral and tibial bones and is 
contained by the synovial membrane. The synovial fluid that nourishes and lubricate 
the cartilage at the end of the tibial and femoral bones. The synovium is closely 
connected to the fat pad. Anteriorly, the patellar a bone which protects the knee joint 
from trauma. The cartilage lays between the synovial space and the bone. The 
structure of articular cartilage changes in the various zones in terms of chondrocytes 





1.3 Cartilage biology 
Cartilage is an avascular, aneural and alymphatic tissue. Articular cartilage is about 3 
mm thick and is composed of chondrocytes, highly specialised cells of mesenchymal 
origin, which make up only 5% of the whole cartilaginous tissue with the extracellular 
matrix (ECM), that surrounds the cells, constituting the remaining 95%. 
ECM has a fundamental role in giving cartilage-specific characteristics. The main 
components of articular cartilage ECM are: 
• Collagens, that constitute 60% of the total dry weight of the ECM, often interact 
with proteoglycans or are assembled with other collagens proteins. Collagen 
type II is the most abundant type of collagen in cartilage, which typically binds 
to collagen type XI. 
• Proteoglycans, large molecules made of polysaccharides and a small protein 
part, which provides hydration and swelling pressure to the tissue enabling it to 
withstand compressional forces. Proteoglycans possess a protein core which is 
bound to glycosaminoglycans (GAG), like hyaluronic acid, chondroitin sulphate, 
keratan sulphate binds. GAGs are negatively charged and therefore attract and 
help retaining water enabling cartilage to withstand load and compression. 
Aggrecan is one of the major proteoglycan present in articular cartilage (Becerra 
et al., 2010). 
• Other proteins include fibronectin that anchor chondrocytes to the surrounding 
matrix (Becerra et al., 2010). 
• The fluid component, including water, gas, metabolites and cations that balance 
the negative charge of GAG, help the tissue to resist compression. The 
metabolic exchange with synovial tissue that surrounds the articulation provides 
chondrocytes with nutrients (Fukui et al., 2008). 
  
Despite composing only a minimal part of the adult tissue, chondrocytes have an 
important role in remodelling the ECM to maintain cartilage mechanical properties. 
Cartilage cells are arranged in four different layers: superficial, middle, deep, and 
calcified zones (fig.3). 
 These zones are easily distinguishable in terms of different cell morphologies and 
spatial arrangement (Zhu et al., 2009). Transcriptional heterogeneity within cartilage 




from different regions (Darling, Hu, & Athanasiou, 2004; Quinn, Häuselmann, Shintani, 
& Hunziker, 2013). The superficial zone (SZ) is 10-20% of total cartilage volume and 
displays high numbers of flattened cells that lay parallel to the articular surface. This 
zone is believed to secrete biomolecules that provide lubrication and resistance to 
shear stresses, and its integrity is fundamental to protect and maintain the deeper 
cartilage layers.  Notably, proteoglycan 4 (PRG4), or lubricin, is produced mostly by 
SZ cells. This large glycoprotein is responsible for lubrication and is also called 
superficial zone protein (SZP) (G. D. Jay, Tantravahi, Britt, Barrach, & Cha, 2001; 
Koyama et al., 2008). PRG4 is also expressed by cells lining the synovial membrane 
(Rhee et al., 2005). Cartilage Oligomeric Matrix Protein (COMP) is also more highly 
expressed in the SZ where it is believed to mediate matrix molecules interactions in 
cartilage and is involved with load-bearing regulation (Chen et al., 2007). The protein 
developmental endothelial locus-1 (DEL1) is also a marker for SZ cartilage (Pfister, 
Aydelotte, Burkhart, Kuettner, & Schmid, 2001). The matrix surrounding SZ 
chondrocytes is mainly composed of tightly arranged collagen fibres, mainly type II and 
IX collagen that are aligned parallel to the articular surface. The combination of these 
proteins provides the water-retaining property and the ability to resist tensile stress. 
Several studies have reported that the superficial layer includes cells with stem-like 
properties both in human, mouse and bovine articular cartilage (Coates & Fisher, 2014; 
Dowthwaite et al., 2004; Hattori, Oxford, & Reddi, 2007; Kozhemyakina et al., 2015; Li 
et al., 2017; Williams et al., 2010). These cells exhibit stem cell characteristics such as 
migratory activity, ability to form colonies, and trilineage differentiation and were shown 
to give rise to adult chondrocytes in mouse (Li et al., 2017). This suggests that the 
superficial layer could host a subpopulation of progenitor cells, whose role in adult 
tissue repair has not been exhaustively investigated.  
The middle zone (MZ) represents 40-60% of the total cartilage volume. The 
chondrocytes in this zone are rounder and their disposition is oblique and scattered, 
occasionally forming clusters of 2-3 cells that tend to have a vertical orientation. The 
matrix in the MZ is characterised by collagen fibre orientated both vertically and 
horizontally. Collagens concentration diminishes in the MZ in favour of proteoglycans. 
In the deeper zone (DZ), which takes up to 30-40% of total volume, cells are clearly 
organised in vertical columns and have a round morphology (Coates & Fisher, 2014; 




in the DZ. The DZ has the highest proteoglycans concentration and the lowest water 
concentration compared to the rest of the tissue. 
 Finally, the tide mark delineates the deep zone from the calcified cartilage which sits 
on the subchondral bone. The calcified zone is a transitional space between cartilage 
and subchondral bone.  
1.4 Joint and cartilage development 
Skeletogenesis is the process by which the vertebrate skeleton is formed. In early 
embryonic life, in the process called gastrulation, the initial cluster of cells that will 
become the embryo organizes into layers that will give rise to all of the organs and 
structures of the body. The endoderm (inner layer), the ectoderm (outer layer) and the 
mesoderm (middle layer) are called the primary germ layers. The embryonic tissue that 
gives rise to bones, cartilage and connective tissue is the mesenchyme (S. F. Gilbert, 
2000). The mesoderm produces most of the mesenchyme, however also the neural 
crest, a specialised structure of the ectoderm, give rise to a small amount of 
mesenchyme (S. F. Gilbert, 2000). The mesenchyme in the neural crest can become 
specialised into craniofacial cartilage and bones. In higher vertebrates, the mesoderm 
is subdivided into different parts. The skeleton originates from three regions: the neural 
crest forms the skull, the vertebrae are formed by the somites, and the limb buds that 
will go on to form the limbs arise from the lateral plate mesoderm. The limb buds form 
at 4 weeks of gestation in the flank and are made up of a core of loose mesenchyme 
surrounded by the epidermis. Embryonic limb formation requires the interplay of two 
main signalling pathways: Wnt and TGFβ pathways (Decker, Koyama, & Pacifici, 2014; 
Khan et al., 2007). The limb bud formation is initiated by Wnt/β-catenin through 
Wnt2b/Wnt8c activity resulting in the stable expression of FGF10. Wnt3a then induces 
the expression of FGF4 and FGF8 at the top of the limb bud- the apical ectodermal 
ridge (AER), that produces a feedback loop with FGF10 in the mesenchyme that drives 
growth and proximodistal patterning. From the coordination of the AER and the zone 
of polarising activity (ZPA) located at the posterior limb mesenchyme, the limb starts 
forming. A common pattern for the limbs is set up with a long bone in the proximal 
region (stylopod) and two long bones in the intermediate part (zeugopod) to culminate 





Each limb bud starts to grow and elongate during the sixth week: the mesenchyme 
gradually differentiates into models of the future bones composed of hyaline cartilage 
(S. F. Gilbert, 2000). In the continuous anlages of developing limbs, a region of 
condensed cells, called the interzone, forms at putative joint sites. Holder showed in 
1977 that upon removal of interzone cells, joints do not develop in chick and bones 
remained fused (Holder, 1977). Wnt signalling is involved in the specification of the 
interzone: Wnt4, Wnt16 and Wnt9a (also known as Wnt14) are markers of synovial 
joint formation and joint fusion results from β-catenin removal from the interzone (Xizhi 
Guo et al., 2004; Hartmann & Tabin, 2001). 
Cells at the centre of the interzone region undergo cell death to form the joint cavity 




Figure 4 Synovial joint development. 
The morphogenesis of synovial joint starts with 1) the condensation of mesenchymal 
cells which are present during endochondral ossification. 2) Highly condensate cells 
are present at the joint specification site, the interzone. Cells around the interzone start 
expressing Col2. 3) Cavitation occurs as the opposite ends of the interzone begin to 
differentiate into articular cartilage surfaces. 4) Cells start differentiating to give rise to 
different tissues including synovial membrane and articular cartilage and progressively 





The embryonic connective tissue is replaced by the skeleton in two main mechanisms: 
intramembranous and endochondral ossification (Shapiro, 2008). Intramembranous 
ossification occurs in the flat bones of the skulls and the clavicles. The mesenchymal 
cells differentiate into mature bone cells, osteoblasts. The osteoblasts secrete 
uncalcified bone matrix and then deposit calcium and other mineral salts, hardening 
the matrix.  The osteoblasts then become resting cells on the surface of the bone with 
a smaller number becoming entombed in the bone matrix and termed osteocytes.  In 
time, a layer of dense connective tissue (periosteum) is formed around the bone, while 
the centre gets infiltrated with blood vessels to form red bone marrow. 
The process of endochondral ossification converts the early cartilaginous structures 
into long bones through a longer process: most bones of the vertebrate body are 
formed by this process. After birth, the ossification process of long bones is mostly 
complete and hyaline cartilage is only present at the end of bones of synovial joints. 
According to the current model, the precursor mesenchymal cells differentiate into 
“early chondrocytes” that form the embryonic hyaline cartilage structures. Starting from 
the primary ossification centre, at the centre of the prospective bone, early proliferative 
chondrocytes undergo differentiation to hypertrophic chondrocytes. The terminally 
differentiated hypertrophic chondrocytes undergo apoptosis and the calcified matrix is 
invaded by blood vessels along with osteoprogenitors and osteoclasts and is replaced 
by bone and marrow. 
 
1.4.1 Current understanding of cartilage development 
Cartilage development starts at the embryonic stage, however, the molecular 
mechanisms and their organisation are not fully understood. How cartilage develops 
has been discussed for many decades, but only recently in vivo genetic tracing studies 
in mice have shed light on the origin of chondrocytes precursors and how they originate 
embryonic and adult cartilage. 
The main question about cartilage development revolved around a few major points: 
• Which are the cells from the interzone that give rise specifically to the joint 
articular cartilage? 






In 1996 Storm and Kingsley showed that the condensating cells in the interzone 
overexpress growth differentiation factor 5 (Gdf5) (Storm & Kingsley, 1996), more 
recently genetic tracing studies in mice showed in Gdf5-Cre reporter mice that cells of 
all mature joint components originate from Gdf5-expressing lineages (Koyama et al., 
2007, 2008; Shwartz et al.,  2016).  
From Gdf5 expressing cells derive chondrocyte cells with different lineages. 
Depending on receiving Wnt signalling, and not BMP, Gdf5 cells are competent to 
differentiate into articular cartilage (Ray, Singh, Sohaskey, Harland, & 
Bandyopadhyay, 2015). 
In the past three years, three new lineage tracing studies in mouse have advanced our 
understanding of cartilage development from embryonic progenitors to mature 
chondrocytes. Although the presence of cartilage stem cell has for a long time been 
postulated, a marker to genetically study these cells has been elusive for a long time. 
Many studies have suggested the presence of a stem cell population in the superficial 
zone of cartilage, which expresses among others PRG4 as previously described in 
paragraph 2 of this chapter. Three independent studies have described how PRG4+ 
cells not only self-renew and are positive for stem cell markers, but they also 
differentiate into chondrocytes in postnatal knee joints (Decker et al., 2017; 
Kozhemyakina et al., 2015; Li et al., 2017). Despite showing that this stem cell 
population is present in juvenile-adult mice cartilage, Decker et al. (Decker et al., 2017) 
reported that in response to cartilage injury the PRG4+ cells nor their progeny 
proliferate, whereas the PRG4+ cells in the synovial lining significantly grow in number 
and are found at the site of repair. Because of this observation, both Decker et al. and 
Chagin et al. (Chagin & Medvedeva, 2017) argue that PRG4+ cells present in cartilage 
do not take part in cartilage regeneration. However, proliferation is not necessarily a 
positive response to injury. As shown by Zhang et al. (Minjie Zhang et al., 2016), cell 
death induced by diphtheria toxin in the superficial cells before inducing cartilage 
degeneration, provides protection from degeneration. It is not impossible that the role 
of chondroprogenitors in cartilage repair is not just to proliferate and replace damaged 
chondrocytes, but perhaps maintaining homeostatic signalling to prevent matrix 
catabolism and inflammation. The study suggests that tissue degeneration is caused 




1.5 Cartilage defects and degeneration 
Adult articular cartilage is limited in its ability to self-repair. Lesions in articular cartilage 
are thought to be caused by trauma (generally focal lesion) or could be due to 
degeneration (‘wear and tear’ or degenerative lesion). Particularly common in the knee, 
lesions like a tear or a fracture tend to be undiagnosed. With cartilage being an aneural 
tissue, a lesion can be asymptomatic and therefore left untreated for long periods. 
Cartilage defects of both kinds may cause pain, loss of function and could lead to long 
term complications, like OA (Palazzo, Ravaud, Papelard, Ravaud, & Poiraudeau, 
2014).  
OA is a disease that affects the whole joint, not only affecting articular cartilage but 
also subchondral bone and synovium. It causes patients serious limitation of daily 
activities and as a result, affects significantly the quality of life. By 2020 OA is estimated 
to become the fourth-largest cause of disability worldwide and is already representing 
a major cost for developed countries, amounting to 1-2% of GDP (Wittenauer, Smith, 
& Aden, 2013). To date, approximately 10% of men and 18% of women above the age 
of 60 worldwide presents to their clinician with stiffness, pain, and limitation of 
movement as a result of OA (Wittenauer et al., 2013). Because older age and obesity 
are two of the main risk factors for OA, this social burden is destined to rise as a 
consequence of longer life expectancy and the obesity epidemic (Arthritis By The 
Numbers, n.d.; Wittenauer et al., 2013).  
Many hypotheses to explain the aetiology of OA have been proposed. Historically, 
cartilage degradation resulting in OA was considered an inevitable consequence of old 
age, partly because of the age-related reduced production of collagens which is also 
observed in other tissues. OA risk factors include, in addition to age, obesity, sports 
injuries, and lack of exercise (Wittenauer et al., 2013). All these risk factors have such 
an effect on cartilage because regular movement and joint loading is required for 
optimal metabolic activity and regulates homeostatic pathways in articular cartilage (S. 
J. Gilbert & Blain, 2018; Vincent & Wann, 2019). At the latest OARSI meeting in 
Toronto (2019), Tonia Vincent and Frank Beier argued in a plenary session that OA is, 
in fact, one single disease with different underlying causes. Professor Vincent used the 
term “mechanoflamation” to indicate the combination of altered mechanical loading 
and inflammation that would lead to an inability to repair cartilage due to underlying 




aetiology and development remain elusive and consequently, a clear strategy to 
prevent or heal this disease is currently lacking.  
 
When articular cartilage is damaged its zonal architecture is compromised, cell clusters 
appear around the site of injury and are considered a hallmark of osteoarthritis. Cell 
clusters are defined as five or more cartilage cells residing in one large lacuna and 
their significance is still not fully understood (Lotz et al., 2010). This type of cell 
organization is well described in OA cartilage and it is thought to result through cells 
migrating from degrading matrix and then proliferating. The phenotype of the cells 
residing in cartilage clusters has not been thoroughly delineated, so it is not known if 
clusters are composed of clonal cell populations or heterogeneous chondrocytes and 
whether they include cartilage progenitors. As a consequence, it is not fully understood 
if cell clusters are simply the result of cell migration in response to damage or if they 
have a role in cartilage repair (Lotz et al., 2010). A recent study has suggested that cell 
clusters present in late OA stages in humans include cells with stem-like progenitors 
properties (Hoshiyama et al., 2015). OA cell clusters could be the result of 
chondroprogenitor proliferation or de-differentiation of chondrocytes to address 
cartilage damage and repair the lesion. In a recent study, Matthew Warman’s group 
showed that the death of superficial chondrocytes protects from cartilage degeneration 
in a mouse model of OA (Zhang et al., 2016). This would indicate that the high 
cellularity found in OA cartilage is contributing to exacerbating matrix catabolism and 
OA development. When performing bone marrow recruiting techniques (one of the 
therapeutic techniques discussed in the next paragraph), surgeons remove 
defibrillated cartilage around the site of damage to provide a neat interface for the clot 
to interact with cartilage. Microscopically, OA cell clusters are probably removed with 
this operation and could contribute to creating a less catabolic environment and 
therefore aid tissue regeneration.  
1.6 Therapeutic approaches for cartilage repair 
Surgical replacement of the joint (arthroplasty) is the gold standard method for end-
stage OA, first introduced in the UK in 1960s (Knight, Aujla, & Biswas, 2011). This 
surgical approach has been described as one of the most successful for its safety and 
efficacy. Despite its effectiveness in re-establishing patients’ motility and reducing or 




replacement lasts between 10 and 20 years, but when performed on patients aged 50 
or younger, the likelihood of a revision surgery to substitute the artificial implant is high. 
This comes at a greater financial cost and further risks of complications for the patient. 
Revision total joint replacement surgeries are becoming more common as patients 
may undergo joint replacement surgery as young at 30 years old. Secondly, patients 
suffering from cartilage defects and/or OA are faced with many years of an increasingly 
painful and debilitating condition until a total knee replacement is prescribed. Symptom 
management and palliative cures are only partially able to reduce pain and return full 
mobility (fig. 5). 
 
Figure 5 Symptoms management and current treatments for patients with 
Osteoarthritis  
(Adapted from McAlindon et al., 2014).  
 
To address this unmet clinical problem, alternative approaches have been developed 
to tackle the early stages of OA to repair cartilage damage (Mastbergen, Saris, & 
Lafeber, 2013). Several surgical methods and approaches such as subchondral 
drilling, microfracture, autologous chondrocyte implantation (ACI), MSC injections 





Figure 6 Surgical and cellular therapies for cartilage repair. 
Novel approaches that are targeted to treat cartilage defects: a) ACI, B) Marrow 
stimulating technique and C) MSCs/EVs injections. Adapted from Cartilage Surgery by 
M. Brittberg and W. Gersoff. 
 
1.6.1 Autologous chondrocytes implantation (ACI) 
In 1994, Brittberg and colleagues described a two-stage method to heal moderate size 
cartilage defects (Brittberg et al., 1994). After inspecting the cartilage lesions, 
chondrocytes are harvested from non-weight bearing areas of the long bones and 
expanded ex-vivo. In a second stage, expanded chondrocytes from non-weight 




ACI is a standard procedure for the treatment of moderately sized cartilage defects of 
the knee and is recommended by the National Institute for Health and Care Excellence 
(NICE) and other international medical associations (NICE, 2017). 
Follow up studies showed that although the repair is achieved, the resulting cartilage 
is fibrotic and has reduced mechanical properties. One of the reasons for the 
development of fibrotic rather than hyaline cartilage is the expansion phase of 
chondrocytes ex vivo. Chondrocytes tend to de-differentiated when expanded, 
resulting in an unstable phenotype (Benya, Padilla, & Nimni, 1978).  
To overcome this issue, a couple of interesting approaches have recently been 
proposed. First, Saris and colleagues performed a one-stage procedure to repair 
chondral lesion by using a 10-90 or 20-80 mix of autologous chondrocytes and 
allogeneic MSCs in fibrin glue. The autologous chondrocytes were obtained from the 
debrided tissue to create stable borders at the site of the defect. Debrided cartilage 
was enzymatically digested and mixed with allogenic BMSCs. This proof-of-concept 
study showed that the procedure is safe and on follow up MRI the regenerated tissues 
looked well integrated. Hyaline cartilage was observed, indicating that the repaired 
tissues were similar or superior to the classic ACI technique (de Windt et al., 2017). 
Genetic analysis also showed that the regenerated tissue contained patient‐DNA only, 
indicating that the allogeneic MSCs were not differentiating into cartilage but instead 
stimulated host tissue regeneration. 
Another recent approach that tries to overcome the unstable phenotype observed 
when culturing chondrocytes ex vivo, is the use of nasal chondrocytes. A recent study 
published by Mumme et al., derived chondrocytes from nasal septum for ACI (Mumme 
et al., 2016). A study conducted in 10 patients with knee full-thickness cartilage lesions 
(2-6 cm2) show that nasal chondrocytes have more stable chondrogenic phenotype 
during expansion ex vivo, less inter-donor variability and equal responsiveness to 
mechanical loading to chondrocytes from articular cartilage. After 2 years from surgery, 
the cartilage damages treated with nasal chondrocytes resulted in well-integrated 
regenerated cartilage from histological analysis in 3 of the 10 patients (Mumme et al., 
2016). However, low patient number, no mechanical tests, and the absence of a control 
group are substantial limits to the conclusions that can be drawn from the study. A 
large multicentre clinical trial (including patients with late-stage OA) is underway 
(NCT02673905) to confirm the initial results. The authors of this work suggest that the 




due to a different embryonic derivation, could explain the difference between the two 
cell populations. 
 
1.6.2 Bone Marrow stimulating techniques 
Subchondral drilling is a surgical technique first proposed for the treatment of  OA by 
Pridie in 1959 (Pridie and Gordon, 1959). It is now a widely used marrow stimulation 
technique for articular cartilage repair in the clinical setting. Bone marrow stimulation 
techniques produce controlled bone damage and allow bone marrow and blood cells 
to accumulate at the joint surface, at the site of cartilage damage (Erggelet & Vavken, 
2016) (fig. 6B). The underlying rationale is that by allowing MSCs contained in the bone 
marrow and other blood inflammatory cells to the damage site, a reparative 
environment can create and trigger repair. The outcomes of these techniques are 
similar to what is achieved with ACI, 5 and 15 years after surgery (Knutsen et al., 2007, 
2016). Smaller size defect tends to heal quite well but fibrocartilage containing collagen 
type I is often formed, especially in larger defects, and the resulting cartilage is 
biochemically and structurally unstable. In addition, observed subchondral bone 
overgrowth (25%–49%) is often observed following subchondral drilling, which might 
hinder the long-term effect of this therapy. 
 
1.6.3 MSCs as cell therapy 
Friedenstein and colleagues suggested in the late 1960s that a subpopulation of cells 
present in the bone marrow were an adult reservoir of cells able to restore skeletal 
tissues (Friedenstein, Chailakhjan, & Lalykina, 1970; Friedenstein, Chailakhyan, 
Latsinik, Panasyuk, & Keiliss-Borok, 1974). MSCs were first described as a fibroblast-
like stem cell subpopulation in the bone marrow, distinct from haematopoietic stem 
cells, able to give rise to skeletal tissues upon heterotopic transplantation. Caplan et 
al. in 1991 proposed the term “Mesenchymal Stem Cell” after showing in vitro 
differentiation of MSCs to cells of cartilage, bone, fat and muscle fate (Caplan, 1991).  
Since then, MSCs have been isolated from several other tissues: synovium, fat, 
placenta, Wharton jelly, heart, liver, etc. In an effort to create a consensus in the field 
about how to define MSCs isolated from different tissues, in 2006 the International 
Society for Cellular Therapy (ISCT) established that MSCs are plastic adherent cells 




or CD11b, CD34, CD45, CD79α or CD19, and HLADR. MSCs should show 
multipotency through their ability to differentiate into adipocytes, osteoblasts, myocytes 
and chondrocytes in vivo and in vitro, and be able to self-renew (Dominici et al., 2006).  
Currently, the idea that such defined MSCs are true progenitors of skeletal cell types 
of the mesodermal lineage is no longer considered accurate. Different studies have 
shown differentiation of MSCs into not only cells of mesodermal lineage other than 
skeletal, but also cells of ectodermal origin, such as neurons and epithelial cells. It is 
difficult to reconcile the exact implications of these studies. Mostly, they make the point 
that in vitro experimental conditions can lead to a variety of outcomes and artefacts.  
Nevertheless, the ability to obtain cartilage tissues in vitro has made MSCs an 
interesting tool for cartilage regeneration As MSCs offer a less invasive approach to 
treat both cartilage lesions and OA. The use of MSCs to treat cartilage damage has 
been largely explored in recent years and is well summarised in a review article by 
Iijima and colleagues (Iijima, Isho, Kuroki, Takahashi, & Aoyama, 2018). The field has 
generally moved away from the assumption that MSCs would differentiate into 
chondrocytes and form de novo cartilage at the site of damage. In the clinical studies 
that explored the therapeutic effect of bone marrow-derived- or adipose-derived-
MSCs, the isolated cells were administered as an intra-articular injection in the OA 
joint. After homing to the site of injury, MSCs are described to be present for only a 
limited amount of time and then no longer trackable. The disease-modifying effect 
detected in the damaged joints upon MSCs injection is thought to be due to the release 
of bioactive factors (growth factors, cytokines, miRNAs and mRNAs) that are 
immunomodulatory and trophic (Iso et al., 2007). 
For this reason, Caplan himself has proposed to change the name from Mesenchymal 
Stem Cells to Medicinal Stromal Cells, arguing that using the term “stem” is not just 
inaccurate but misleading (Caplan, 2017). Recent reports have highlighted that MSCs 
are beneficial and result in cartilage repair not by undergoing chondrogenic 
differentiation. Hence the term “medicinal” and these cells are acting more like drugs 
in situ that stem cells. 
 
1.6.4 Novel MSCs mechanism of action: extracellular vesicles (EVs) 
Despite MSCs being described more than 60 years ago, the exact mechanism of action 




paracrine signals, EVs have been suggested to be one of the mechanisms by which 
MSCs signal to other cells, other than through releasing growth factors and cytokines 
(Cosenza, Ruiz, Maumus, Jorgensen, & Noël, 2017).  
EVs are membranous vesicles secreted by a number of different cell types, in both 
normal and pathological conditions, including MSCs, chondrocytes and bone cells. The 
term “EVs” is used as a general term to describe several types of vesicles that includes 
exosomes, microvesicles, and apoptotic bodies (van der Pol, Böing, Harrison, Sturk, & 
Nieuwland, 2012). These subtypes can be discriminated by their function and 
biogenesis.  Because of their different origin, they display different membrane specific 
receptors that can be taken up specifically by other cells by ligand-receptor interaction 
to release intracellularly their cargo (van der Pol et al., 2012).   
 
 
Figure 7 Cell communication through EVs. 
EV cargo is sorted into two distinct EV populations: Exosomes or Microvesicles. 
Microvesicles are excreted in the intracellular space by membrane budding while 
exosomes are generated via inward budding of the multivesicular body. Cell 
communication through direct membrane fusion and release of EV contents into the 
target cell cytoplasm, or through endocytosis (original work).  
 
 
Microvesicles and exosomes are specifically an interesting subtype of EVs as their role 
is primarily cell-cell communication (fig. 7). Exosomes are generally sized 30-150 nm 




between cells. The cargo is mostly composed of coding and non-coding RNAs, lipids, 
and proteins (van der Pol et al., 2012).  
Currently, the use of exosomes derived from MSCs is being explored as an alternative 
therapy to MSCs transplantation for tissue regeneration (fig. 6C). The advantages are 
numerous: they have low immunogenicity, can be stored without losing function and 
have a long half-life, and being non-cellular are safer as a biological therapy (Lener et 
al., 2015). Already two studies using MSCs-derived EVs in human patients have been 
published. In one study EVs were administered to a patient suffering from steroid-
refractory graft-versus-host disease (Bader et al., 2018), the other study evaluated 
their effect on forty patients with chronic kidney disease. In both cases, the treated 
groups showed no side effect but also a significant improvement of clinical symptoms. 
The MSCs derived EVs showed both immunomodulatory (anti-inflammatory) and 
regenerative (increased presence of progenitor cells) effects. 
EVs are also studied in the context of cartilage damage and degeneration. In the last 
three years, the first studies showed that MSC-derived EVs indeed were able to induce 
osteochondral regeneration in vivo (Cosenza, Ruiz, Toupet, Jorgensen, & Noël, 2017; 
S. Zhang et al., 2018) and cartilage regeneration in vitro (Vonk et al., 2018). 
 
1.7 Limits and challenges - what is missing to achieve the optimal repair. 
Despite good outcomes of the listed therapies, a few shortcomings are linked to the 
techniques just described. First, the use of autologous cells in clinical therapy requires 
costly preparation and secondly, there is a lack of reproducibility between patients. In 
addition, the degree of repair is generally suboptimal (Knutsen et al., 2004). The quality 
of repair observed in various clinical trials using ACI, microfracture/subchondral drilling 
or MSCs cell therapy is highly heterogeneous and varies depending on age, sex, and 
most importantly size of the defect. It often displays fibrotic features and fails to 
reproduce the highly organised structure typical of hyaline cartilage which is 
instrumental to its ability to withstand loads and maintain the homeostasis of the tissue. 
This thesis argues that one important limitation preventing the development of a 
successful repair strategy is the lack of understanding of the cell and molecular biology 
of resident cartilage and their contribution to this repair. As discussed above, recent 
studies have highlighted how the superficial zone hosts chondroprogenitor cells. 




and therefore role in cartilage repair and in maintaining homeostasis than the 
chondrocytes from MDZ. Histogenesis, the process through which precursor cells form 
a tissue, and tissue repair share similar cell regulatory pathways.  These signalling 
pathways drive stem cell specification to produce the target tissue. Extracellular signals 
are sensed and transmitted by signalling molecules, the effector proteins of molecular 
pathways, resulting in specific gene transcription. The regulation of such pathways in 
cartilage development and histogenesis is still incomplete and limiting our 
understanding of cartilage regeneration. 
 
 
1.7.1 Developmental engineering 
The idea of regenerative medicine and tissue engineering as a novel approach to repair 
tissues using stem cells in combination with intelligent materials and bioactive 
molecules has greatly revolutionized modern medicine. Only a few decades after the 
introduction of this concept, relevant solutions for tissue repair have been developed. 
The translation of cartilage engineered tissues into clinical settings has had however 
several issues. Again, effective production of therapeutic engineered tissues or 
regenerative cell therapies has been hindered by the limited molecular and cellular 
understanding underlying regeneration of this tissue. The term developmental 
engineering has been proposed as a novel approach. The idea is to harness our 
knowledge of developmental pathways and use this information to imitate the natural 
mechanisms that control cell differentiation to achieve tissue repair. Important 
molecular mediators of cartilage development, maintenance and repair are growth 
factors such as connective tissue growth factors (CTGF, or Cellular Communication 
Network Factor 2, CCN2), insulin-like growth factor (IGF)-1, fibroblast growth factor 
(FGF), transforming growth factor (TGF)-β, bone morphogenic proteins (BMPs), and 
other signalling proteins including indian headghog (IHH) and parathyroid hormone-
related peptide (PTHrP). 
 
1.7.1.1 CTGF  
CTGF is a member of the CCN family of secreted proteins, which is an important 
inducer of ECM deposition and is expressed by chondrocytes in homeostatic and 
diseased cartilage (X. Tang et al., 2018). CTGF is known to drive the production of 




development as it stimulates chondrocyte proliferation and maturation of developing 
limbs (Ivkovic et al., 2003). CTGF KO mice do not survive after birth due to skeletal 
malformations (Ivkovic et al., 2003; Nuglozeh, 2017). CTGF was suggested to bind to 
TGFβ binding protein, and thus sequestering latent TGFβ in the matrix of cartilage in 
a heparan sulphate-dependent manner and controlling its release on cartilage injury 
(X. Tang et al., 2018).  
 
1.7.1.2 IGF1 
IGF-1 is a growth factor that shares 45% homology with insulin and is primarily 
produced in the liver, although is produced by many cells of the body, where it plays a 
role in embryonic development and postnatal growth. Immune cells, particularly 
lymphocytes and natural killer (NK) cells, are also responsive to IGF-1. IGF-1 has an 
important effect on cartilage as it regulates differentiation and apoptosis of ACs. In 
MSCs, administration of IGF-1 drives chondrogenic differentiation independently of 
TGFβ, and increased proliferation was also observed (Lara Longobardi et al., 2006).  
In support of the role of IGF-1 in proliferation, when antibodies against IGF-1 are added 
to chondrocytes, apoptosis is initiated in the cells (Loeser & Shanker, 2000).  Different 
studies have reported increased production of proteoglycans in vitro upon 
administration of IGF-1 (Z. Zhang et al., 2017). In OA, the IGF-1 and IGF-1 receptor 
(IGFBP-3) are expressed in ACs and upregulated (J. A. Martin & Buckwalter, 2000; 
Olney et al., 1996). IGF-1 was incorporated in a scaffold for cartilage repair. In vivo 
animal model showed that the addition to IGF-1 to the scaffold was beneficial in a full-
thickness cartilage defect for cartilage formation and integration (Z. Zhang et al., 2017). 
 
1.7.1.3 FGF 
FGF proteins are growth regulatory factors, and FGF2 is relevant to cells of 
mesenchymal origin, including MSCs and chondrocytes. FGF2 regulates MSCs growth 
and differentiation. For example, FGF2 is used in MSC culture expansion in vitro as it 
stimulates growth and the preservation of differentiation potential (Mastrogiacomo, 
Cancedda, & Quarto, 2001; Tsutsumi et al., 2001). 
FGF2 has a different and contrasting role in murine and human cartilage OA, probably 




mouse, Fgf2 has a chondroprotective effect. In OA mice models, both surgically 
induced and spontaneous, deletion of Fgf2 exacerbate cartilage degradation (Chia et 
al., 2009; Vincent, Hermansson, Bolton, Wait, & Saklatvala, 2002). After cartilage 
injury, cartilage ECM releases FGF2 which shows chondroprotective effects in murine 
joints (Chia et al., 2009). In human, FGF2 induces catabolic changes in cartilage. 
FGF2 activates signalling pathways through MAP kinases phosphorylation, that 
eventually results in transcription of target genes such as MMP13 (H.-J. Im et al., 2007; 
Muddasani, Norman, Ellman, van Wijnen, & Im, 2007). Through this mechanism, FGF2 
was also found to was found to inhibit the synergistic anabolic effects of IGF-1 and 
BMP7 in human ACs (Loeser, Chubinskaya, Pacione, & Im, 2005).  
FGF18 and FGF8 have been also been linked to cartilage homeostasis. FGF18 is an 
anabolic growth factor, affecting both chondrogenesis and osteogenesis depending on 
cell types (Moore et al., 2005; Ohbayashi et al., 2002). FGF18 in articular cartilage was 
found to reduce cartilage degradation and to have an anabolic effect on ECM 
deposition in rat post-traumatic osteoarthritis (Yao et al., 2019). FGF8 is growth 
regulatory factor that has a catabolic role in cartilage. When an anti-FGF8 antibody is 
injected into rat knee joints, ECM degradation is reduced, suggesting that  FGF8 might 
play a role in cartilage degeneration in OA (Uchii et al., 2008). 
 
1.7.1.4 TGFβ and BMPs 
Another extensively studied growth factor in cartilage tissue-engineering is 
transforming growth factor-beta1 (TGFβ1), which is central in the development and 
differentiation of chondrocytes. TGFβ signalling has an important in the maintenance 
articular cartilage homeostasis alterations in the pathway leads to OA (Serra et al., 
1997; Shen et al., 2013). The TGFβ superfamily, including TGFβ1, TGFβ2, TGFβ3 and 
bone morphogenic proteins (BMPs), have a major role in all stages of chondrogenesis. 
TGFβ is the key factor that drives MSCs differentiation to chondrogenic fate 
(Johnstone, Hering, Caplan, Goldberg, & Yoo, 1998). The SMAD- ( the abbreviation 
refers to the homologies to the Caenorhabditis elegans SMA, "small" worm phenotype, 
and Drosophila MAD, "Mothers Against Decapentaplegic“ family of genes) dependent 
TGFβ signalling pathway is well understood. Type I and II receptors, also known as 
activin receptor-like kinases (ALKs) can start the signalling cascade. Signal 




SMAD 1/5/8 phosphorylation. Alternatively, TGFβ binds ALK 4, 5, and 7 which induce 
pathway activation SMAD 2/3 phosphorylation. The former is considered the TGFβ 
superfamily canonical signalling pathway (Tuli et al., 2003; Zhang, 2009). BMPs are 
regulated by different inhibitors that by competitively interacting with BMPs ligands 
block their binding to the receptor. These inhibitors include Noggin, inhibitory SMADs 
(SMAD6 and SMAD7), and SMAD Specific E3 Ubiquitin Protein Ligases (SMURFs), 
which can ubiquitinate BMP receptors as well as ligands (Itoh et al., 2001; Neul & 
Ferguson, 1998; Zhu, Kavsak, Abdollah, Wrana, & Thomsen, 1999). BMP2 enhances 
mesenchymal differentiation to the cartilage lineage through upregulation of the master 
regulator of chondrogenesis SOX9 (Jin et al., 2006). TGFβ signalling through the 
activation of the mitogen-activated protein kinase (MAPK) pathways results in 
stimulating chondrogenesis (Mu et al., 2012; Tuli et al., 2003; Zhang, 2009). SMAD 
turnover is critically regulated by the E3 ubiquitin ligases SMURF1 and SMURF2, 
which are recruited by SMAD6 and SMAD7. SMAD7 inhibits SMAD signalling, while 
SMAD6 acts selectively to inhibit the SMAD1/5/8 pathway.  
BMPs are investigated to find an efficient dosage and mix of molecular cues to achieve 
proper MSCs differentiation into stable cartilage for cartilage tissue engineering 
purpose or used to induce repair of cartilage damage in vivo. BMP2 is expressed 
during mesenchymal condensation in limb development expression (Ducy & Karsenty, 
2000) and is also expressed in adult MSCs (Kovermann et al., 2019). For cartilage 
reparative reasons, BMP2 use was explored in tissue engineering strategies with good 
reparative outcomes (Vayas, Reyes, Arnau, Évora, & Delgado, 2019). BMP6 has been 
shown to upregulate expression of cartilage ECM proteins such as namely type II 
collagen and aggrecan while inhibiting the expression of the hypertrophic chondrocyte 
marker, type X collagen (Estes, Wu, & Guilak, 2006). BMP7 also can induce matrix 
synthesis and promote repair in cartilage (X. Huang, Zhong, Post, & Karperien, 2018; 
Kuo et al., 2006).  
Tissue engineering approaches to use TGFβ signalling to repair cartilage in vivo has 
shown promising results and is ongoing (Madry, Rey-Rico, Venkatesan, Johnstone, & 





1.7.1.5 IHH and PTHrP 
IHH is a member of the Hedghog family which is involved in cartilage development. 
IHH interacts with other major signalling pathways in joint and cartilage development, 
and its expression is regulated by a variety of peptides. The most well-studied peptide 
interaction is the IHH/PTHrP negative feedback loop. In the growth plate, IHH has a 
key role in regulating chondrogenic differentiation in concert with PTHrP. Pre-
hypertrophic chondrocytes express IHH, and when its expression is altered, 
chondrocytes stop proliferating and undergo hypertrophic differentiation (Lanske et al., 
1996).  IHH induces the expression of  PTHrP, establishing a negative feedback loop 
that affects the rate of chondrocyte differentiation (Lanske et al., 1996). PTHrP induces 
the expression of cartilage master regulator SOX9 and by increasing cell proliferation 
through induction of cyclin D1 (CCND1) (M. Zhang et al., 2009). In adult MSCs, PTHrP 
has been shown to induce chondrogenic differentiation and in chondrocytes  (Fischer, 
Ortel, Hagmann, Hoeflich, & Richter, 2016; Kafienah et al., 2007), it prevented their 
hypertrophic differentiation (Bach et al., 2014). When injecting intra-articularly in 
osteochondral defects in animal models, PTH stimulated tissue regeneration in vivo 
(Kudo, Mizuta, Takagi, & Hiraki, 2011). PTHrP is key to maintain chondral phenotype 
in native cartilage, and its effect has been exploited to attempt to maintain the 
chondrogenic profile of in vitro expanded ACs for ACI (Rutgers et al., 2019). 
 
1.8 DACTs: Wnt and TGFβ pathways regulators 
 
1.8.1 Wnt signalling pathway 
Wnt signalling pathways are initiated by Wnt proteins (a family of glycoproteins that 
includes 19 members in mammals) to regulate aspects of embryonic development, 
including chondrogenesis, and tissue homeostasis of all joint tissues (Lories, Corr, & 
Lane, 2013). Mutations in Wnt genes have been shown to be associated with skeletal 
malformations, osteoporosis, and dwarfism and more generally with joint disorders. 
 
The canonical Wnt pathway transmits signals within cells by regulating the levels of 
cytoplasmic β-catenin. When Wnt proteins are not present, the β-catenin levels are 
kept in a steady state.  When Wnt proteins are present and bind to their membrane 




and 6 (LRP5/6), a signalling cascade starts. In the canonical pathway, this cascade 
leads to β-catenin stabilisation, allowing β-catenin to translocate to the nucleus and 
upon binding to T-cell factor/lymphoid enhancer-binding factor TCF/LEF transcription 
factors result in the transcription of target genes. FZD binds to Dishevelled (DVL), 
which allows the recruitment of axin-GSK3 (glycogen synthase kinase 3) complex. This 
complex promotes the phosphorylation of LRP6 that inhibits the destruction complex 
(composed of AXIN, GSK3, DVL, and Casein Kinase 1), allowing β-catenin 
accumulation.  
The non-canonical pathway is β-catenin independent and can be subdivided into the 
Planar Cell Polarity (PCP) pathway and the Wnt/Ca2+ pathway.  
The Wnt pathways are shown in figure 8. 
 
  
Figure 8 Canonical and non-canonical WNT signalling pathways. 
When Wnt signal is not present (A), β-catenin is phosphorylated by a destruction 
complex consisting of APC, CK1, axin and GSK3β. This complex targets β-catenin for 
ubiquitination and then gets degraded by the proteasome. Depending on the ligand, 
FZD receptors activate the WNT canonical (B) or non-canonical pathways (C). 
Inhibitors of Wnt pathway can be Wnt inhibitory factor 1 (WIF), Secreted frizzled-
related protein 1 (sFRPs), Dickkopf-related protein 1 (DKK1) and sclerostin. Binding of 
a Wnt ligand initiates a cascade of signals, starting with the recruitments of DVL which 
phosphorylates and activates LRP that then binds to Axin. The destruction complex is 
then dismantled so that dephosphorylated (active) β-catenin can accumulate and then 
translocate to the nucleus. In the nucleus, β-catenin binds to TCF/LEF to regulate the 
expression of Wnt target genes. Non-canonical pathways also rely on the Frizzled 
receptor. In the PCP pathway, DVL activate RAC and RHOA to regulate JNK activation 




to raise intracellular Ca2+ levels, which led to specific gene expression regulation. 
Image from C. Warboys (Warboys, 2018). 
  
Wnt signalling is required during the development of all the tissues of the knee and 
involved in maintaining in an undifferentiated state, precursor cells (ten Berge, 
Brugmann, Helms, & Nusse, 2008). WNT3a is a key regulator of self-renewal, it 
maintains the potency of MSCs as well as improves their chondrogenic capacity 
(Boland, Perkins, Hall, & Tuan, 2004; Narcisi et al., 2015). It is possible that this is also 
true in vivo, as Wnt signalling is required to sustain the function and regulate 
chondroprogenitor rich cartilage SZ. Yasuhara et al. showed that by upon Wnt3a 
stimulus, SZ chondrocytes proliferate while maintaining PRG4 expression. If the β-
catenin expression is blocked, proliferation and phenotypic expression are stopped 
(Yasuhara et al., 2011). 
 
1.8.2 Wnt signalling and osteoarthritis  
Alteration of molecules that belong to the Wnt pathway is involved in cartilage 
pathologies. Human genetic studies have identified genes for these molecules which 
are potentially linked to OA development. The gene sFrp3 codes for sFRP3 which a 
negative regulator of Wnt signalling. When a single-nucleotide polymorphism (SNP) is 
present in sFrp3, an increased risk for OA in weight-bearing regions of the joint is 
present (Loughlin et al., 2004; Min et al., 2005).  
Despite signalling role for Wnt in maintaining the cartilage progenitor subpopulation, 
Wnt pathway activation results in the catabolic breakdown of cartilage matrix. 
Activation of β-catenin in articular chondrocytes in adult mice leads to the development 
of an OA-like phenotype (Zhu et al., 2009) and β-catenin levels are increased in human 
OA samples (Yuasa, Otani, Koike, Iwamoto, & Enomoto-Iwamoto, 2008). 
Both negative and positive regulators of Wnt signalling are altered in OA.  
Wnt1-inducible-signalling pathway protein 1 (WISP-1) is upregulated both in human 
and murine OA cartilage and synovium, regulating chondrocyte and macrophage MMP 
and aggrecanase expression (Blom et al., 2009). 
Dickkopf-1 (Dkk-1) is a protein secreted by cells and inhibits Wnt/β-catenin signalling 
by binding competitively to the LRP5/6 co-receptors of FZD (fig. 8). DKK1 is present in 





Sclerostin is another inhibitor of Wnt which is deregulated in OA (fig.8) (Chan et al., 
2011). Studies in OA mouse models suggested that Sclerostin plays a role in 
preserving articular cartilage integrity. In a Sclerostin knockout mouse, upon OA 
induction cartilage degradation is increased (Bouaziz et al., 2015). When Sclerostin 
treatment was applied to chondrocytes, Wnt canonical and non-canonical pathways 
were inhibited, preventing cartilage matrix catabolism (Bouaziz et al., 2015). 
As previously discussed, mechanical loading is a central factor in OA development and 
progression (S. J. Gilbert & Blain, 2018). It is well established that Wnt pathways are 
modulated by mechanical loading but how exactly they contribute to cartilage 
degeneration is still unclear. Novel studies are unravelling the mechanism by which 
proteoglycans are sequestering Wnt ligands and suggest that blocking or reducing Wnt 
signalling could protect cartilage from degradation (Praxenthaler et al., 2018). 
 
The regulation of the Wnt pathway in OA has been one of the main topics of research 
in the quest to find a therapy.  Several inhibitors and modulators of Wnt signalling have 
been developed and are entering clinical trials, including OA treatment (Yazici et al., 
2017). Further insight into the regulation of the Wnt pathway could greatly advance not 
only our current understanding of cartilage degeneration and repair but also offer novel 
targets for therapy. 
 
1.8.3 DACT protein family 
Dishevelled antagonist of β-catenin (DACT, or Dapper, or Frodo) are vertebrate 
proteins that were first described in Xenopus laevis and then in other organisms as 
binding protein of DVL, a cytoplasmic protein central to Wnt signalling (Cheyette et al., 
2002; Gillhouse, Wagner Nyholm, Hikasa, Sokol, & Grinblat, 2004; Gloy, Hikasa, & 
Sokol, 2002; Hunter, Hikasa, Dymecki, & Sokol, 2006; Long Zhang, Gao, Wen, Ning, 
& Chen, 2006).   
Three homologous proteins exist in humans: DACT1, DACT2 and DACT3 and each 
has been shown to have a different role in different tissue types. In zebrafish, DACT1 
has an effect on the Wnt canonical pathway, whereas DACT2 has a greater impact on 
the Wnt/PCP pathway (Waxman, Hocking, Stoick, & Moon, 2004). In both zebrafish 
and mammalian cells, DACT2 can inhibit Nodal signalling by targeting for degradation 
TGFβ receptor, ALK4 (L. Zhang et al., 2004). Despite the documented role of DACT 




cartilage at different stages of development, adult homeostasis and degeneration, 
DACTs have not been studied extensively in joint tissues. 
 
1.8.4 DACT1 
DACT1 is highly conserved in vertebrate animals, suggesting its important 
physiological role. Dact proteins were first discovered in Xenopus laevis as a ligand of 
Dvl, which indicated its role as a Wnt pathway inhibitor (Cheyette et al., 2002). 
The role of Dact in developmental biology was investigated in a classic mouse genetic 
knockout study by Wen et al. (Wen et al., 2010). Because Wnt plays a major role in 
embryogenesis, the study showed that Dact1 knockout has indeed a fundamental role: 
loss of Dact1 leads to embryological malformation in mice including neural tube 
defects, a shortened and/or curly tail, no genital tubercle, anorectal malformation, 
hydronephrotic kidneys, and loss of bladder. The severe posterior malformation 
observed in Dact1−/− mouse is explained by alteration of the Wnt/PCP pathway 
following high Dvl levels (Wen et al., 2010). 
DACT1 is well studied in malignancies, as it has been found to be differentially 
expressed in many cancer types. In hepatic, gastrointestinal and non-small-cell lung 
cancer, Dact1 expression is reduced (Astolfi et al., 2010; Yang et al., 2010; Yau et al., 
2005). In these malignancies, DACT1 seems to regulate the Wnt pathway by targeting 
for degradation DVL resulting in β-catenin cytoplasmic accumulation.  On the other 
hand, in colon and squamous carcinomas, DACT1 is overexpressed and is suggested 
to regulate autophagy (Jian Hou et al., 2011; Yuan et al., 2012).  
Several other studies on Dact1 have been carried out on cells from different tissues. 
DACT1 is also expressed in the brain. In mouse, Dact1 is expressed in the forebrain, 
and hippocampus of mouse embryos (Okerlund et al., 2010). It is thought to participate 
in neuronal maturation in a β-catenin-independent biochemical pathway. Dact1 also 
participates in the maturation of these neurons postnatally (Okerlund et al., 2010). 
In cardiomyocytes, DACT1 regulates the non-canonical PCP pathway. DACT1 
inhibition resulted in hypertrophy of cardiomyocytes and acts downstream of WNT5a.  
In kidney cells, DACT1 was shown to be upregulated by TGFβ1 resulting in cell 
apoptosis (Jardim, Poço, & Campos, 2017).  
In human and murine fat-derived-MSCs during in vitro adipogenesis, DACT1 




differentiation is blocked in a mouse cell line of pre-adipocytes. This suggests that 
Dact1 has a role in maintaining an undifferentiated phenotype (Lagathu et al., 2009) 
Sirtuin 1 (Sirt1) acts as an inhibitor of MSC adipogenic differentiation by epigenetic 
regulation of different genes, including Dact1. Both studies were performed in mouse 
cell lines, and it remains to be shown if the same is true for human pre-adipocytes/fat-
derived-MSCs (Zhou et al., 2016). 
These studies illustrate how the role that DACT1 plays in modulating the Wnt pathway 
is highly dependent on cell and tissue contexts. 
 
1.8.4.1 DACT1 in cartilage 
Only a few published studies discuss DACT1 in cartilage tissues. The first published 
in 2014, links Dact1 and Dact2 to chick limb development (Sensiate et al., 2014). Dact1 
expression is described in the undifferentiated limb mesenchyme at the region forming 
joints.   
In a study by Chou et al., DACT1 was described to be downregulated in chondrocytes 
found in severely damaged human cartilage. This study compared the expression 
DACT1 in osteoarthritic cartilage from the weight bearing condyle to the non weight-
bearing condyle of patients undergoing total knee replacement. DACT1 was 
downregulated in severe OA specimens (Chou et al., 2015). 
Most recently, a small-molecule inhibitor of the Wnt pathway (SM04690) was 
developed by the company Samumed (San Diego, USA) and is being explored for the 
treatment of articular OA. On May 2nd 2019 it was announced that a Phase 3 clinical 
trial was underway (“Samumed Launches Phase 3 Lorecivivint (SM04690) Clinical 
Program in Knee Osteoarthritis”). In the work published by Samumed researcher 
Deshmukh and his colleagues, SM04690 was able to drive chondrogenic 
differentiation of BMSCs and when injected into a rat OA model showed cartilage 
regeneration (Deshmukh, Seo, Swearingen, & Yazici, 2018). The Wnt pathway 
inhibitor SM04690 acts by targeting two kinases, CDC Like Kinase 2 (CLK2) and Dual 
Specificity Tyrosine Phosphorylation Regulated Kinase 1A (DYRK1A), which result in 
the upregulation of DACT1 (Deshmukh, Seo, Swearingen, & Yazici, 2018). This 
pathway was however only tested in a colon cancer cell line. 
Despite these interesting reports and involvement of DACT1 in cartilage, no work has 





1.8.5 DACT2  
As it can bind and facilitate Alk5 degradation, DACT2 has been described as a 
suppressor of TGFβ-dependent wound healing and Nodal-dependent mesoderm 
induction (Zhang et al., 2004). Dact2, mainly by binding to the Alk4/5 receptors, 
promotes their degradation (Zhang et al., 2004). 
Dact2 expression is most prominent during organogenesis of the thymus, kidneys, and 
salivary glands, with much lower levels found in the somites and the developing CNS 
(Fisher et al., 2006). Compelling evidence of the different roles and activities of Dact 
family members was provided by the mouse mutant Dact2-/-. These mutant mice, not 
only are not affected during embryogenesis but also show no major abnormalities at 
birth (Meng et al., 2008). However, an effect on wound healing, probably resulting from 
TGF-β signalling was observed in Dact2-/- mice (Meng et al., 2008). 
Similarly to DACT1, DACT2 is largely studied in cancer as its altered expression is 
associated with several different carcinomas. DACT2 mechanism of action differs in 
cancers that can be found in different tissues. DACT2 was showed to act as a cancer 
suppressor in breast cancer and it is often epigenetically silenced in affected patients 
(Guo et al., 2018). It acts by blocking the Wnt canonical pathway resulting in 
suppression of epithelial-to-mesenchymal transition. DACT2 is also a tumour 
suppressor gene in colon cancer through inhibiting Wnt/β-catenin signalling and the 
DACT2 gene shows hypermethylation in patients (Wang et al., 2015). DACT2 
expression was shown to be reduced in gliomas. In glioma cells, DACT2 acts as a 
negative regulator of the Wnt canonical pathways by preventing Yes-associated 
protein translocation to the nucleus (Tan et al., 2017). DACT2 interferes with the TGFβ 
pathway in oesophageal cancer. Hou et al. showed that an increase in DACT2 
correlates with poor survival of patients with oesophageal cancer (J. Hou et al., 2013).  
 
1.8.5.1 DACT2 in cartilage 
In limb development, Dact2 expression localised with Dact1, Sox9 and Gdf5 (Sensiate 
et al., 2014). Sensiate et al., suggest that Dact2 could act as an inhibitor of TGFβ 
signalling in the interzone, to suppress chondrogenesis and promote joint formation 
(Sensiate et al., 2014). Their work does not provide any mechanisms through which 




 Recently, Dact2 was shown to be significantly more expressed in the superficial zone 
of articular cartilage (Mori, Chung, Tanaka, & Saito, 2014). Using laser microdissection 
of rat articular cartilage, Mori and colleagues were able to isolate SZ chondrocytes and 
compare their expression to deeper chondrocytes. Dact2 was among the 20 most 
upregulated genes in the SZ (Mori et al., 2014). 
 
1.8.6 DACT3 
The third Dact paralog is the most recently identified. When the Dact3 amino acid 
sequence is aligned to its paralogs, mouse Dact3 is more similar to Dact1 (27% 
alignment) then to Dact2 (24%) (Fisher et al., 2006). Dact3 is expressed in the limb 
bud and somites, as well as the central nervous system during development.  A mouse 
mutant Dact3−/− was developed by Xue et al. showing that Dact3 is not as 
fundamentally important in embryogenesis as Dact1 (Xue et al., 2013). Mutant mice 
have a reduced body weight compared to wild type controls but mostly show a 
phenotype in kidneys where the loss of Dact3 results in renal fibrosis through regulation 
of the canonical Wnt/β-catenin pathway (Xue et al., 2013). Like its 
paralog DACT1, DACT3 acts a regulator of canonical Wnt pathway and is 
transcriptionally downregulated in colorectal cancer (Jiang et al., 2008; H. Zhao et al., 





2 Thesis Aims  
The development of effective regenerative therapies to treat cartilage defects should 
derive from an in-depth understanding of the cell populations that participate in repair. 
In the context of bone marrow stimulation techniques to heal cartilage defects, 
understanding the contribution of resident chondrocytes to the repair is of great 
importance to implement the treatment, as it would allow stratification of patients that 
would determine best candidates for these regenerative approaches. Further progress 
must be made in understanding the mechanisms that regulate chondrocyte-progenitor 
(MSCs) interaction and communication. A better understanding of the differences 
between cartilage subpopulations and how these different chondrocytes regulate 
cartilage homeostasis and contribute (if they do) to repair. The specifics of such 
crosstalk are still largely undescribed, in particular, at cartilage subpopulation level. A 
better understanding of the differences between superficial and deeper chondrocytes 
is missing. In addition, because of the known importance of Wnt and TGFβ signalling 
in ensuring development and homeostasis of joint tissues, regulators of these 
pathways are optimal candidates for studying the regulations of progenitor cartilage 
cell populations.  
Dact2 was identified in rodent cartilage to be significantly more expressed in the 
superficial zone. Given the presence chondroprogenitors in the superficial zone and 
the role of Wnt in maintaining MSCs in an undifferentiated state, the hypothesis is that 
DACTs might have an important role in pre-chondrocytes. To date, there is no thorough 
study of DACT proteins in cartilage homoeostasis and disease. DACT proteins could 
be interesting mediators of the cartilage reparative process as they are present in the 
superficial, stem cells/progenitors enriched zone of articular cartilage.  A better 
understanding of how Dact proteins regulate early chondrogenesis and development 











The aims of this thesis are therefore: 
1. To resolve at a subpopulation level the cell communication in a model of 
subchondral drilling (Chapter 4).  
  
Objectives: 
• Develop an approach to reproducibly isolate chondrocyte subtypes based on 
distinct cartilage zones. 
• Determine the cytokine profile secreted by cartilage from different zones. 
• Study the miRNA cargo of EVs produced by chondrocytes from different 
zones. 
• Analyse the influence of chondrocytes from different cartilage regions on MSC 
chondrogenesis. 
 
2. To determine the presence of DACT1 and DACT2 in articular development 
and adult knees (Chapter 5). 
 
Objectives:  
• Study DACT proteins expression in different joint tissues at different point of 
development: 
o In adult human healthy and osteoarthritic articular cartilage and 
synovium. 
o in mouse developing joints and juvenile joints. 
o In bone marrow-derived- and synovium-derived-MSCs. 
 
 
3. To investigate the role of DACT1 in MSCs (Chapter 6). 
 
Objectives: 
• Determine DACT1 and DACT2 expression in MSCs chondrogenic 
differentiation 
• Elucidate the role of DACT1 and DACT2 by RNAi. 
• Individuate Dact1 targets by RNA sequencing. 





3.1 Cell isolation and culture 
Cells and tissue work were carried out in standard aseptic technique in a Category 2 
certified biological safety cabinet. Cells were incubated at physiological 5 % CO2 and 
21 % O2, and 37 ℃ humidified temperature. Cell culture media was changed twice per 
week during cell expansion. For long term storage, cells were cryopreserved in liquid 
nitrogen. For cryopreservation cells were re-suspended in a specific cryopreservation 
medium (FCS, 10% dimethyl sulfoxide, DMSO (Sigma) and transferred in cryovials. 
When required, cells were thawed in 37 °C water, transferred to complete media and 
media was refreshed the following day.  
Passaging of cells was performed at 70-80% confluence by adding pre-warmed 
TrypLE Express (Thermo Fisher Scientific) to detach cells from plastic. Cells were 
recovered from suspension by pelleting at 300 x g for 5 minutes and then resuspended 
for counting or seeding. Cells were then counted manually using Glass Slide 10 with 
Grids (Kova International). Cells were seeded at a concentration that would ensure 
40% confluence (for MSCs, 4,000 cells/cm2). 
When cells were obtained from patient tissues, that was done in accordance with 
Addenbrookes hospital ethics directives. All tissue samples were collected after 
obtaining written informed patient consent under the Cambridge Local Research Ethics 
Committee approval (No. 06/Q0108/213) 
3.1.1 Isolation and Culture of human MSCs from Bone Marrow 
Human bone marrow-derived MSCs (BMSCs) used in the thesis were either purchased 
from Lonza or isolated from patients’ tissues. 
Adult human MSCs were obtained from bone marrow femoral biopsies of donors 
undergoing total knee replacement. Upon given informed consent from donors, about 
5 mL of bone marrow wash-out from the femoral bone was filtered in 70 µm filters 
(MACS) and then seeded on plastic flask in alpha-MEM (GIBCO) supplemented with 
10% FCS, 25 µg/mL ascorbic acid-2-phosphate, 1 ng/mL  FGFb (AbD Serotec), 
penicillin-streptomycin (Thermo Fisher Scientific) (From now referred to as MSC 
Expansion Medium). 48 hours after seeding unattached cells and debris were 




passaged After 4-5 days colonies were observed and enzymatically detached and 
expanded. BMSCs obtained from patients used in this thesis were not characterised 
by antigen marker profile, other cells isolated with the same method in the laboratory 
were phenotypically characterised and resulted positive for CD105, CD166, CD29, 
CD44 and negative for CD14, CD34, CD45, confirming they are MSCs. Pre-
characterised human mesenchymal stem cells (Lonza) were also used. The supplier 
ensures multipotency at least till passage 5, and the cells express the essential 
markers according to the international standards for MSCs. Lonza BMSCs were used 
at passage 4-6 in the experiments. 
3.1.2 Isolation and culture of human Synovial Membrane-MSCs 
MSCs from synovial membrane tissue (SynMSCs) were obtained from the synovium 
lining the fat pad of patients undergoing total knee replacement at Addenbrooke’s 
hospital. The synovial membrane was washed in Phosphate-Buffered Saline (PBS) 
and cut in small pieces before being incubated overnight in 2 mg/ml Collagenase A 
(Roche, Germany) at 37 ℃ on a shaker. The following day, the cell suspension was 
filtered through a 70 um filter and single cells were plated at 10,000 cells/cm2 in MSC 
Expansion Medium. After 48h, cell debris and cell in suspension were removed and 
new medium was added to the attached cells. Once colonies formed, cells were 
passaged and expanded or directly used for experiments. Medium renewal was done 
twice weekly and cells were passaged up to passage 3 for the experiments when they 
reached 80% confluence. 
3.1.3 Chondrogenic Differentiation 
One of the key characteristics of MSCs is their ability to undergo tri-lineage 
differentiation in vitro when specific morphogenic stimuli are present. To determine the 
ability of MSCs to undergo chondrogenic differentiation, the following protocol was 
followed. 
Before reaching confluence, MSCs were harvested and 250,000 cells were pelleted in 
a 15 mL plastic tube at 300 x g for 8 min. Pellets were cultured in chondrogenic medium 
containing DMEM-high-glucose GlutaMAX+ (GIBCO), 1:100 insulin, transferrin, and 
selenium (ITS+: BDBiosciences), 40 µg/mL L-proline (Sigma-Aldrich), 1 mM sodium 
pyruvate (GIBCO), 100 nM dexamethasone (Sigma-Aldrich), 10 ng/mL transforming 




refreshed twice a week. For the co-culture experiments, MSCs between passage 4-5 
were used; these still possessed tri-lineage differentiation potential (as certified by the 
producer). Pellets were transferred to a trans-well for starting co-culture 24 hours after 
preparation or kept in culture for 24 days in DMEM with additional 10% FCS. 
3.1.4 Isolation and Culture of Human Chondrocytes from Superficial, 
Middle/Deep and Osteoarthritic Articular Cartilage 
Articular cartilage was obtained from different patients undergoing total knee 
replacement, following full consent from the donor to participate in the study. Within 2 
hours of the operations, superficial and middle-deep cartilage chips of 150-200 µm 
were obtained with a dermatome (Swann-Norton, UK) from the “control” cartilage 
condyle, lateral condyle, hereafter referred to as superficial zone (SZ) and middle-deep 
zone (MDZ) chips. The use of lateral condyle when macroscopically non affected by 
OA is a generally used and valid approximation as showed by genome studies 
(Tachmazidou et al., 2019).  From cartilage presenting fibrillated osteoarthritic parts, 
chips were removed around the fibrillations. Chips from fibrillated osteoarthritic regions 
of the cartilage are indicated osteoarthritic zone (OAZ) chips. Full-thickness cartilage 
samples were also obtained for evaluating tissue histological features. 
Part of the chips was digested overnight in 6mg/mL Collagenase A (Roche) on a 
shaker at 55 rpm at 37 °C 5% CO2. The following day, the digested cartilage was 
strained with a cell strainer (70 µm pores) to ensure a single cell suspension and 
consequently seeded in Dulbecco's Modified Eagle Medium (DMEM, ThermoFisher) 
supplemented with 10% Fetal Calf Serum (FCS) and 100 U/mL Penicillin/Streptomycin 
(Invitrogen) at 8000 cells/cm2 density. Chondrocytes from SZ, MDZ, and OAZ were 
cultured either in normoxic (21 % O2) or in hypoxic (5% O2) condition. 
The remaining cartilage chips were transferred to a 24 well plate well containing 500 
µl of DMEM supplemented with 25 µg/mL ascorbic acid-2-phosphate (Sigma-Aldrich), 
1:100 insulin, transferrin, and selenium acid (ITS+, BDBiosciences), 100 U/mL 
Penicillin/Streptomycin (Invitrogen) and 50 µg/mL L-Proline. 
3.2 Colony Forming Unit Assay 
In vitro self-renewal capacity of progenitors present in the different zones was 




performed by seeding 100, 200 or 300 chondrocytes from each zone (SZ, MDZ, or 
OAZ) in DMEM in 6-well plates. The plates were incubated in the hypoxic incubator 
and refreshed twice a week. On the 10th day from plating, each well was washed twice 
with 1x PBS (Gibco) and then fixed for staining with 4% formalin for 20 minutes. After 
fixation, the wells were washed twice with PBS and a 1% Crystal Violet solution was 
added and left for 40 minutes incubation. Finally, wells were washed with distilled water 
to remove staining solution excess and plates left to dry. The number and size of the 
colonies were determined by using ImageJ (NIH). Chondrocytes at passage 1 were 
used for this experiment to prevent the loss of chondrogenic phenotype during 
passaging. 
 
3.3 Co-culture of chondrocytes and MSCs 
For co-culture conditions, a 0.8 µm pore transwell (Corning®) containing MSCs pellets 
(day 1) was inserted into the well containing different zonal chips. DMEM with 1% FCS 
and 100 U/mL Penicillin/Streptomycin (Invitrogen), referred as “basal medium”,was 
refreshed twice weekly and the harvested media from each condition (total of 1 mL) 
was conserved for downstream analyses or stored at – 70 °C. 21 days after pellet 
formation, the different components were harvested for gene expression analysis or 
for histology. 
 
3.4 Proliferation and Viability Assays 
3.4.1 XCELLingence 
To measure cell proliferation, cells were seeded on E-Plates (ACEA Bioscience) and 
cell adherence was measured by an XCELLigence System RTCA DP. This device can 
provide a real-time measure of electrical impedance allowing to determine changes on 
the plate surface covered by cells rendered with a parameter termed “cell-index”. The 
cell-index can, therefore, be used as a measure of cell proliferation over time. 
A blank reading (cell culture medium only) is first measured to blank the XCELLigence 
System, and then the cells are seeded onto the E-Plate well and left to settle for 30-40 




used, with each condition performed in technical duplicate. The plate device was then 
inserted in the xCELLigence cradle and the measurements were carried out every 15 
minutes for up to 96 hours, and medium refresh was performed once. Cell-index values 
were normalised at the time at which treatment was added, and exported using the 
XCELLigence RTCA software (v2.0).  
3.4.2 CyQUANT Assay 
Cell proliferation was measured with a second technique using the CyQUANTDirect 
Cell Proliferation Assay Kit (Thermo Fisher Scientific). The kit allows determining the 
number of living cells present in a well, both adherent and non-adherent, by linking a 
cell-permeant fluorescent dye to DNA. Because of the presence of a masking die in 
the solution, only alive cells are stained, and the assay can determine both 
proliferation and cytotoxicity. 
To test for cell proliferation and cytotoxicity, MSCs were plated in a 96 well plate at cell 
density of 4,000 c/cm2. On the day after plating, the cells were treated and the 
CyQUANT assay was performed after 24 h or 48 h. 100 µl of 2X detection agent, which 
contains CyQuant® Direct nucleic acid stain, CyQuant® Direct background suppressor 
I  and PBS in 0.004:0.021:1 proportion, was added to each well containing cells and 
incubated at  37 °C for 1 hour. After the incubation, the fluorescence was measured at 
an excitation wavelength of 480 nm and emission of 520 nm using a FluoStar Optima 
plate reader (BMG Labtech). 
 
3.5 Cell Imaging Techniques and Analysis 
3.5.1 Standard Light Microscopy 
Cell morphology was assessed and imaged using a phase-contrast Leica DM IRB 
Inverted Brightfield microscope. Images were acquired with a microPublisher 3.3 RTV 
camera.  
3.5.2 Immunocytochemistry 
Immunocytochemistry allows the visualisation of proteins using antibodies for specific 
target antigens. The unconjugated primary antibody, when added to fixed cells, is able 
to bind to a target antigen. A fluorophore-conjugated secondary antibody is then added 




were conjugated with AlexaFluor488 or AlexaFluor555 (Invitrogen). These are 
subjected to short-wavelength, high energy light which is absorbed and emitted to a 
lower energy as light of a longer wavelength. The light emitted from the antibodies that 
are binding with high specificity to a cellular protein is detected using a fluorescence 
microscope. This technique enables multiple secondary antibodies to bind to one 
primary antibody, to amplify the detection signal. However, there is a higher chance of 
background signals, due to antibody cross-reactivity or non-specificity. 4',6-diamidino-
2-phenylindole (DAPI) (Sigma Aldrich) was used as a counterstain, as it binds to AT-
rich regions of DNA within the nucleus.  
MSCs and ACs were seeded in an 8-well Millicell® EZ Slide (Millipore) at a density of 
1 x 1,000 cells/well. At the end of the experiment, the medium was removed and the 
cells were washed twice with PBS and fixed with 4% paraformaldehyde for 15 minutes. 
After washing twice with PBS, the cells were permeabilised for five minutes with 0.2% 
Triton-X-100. Blocking was performed for twenty minutes with 10% PBS-Goat serum 
(blocking buffer), before incubating with the primary antibody solution overnight at 4°C. 
Cells were then washed three times for 5 minutes with blocking buffer before incubating 
with secondary antibodies diluted in blocking buffer. To visualise actin in the 
cytoskeleton, a 20-minute incubation of   Alexa Fluor® 555 Phalloidin (Thermo Fisher). 
Primary and secondary antibodies and concentrations used for immunofluorescence 
are listed in Table 1. A coverslip was adhered to the slide using ProLong® Diamond 
Antifade Reagent with DAPI (Invitrogen) and visualised using the SP5 confocal 
microscope (Leica) with a Retiga EXi fast 1394 camera (QImaging). Images were 
analysed using Q-Capture Pro 6 software, ICY and FIJI (De Chaumont et al., 2012, 









Table 1 Antibodies used for immunocytochemistry 
Antigen ID Species Company Dilution 
Primary antibodies 
DACT1 ab51260 Rabbit pAb Abcam 1:500 
DACT2 ab79042 Rabbit pAb Abcam 1:500 
Type II Collagen ab34712 Rabbit pAb Abcam 1:500 
β-catenin C2206 Rabbit pAb Sigma 1:500 
Active β-catenin 05-665 Mouse mAb Millipore 1:500 
Secondary antibodies 
Anti-Rb Alexa Fluor® 488 ab150077 Goat Abcam 1:1000 
Anti-Ms Alexa Fluor® 488  ab150117 Goat Abcam 1:1000 
Anti-Ms Alexa Fluor® 555 ab150118 Goat  Abcam 1:1000 
 
3.6 EVs study 
3.6.1 EVs isolation 
EVs were isolated from the supernatants of co-cultured BMSCs and cartilage chips. 
They are released in the medium by cell types in culture. The Total Exosome Isolation 
(from cell culture media) reagent (Invitrogen) provides a simple and reliable method of 
isolating and concentrating EVs. The EVs are forced out of solution so that can be 
extracted and then collected after short and low-speed centrifugation. The term “EVs” 
is used in place of  “exosomes” when referring to the samples collected from this kit. 
Although the kit claims to be isolating exosomes, that cannot be considered through in 





First, medium depleted of FCS was used that ensures that isolated EVs originate from 
the cells in the co-culture, and do not derive from the FCS that contains high levels of 
EVS. Collected media after 48 hours of co-culture was centrifuged at 2000 × g for 30 
minutes to remove cells and debris. About 1 mL of supernatant was transferred to a 
new tube without disturbing the pellet, to which 0.5 mL of kit reagent was added. The 
solution was then mixed by vortexing for a few seconds to produce a homogenous 
solution. The samples were then stored at 4°C overnight. Centrifugation at 10,000 × g 
for 1 hour at 4°C was performed the following day. A clear pellet containing the EVs 
was visible in all samples, the supernatant was aspirated and discarded. The pelleted 
EVs were resuspended in 0.1 mL of PBS and kept at 4°C before used in downstream 
analysis. 
3.6.2 EVs characterisation 
3.6.2.1  Electron Microscopy (TEM) 
TEM is a widely used technique in EVs studies and is indicated as a standard method 
for EVs morphological evaluation, as it provides images at nanometre resolution 
(Coumans et al., 2017). TEM allows to image samples to distinguish single EVs from 
non-EV particles. TEM uses a high energy beam of electrons instead of light to image 
a sample. The interactions between the electrons and the atoms of the sample can be 
used to observe nanometre sized features and molecules. 
Negative staining using uranyl-acetate was used to visualise the EVs contained in the 
sample. A 10µl droplet of isolated EVs in PBS was pipetted directly to the support film 
on 300 mesh grids (Gilder Grids, UK). The grids are filmed with pioloform, carbon 
coated, and plasma etched before use. After a few seconds to allow adsorption of the 
EVs, the excess PBS was removed by touching the edge of the droplet with filter paper. 
A 10 µ droplet of 2% aqueous uranyl acetate (Agar Scientific, UK) was added to the 
grid and after a few seconds was removed with filter paper. The grid containing the 
EVs was allowed to dry completely before acquiring the images. The grids were 
examined on a Hitachi HT7800 transmission electron microscope (TEM) using an 
Emsis Xarosa camera with Radius software (Electron Microscopy Research Services, 
Newcastle University). Images were collected using an AMT CCD camera (Deben). To 
ensure the selection of representative images, an unbiased selection of zones of 3 




3.6.2.2 Nanoparticle Tracking Analysis (NTA) 
NTA is another standard method to characterize EVs, as it allows to measure 
nanoparticles in suspension in the range from 10 – 1000 nm. NTA calculates the size 
of particles from their Brownian motion. Particles in the sample are visualized by the 
illumination with a laser beam and the scattered light of the particles is recorded by a 
camera. Using a dedicated algorithm, particles paths are registered. NTA can, 
therefore, inform about the size distribution and concentration of the particles present 
in the sample.   
NTA was performed using a NanoSight LM10-HS microscope equipped with NTA 
software v2.3 (NanoSight Ltd., UK). Background extraction was applied and the 
automatic setting for the minimum expected particle size and minimum track length. 
60 s recordings at 30 frames per second were taken for each sample, which was 
diluted at 1:10,000 in sterile filtered PBS (Sigma). 4 different set of measurements were 
performed on the same samples and only measurements with > 1000 completed tracks 
were analysed. 
3.6.3 RNA isolation from EVs and concentration 
Amicon Ultra-0.5 centrifugal filter units with Ultracel-3 membrane (Merck Millipore) 
were used to concentrate the RNA. The eluted RNA was top up to 0.4 mL with RNase-
free water and the volume was added to the filter column. The tube was centrifuged at 
4° C 14,000 x g for 88 minutes (JA refrigerated centrifuge). The filter column was then 
inverted into a new collection tube and centrifuged 8,000 x g for 2 minutes to collect 
the concentrated sample. 
3.6.4 miRNA Nanostring Analysis of EVs-isolated RNA 
NanoString is a method that provides a digital count of a mRNA or miRNA of interest 
in a given sample. That is achieved using colour-coded molecular barcodes that 
hybridizes to specific nucleic acid sequence. The total RNA isolated from EVs was 
profiled using the nCounter® Human v3.0 miRNA Expression Assay Kit (NanoString 
Technologies), based on miRBase v21. The code set incorporated 799 mature 
microRNAs and included 6 positive controls, 8 negative controls, 6 ligation controls, 
and 5 mRNA housekeeping controls (ACTB, B2M, GAPDH, RPL19 and RPLP0). 
Starting material comprised of 3 μl of concentrated RNA. Data normalization was 




set content normalization to the top 100 microRNAs established using geometric 
means. 
 
3.7 Gene expression Analysis 
Quantitative real time PCR (RT-qPCR) and RNA sequencing methods were utilised to 
study the mRNA transcribed by cells of interest in different experiments. 
3.7.1 RNA Extraction  
To assess gene expression profile of BMSCs and chondrocytes in the different 
experiments, RNA was isolated from the cells in monolayer, retro transcribed to cDNA 
and analyzed by qPCR. The RNeasy Kit (QIAGEN, Germany) was used initially for 
experiments with BMSCs in monolayer.  
RLT plus lysis buffer (QIAGEN, Germany) additioned with 1% β-mercaptoethanol was 
added at 4 °C to monolayer cells at confluence previously washed with PBS 
(phosphate buffered saline, GIBCO®). Cells were detached with a cell scraper and 
collected. Chondrogenic induced pellets were harvested at different time points. Pellets 
were washed with PBS, then transfer in RLT plus lysis buffer where they were manually 
homogenized. Cell lysates were stored at - 70 °C before proceeding to RNA isolation. 
Following low RNA yield, especially from cartilage tissue and MSCs pellets, TRIzol 
(scientific name: guanidinium isothiocyanate-phenol-chloroform) reagent was used as 
extracting agent and isolation performed with the Direct-zol method. The Direct-zol 
method for RNA extraction is based on using the TRIzol: the phenol and guanidinium 
isothiocyanate act to denature proteins and cell lysis, while solubilising organic 
material. The chloroform allowed isolation of proteins, DNA and RNA by causing phase 
separation. Protein partitioned to the organic phase, DNA to the interface and RNA to 
the aqueous phase (Rio et al. 2010). The kit allows an on-column method to specifically 
isolate the RNA phase by binding to a membrane, improving yields. Kit reagents were 
prepared as per the manufacturer’s instructions. Between 350 to 500 µl Trizol was 
used, depending on the cell number and as specified by the manufacturer. Cell lysates 
were thawed on ice and an equal volume of 100% molecular-grade ethanol was added 
and thoroughly mixed by pipetting. The mix obtained was applied onto a spin-column 




RCF for 30 seconds at room temperature and the supernatant discarded. The spin-
column was washed twice with RNA PreWash in the same way. The spin-column was 
then washed at 14000 RCF for 2 minutes with RNA Wash Buffer. The spin-column was 
transferred to a Ribonuclease (RNase) free tube and eluted with 30 µl of RNAse free 
water.  
3.7.2 RNA quality assessment 
To obtain an accurate measurement of RNA quality and concentration for NanoString 
and RNAseq experiments, the isolated RNA was run using the Agilent RNA 6000 Pico 
Assay kit (Agilent) and the Agilent 2100 bioanalyzer. The kit allows a fast analysis of 
the RNA by using a specific chip. The chip used was prepared following manufacturer’s 
instructions. Briefly, 550 µl of the RNA 6000 Pico gel matrix were placed on a spin 
filter, centrifuged at 1500 g and divided into 65 µl aliquots. After the addition of 1 µl of 
the RNA 6000 Pico dye concentrate, the gel-dye mix was vortexed and centrifuged at 
13000 g for 10 minutes prior to analysis. The gel-dye mix was injected into the channel 
system of the RNA 6000 Pico chip by using the chip priming station followed by the 
addition of conditioning solution. After the addition of 5 µl marker to the ladder and 
sample wells, 1 µl of each RNA sample was added in the 11 designated sample wells, 
followed by the addition of 1 µl of diluted RNA 6000 ladder (Ambion) in the ladder well. 
The RNA samples and ladder were prepared by heating the samples at 70º C for two 
minutes. All the procedures were performed maintaining an RNAse free environment. 
The 2100Expert Software (Agilent) was used to analyse data (Assay selected: Total 
RNA Pico assay). 
For Real-Time qPCR analysis, the RNA concentration of samples was determined 
using a NanodropND-2000 Spectrophotometer (Thermo Fisher Scientific). Purity was 
analysed from the 260/280 nm wavelength ratio. 
3.7.3 Complementary DNA (cDNA) retrotranscription 
Polymerase Chain Reaction (PCR) uses double-stranded cDNA for its reaction and 
cannot be performed using RNA molecules. cDNA was synthesized using the 
QuantiTect Reverse Transcription kit (QUIAGEN). A reverse transcriptase enzyme 
synthesised the first strand DNA from the single-stranded mRNA using an RNA 
template and three-prime (3’) complementary primer. The required amount of RNA ( 




Buffer2” and the mix was incubated for 2 minutes at 42 °C and placed on ice. Reverse 
transcription was performed by adding to each sample a mix containing dNTPs, the 
reverse transcriptase enzyme, and reverse transcription buffer (as per manufacturer 
instructions). The samples were then incubated for 30 minutes at 42 °C, and a final 3 
minutes incubation at 95 °C was performed to inactivate the reverse transcriptase. The 
resulting cDNA was diluted in dH2O as required, or stored at – 20 °C. 
3.7.4 RT-qPCR 
PCR can be utilised to determine the relative expression of a gene of interest between 
samples using the amplification products synthesized by reverse transcription (Wittwer 
et al., 1997, Schneeberger et al., 1995). RT-qPCR uses Sybr Green to provide a real-
time measure of the amplification products. Sybr Green is a dye which binds to double-
stranded DNA produced during the amplification of a target sequence by DNA 
polymerase during PCR. The advantage of RT-qPCR is that it has lower running costs, 
as it only requires primers for PCR. However, a drawback is that false positive signals 
can occur as Sybr Green could bind to dsDNA for example primer dimers or any 
genomic DNA/contaminants. It is of importance to ensure genomic elimination when 
synthesising cDNA, as well as designing optimal primer pairs and checking their 
melting curve post-experimentally.   
The cycle threshold (Ct) refers to the number of cycles required for the signal to 
surpass the background fluorescence level. The Ct value is used to quantify relative 
gene expression, using the comparative Ct method. To bypass variables such are the 
amount of starting material and quality of RNA, a stable housekeeping gene is used 
and the Ct value of the gene of interest (GoI) is subtracted from that of the 
housekeeping gene (HK). Quantification of mRNA expression was performed on a 
BioRad C1000 Thermal Cycler instrument. Primers utilised in for RT-qPCR were 
obtained published papers or purchased from Sigma (see section 3.7.5.).  
GAPDH, HPRT, B2M were used as housekeeping genes for MSCs and ACs to 
determine the abundance of a variety of genes (Ragni, Viganò, Rebulla, Giordano, & 
Lazzari, 2013). The most stable housekeeping gene in control and experimental 
conditions was chosen to calculate the relative expression of the gene of interest.  
Relative expression was calculated following the formula 2-∆Ct formula (Schmittgen & 




The following equations were used for the comparative Ct method:  
ΔCt = CtGOI – CtHK  
ΔΔCt = ΔCtsample – Ctcalibrator  
Relative quantification = 2–ΔΔCt  
The calibrator sample was set to show level 1 of expression when PCR data are 
reported in the charts. 
3.7.5 RT-qPCR primer design 
The primers utilised in this thesis were either purchased or designed in house. Some 
primers sequences were obtained by published articles and checked using NCBI 
PrimerBlast (NIH). Custom primers and primers obtained from Sigma were validated 
by testing the primer pair on a serial dilution of cDNA isolated from a cell (HEK293 for 
DACT1) or tissue (cartilage) expressing the gene of interest. cDNA was serially diluted 
to a range from 0.4 to 100 ng per reaction. The cycling profile was performed as 
described below. Primers validation was considered satisfactory if the primer pairs 
produced a slope of −3.3±0.3, an R2 of > 0.90, an efficiency of (100±15)%. The melt 
curve produced had also to show a single, well-defined peak at the same temperature 
for all points on the serial dilution. A table with the primers used in this thesis is reported 
below (table 2). 
 
Table 2 Primers used for RT-qPCR 
Gene Sense (5’-3’) Antisense (3’-5’) 
HPRT1 TGACACTGGCAAAACAATGCA GGTCCTTTTCACCAGCAAGCT 
B2M Quantitec ID: QT00088935 
GAPDH AATCCCATCACCATCTTCCA TGGACTCCACGACGTACTCA 
COL2 GGCAATAGCAGGTTCACGTACA CGATAACAGTCTTGCCCCACTT 
COL10 CAAGGCACCATCTCCAGGAA AAAGGGTATTTGTGGCAGCATATT 
PRG4 CTGGCCTGAATCTGTGTATTTTT TTCTTCCAGGGCACTTCTGT 
COMP AACAGTGCCCAGGAGGAC TTGTCTACCACCTTGTCTGC 
SOX9 GCAGGCGGAGGCAGAGGAG GGAGGAGGAGTGTGGCGAGTC 
MMP13 AAGGAGCATGGCGACTTCT TGGCCCAGGAGGAAAAGC 




CXCL12 Sigma ID: 6387 Ref. Seq. NM_001033886 
CXCL10 Sigma ID: 3627 Ref. Seq.NM_001565 
SEPRIN1 Sigma ID: 5054 Ref. Seq. NM_000602 
MIF1 Sigma ID: 4282 Ref. Seq. NM_002415 
IL6 TTCAATGAGGAGACTTGCCTG ACAACAACAATCTGAGGTGCC 
DACT1 GAAGAGCACCTGGAGACAGACA GCCCCATCACTCAGCTCATAA 
TAPT1 Sigma ID 202018 Ref.Seq. NM_153365 
USP46 Sigma ID: 64854 Ref.Seq. NM_001134223 
CDK6 Sigma ID: Ref. Seq. NM_001145306 
SMURF2b Sigma ID: 64750 Ref.Seq. NM_022739 
CCND1 TATTGCGCTGCTACCGTTGA CCAATAGCAGCAAACAATGTGAAA 
JAG1 N/A N/A 
ID1 CCAGAACCGCAAGGTGAG GGTCCCTGATGTAGTCGATGA 
FZD CGCTCATCGTGGGCATCACGT GCCGGCTGTTGGTGAGACGAG 
 
3.7.6 RNA sequencing (RNAseq) 
RNAseq is a method to study the transcriptome of cells of interest at a given point in 
time. First, a library is prepared with a dedicated kit starting from the RNA isolated from 
the cells. The library is then sequenced, and the data obtained are analysed with 
dedicated bioinformatics tools.  
BMSCs (Lonza) from 4 healthy patients (average age 27±5 years) were transfected 
with either siDACT1 or siCTRL (see section 3.8 for details). RNA was isolated from the 
cells 16 hours after treatment and RNA concentration and quality was assessed as 
described in Section 3.7.2. The isolated RNA was then handed to Dr Maike Paramor 
for analysing RNA quality, preparing the libraries and finally, the bulk sequencing was 
performed at the CRUK at the Cambridge Institute Genomics Core. Libraries were 
prepared using the Illumina Nextera XT DNA preparation kit. Libraries were pooled and 
run on the Illumina Hi-Seq4000 at the CRUK. RNA sequencing data were analysed by 
Dr Lila Diamanti, Stem Cell Institute Bioinformatics department.  
3.7.7 Ingenuity pathway analysis  
The biological targets of identified mRNAs from the RNAseq analysis were investigated 




application for integrating data obtained from hi-throughput experiments as RNAseq. 
Top 300 up- and down-regulated genes (for a total of 300) as determined by a 
bioinformatical analysis performed by Dr Lila Diamanti, were uploaded in the IPA 
software. Interactions and networks between the uploaded significant genes were 
mapped to pathways, regulators, diseases, and functions based on direct/indirect and 
experimentally validated targets. 
 
3.8 RNA interference (RNAi)  
RNA interference (RNAi) is a technique that allows to transiently and efficiently 
knockdown the transcription of a target protein by introducing in the cells the antisense 
sequence of the target mRNA. The siRNA (the antisense RNA) is a 21 to 25 
nucleotides long molecule that binds to the target mRNA. The double RNA molecule 
is then recognised by the RNase complex, RNA-induced silencing complex (RISC), 
which acts on the targeted mRNA to degrade it. This results in the reduction or loss in 
the expression of the protein of interest, as its mRNA is not transcribed. The siRNA is 
delivered to the cell by transfection using lipid-based delivery methods (Agrawal et al., 
2003).  
MSCs or ACs were seeded in at a density of 5,000 cells/cm2 in the appropriate media. 
DACT1 or DACT2 siRNA, GAPDH siRNA and negative control siRNA were obtained 
commercially (Life Technologies) and diluted to a final concentration of 1 pmol/µL in 
Opti-MEM™. This was mixed with 1.5 µL Lipofectamine™ RNAiMAX Reagent (Life 
Technologies), also diluted in Opti-MEM™, and incubated for 15 minutes at room 
temperature. The siRNA-Lipofectamine™ complexes were added on the day after 
seeding to the cells and incubated for up to 6 days before protein or RNA was 
harvested for downstream analysis. 
 
3.9 Protein analysis 
3.9.1 DMMB assay 
The 1,9-dimethyl methylene blue (DMMB) dye is a thiazine chromotrope agent that 




metachromasia when bound to sulfated GAGs. By adding this dye to the supernatant 
of chondrocytes of chondrogenic differentiated MSCs, rapid detection of GAGs in 
solution is made possible (Whitley et al., 1989; Chandrasekhar et al., 1987; Farndale 
et al., 1982). 
A ratio of 40 μL of sample supernatant with 250 μL of dye made of 16 mg/litre DMMB 
(Sigma), 3 g/L Glycine (Sigma), 40 mM NaCl (Sigma) finally adjusted to pH 3 was used. 
The samples were placed first in triplicate in clear 96 well plates (Costar, Corning, NY) 
and later DMMB dye was added to the wells. Samples were analysed for absorbance 
at room temperature immediately after adding DMMB dye at 545 nm wavelength with 
the FluoStar Optima plate reader (BMG Labtech). 
3.9.2 Proteome profiler cytokine array 
The proteome profiler cytokine array (R&D systems) is a membrane-based antibody 
array that is used for determining relative levels of human cytokines, chemokines, 
growth factors present in a certain solution.  
After 48h of co-culture between BMSCs (Lonza) and cartilage chips from either SZ, 
MDZ, OAZ, supernatant from the three different conditions was probed with the 
proteome profiler cytokine array kit. Particles and debris were removed from the lysate 
by centrifugation of the samples for 10 min at 300 x g. The membranes were blocked 
on a rocker for 1 h with a blocking buffer provided in the kit. 15 μL of Human Cytokine 
Array Detection Antibody Cocktail was added to each sample supernatant, mixed and 
left at room temperature for one hour. The supernatant and Human Cytokine Array 
Detection Antibody Cocktail mix solution were then added to the membrane and left 
overnight on a rocker at 4 °C. After one wash with the kit Wash Buffer and 4 washes 
with dH2O (each was for 10 minutes), Streptavidin-HRP was added to the membranes 
and left to incubate for 30 minutes at room temperature. Membranes were then washed 
as just described. 1 mL of the prepared Chemi Reagent Mix was added evenly onto 
each membrane and incubated for 1 minute. An X-ray film was used to detect 
cytokines, which was exposed to the membrane for 3 minutes. 
ImageJ was used to measure the pixel intensities of each spot of the array. The 
average pixel intensity of each pair of duplicate spots was calculated and the averaged 
background was subtracted to determine the intensity of each cytokine.  Determine the 




3.9.3 Protein isolation and quantification 
To isolate proteins from BMSCs, a lysis reagent was added to cell culture plates after 
washing twice with PBS. The lysis reagent was prepared with RIPA buffer (Millipore) 
with the addition of cOmplete Protease Inhibitor Ccocktail (Sigma) and PhosSTOP 
phosphatase inhibitor reagent (Sigma). 100 µL/10cm2 of lysis reagent was added to 
culture cells, incubated for less than a minute and finally, a cell scraper was used to 
help detaching and cell lysis. The lysate was then transferred to an Eppendorf tube 
and stored at – 70 °C. The cell lysate was centrifuged at 14,000 x g for 15 minutes 
before analysis to pellet cell debris and supernatant transfer to clean tubes. Samples 
were aliquoted in smaller volumes to avoid excessive freeze-thaw cycles that might 
result in protein degradation. 
The BCA assay was used to quantify protein to standardise the amounts loaded in 
Western blotting using a Pierce™ BCA Protein Assay Kit (Life Technologies). The BCA 
assay allows determining the concentration of the samples by running a standard curve 
of known concentration alongside. A working reagent comprising of BCA added to 
CuSO4 pentahydride solution (4 % w/v) in a ratio of 1:50. The standard curve was 
generated by diluting bovine serum albumin (BSA) in cell extraction buffer at a range 
of 25 to 2000 ng/mL. The samples were diluted 1:8 by mixing 25 µL cell lysate or 
protein standards with 200 µL of working reagent and incubated for at least 30 minutes 
at 37°C. The absorbance for samples and the protein standards were measured in 
triplicate at a wavelength of 562 nm using a FluoStar Optima plate reader (BMG 
Labtech).  
3.9.4 Western Blotting 
Western Blotting is a method used to detect and analyse proteins (Towbin et al., 1992, 
Burnette, 1981). After isolation and quantification of the proteins from cell lysates 
(section 3.9.3), the cell lysates containing the proteins are diluted in a loading buffer 
containing glycerol which increases the density of the sample, along with a dye to aid 
visualisation. The mixture is heated at high temperature to denature the proteins. That 
helps the separation by the size of the proteins through gel electrophoresis. A marker 
is also run alongside the samples to allow the molecular weight determination of the 
protein of interest. After electrophoresis, the resolute proteins are transferred from the 




avoid nonspecific binding of the primary antibody. The protein of interest is specifically 
bonded by the primary-antibody, which is then visualised by adding the secondary 
antibody. The secondary antibody is labelled with a fluorescent protein that is detected 
by a dedicated imaging system. 
3.9.4.1 Electrophoreis and membrane transfer 
After determining the lysate protein concentration, an equal amount of total protein per 
samples was mixed with 4XNuPAGE sample LDS loading buffer (Thermo Fisher 
Scientific) and 10X NuPAGE reducing agent (Thermo Fisher Scientific) and 
denaturated at 80 °C for 10 minutes. The denaturated mix was then loaded onto a mini-
PROTEAN TGX pre-cast gel 10-well 4-20% stain free gel (BioRad) alongside a ladder 
(Chameleon Duo Pre-stained, Licor). Gels were run at 250 V for 30 minutes in 
Tris/Glycine/SDS running buffer (BioRad). The proteins were transferred to a 0.45 µm 
PVDF membrane (BioRad) using the Trans-Blot Turbo semi-dry System for 7 minutes 
at 25 V. 
3.9.4.2 Immuno-probing and detection 
The membranes were blocked for unspecific bindings in Odyssey blocking solution 
diluted 1:1 in TBS (Thermo Fisher Scientific) for 2 hours. Primary antibody anti-
ubiquitin (Abcam, ab7780) was diluted (1:500) in TBS buffer containing 0.05% 
Tween20 (Sigma) (TBS-Tween) and added to the membrane. The incubation was 
carried out overnight at 4 °C. After washing with TBS-Tween for 3 times, the blotted 
membranes were incubated with donkey-anti-rabbit IRDye800CW (ID:925-32213, 
Licor) diluted 1:15,000 in TBS-Tween.  The secondary antibody was incubated for 1.5 
hours before washing the membrane with TBS and imaging with ChemiDoc system 
(BioRad) in automated settings. 
 
3.10 Mouse ex-vivo work 
3.10.1 Animal husbandry 
Animal husbandry was performed in accordance with the regulations described in the 
Animals (Scientific Procedures) Act 1986. Mice used were housed in the Phenomics 




Home Office requirements. Mice were housed in groups in individually ventilated cages 
under a 12 h dark/12 h light cycle and fed a standard diet. All animals used in this 
thesis are wild type C57BL/6 strain, supplied by Charles River. Legs of adult animals 
were obtained from  Dr. Virginia Piombo.  
3.10.2 Mouse chondrocytes isolation  
Mouse articular chondrocytes were isolated from the cartilage of femoral heads 
obtained from the legs of adult mice (3-6 weeks old). The cartilage at the top of the 
femur bone was dislocated with forceps, applying a small pressure. The hip cartilage 
from 4-5 mouse femoral heads was then collagenase digested as described in section 
3.1.4. 
3.10.3 Collection and storage of mouse embryos 
Mice at different embryological (E) stage were used in this study: E13.5, E14.5, E15.5, 
E16.5, E17.5. Mice were mated and the morning of vaginal plug formation counted as 
E0.5. Pregnant mothers were killed by cervical dislocation and embryos fixed overnight 
in 4% formalin (Sigma)  in phosphate buffered saline (PBS). 
3.10.4 Collection and storage of mouse limbs 
Mouse limbs were donated as unutilised samples from Dr Virginia Piombo. The knees 
were resected with a scalpel, skin and muscle tissues were removed and washed with 
PBS. To preserve the tissues, fixation with 4 % formalin was performed overnight.  
 
3.11 Histological tissue processing 
Tissue processing is the collection of the steps required to perform a histological or 
immunochemical analysis of the tissue of interest. Human or animal tissues are first 
harvested, then a fixation step is performed to preserve the tissue. Subsequently, the 
sample is treated so that is infiltrated by a suitable histological wax and then embedded 
so that it can be cut in µm thick section that can be stained.  
3.11.1 Sample preparation  
Osteochondral samples were harvested from the condyles of both lateral and medial 
condyles of osteoarthritic knees. The samples were obtained by using a surgical tool 
that retrieves a cylindrical osteochondral plug. The samples were then washing in PBS, 




Synovial tissue was also harvested by the surgeons during total knee replacement. 
The synovial samples were resected with a scalpel from the fat-pad, recognisable by 
different texture and colour and washed in PBS. The tissue was fixed in 4 % formalin 
overnight before embedding. 
3.11.2 De-calcification 
In order to stain human and mouse knee samples a decalcification step is necessary 
to allow sectioning, which is hindered by the mineralised calcium present in bones. 
Ethylenediaminetetraacetic acid (EDTA) was used to achieve gentle de-calcification 
that preserved tissue morphology and protein epitopes for immunohistochemistry. 14 
% EDTA (Sigma) at pH 8 was added to the samples, after washing them in PBS to 
remove formalin residues. Samples were incubated for 2-3 weeks until the bone tissue 
appeared soft when poked with a needle. Samples were washed for 20 minutes in 
water before proceeding to further preparation. 
   
3.11.3 Embedding and sectioning 
To analyse histologically or by immunohistochemistry, the tissues were embedded in 
paraffin (Sigma). Paraffin embedding was achieved by using a Leica TP1020 Tissue 
Processor. Samples were de-hydrated through sequential steps of 1 hour each 50%,  
70%, 80%, 90%, 95% ethanol solutions and three final 100% ethanol steps for 1 hour. 
Two additional steps of 2 hours each in xylene (Sigma) were performed before the 
samples were immersed in paraffin wax at 60 °C, for 2 hours. All the steps were 
performed under vacuum to improve penetration in the samples. A Leica HistoCore 
Arcadia H Embedding Station was utilised to embed and orientate samples for 
sectioning.  
5 µM sections of the samples were obtained using a microtome Leica BM2255 and 
dried onto Superfrost Plus Slides (Thermo Fisher Scientific).  
 
3.11.4 Histological Stains and counterstains 
Before staining, paraffin sections mounted on slide were re-hydrated. Slides were 
located on a hot plate at 60 °C for a few minutes until the paraffin wax surrounding the 
sample melted. The slides were then transferred in xylene for 10 minutes, and the 
same step was repeated a second time to ensure removal of the paraffin. Slides were 




decreasing ethanol concentration (95%, 90%, 80%, 70%, 60%, 50%, 30%) for 5 
minutes each. Finally, slides were incubated in two 5 minutes step in dH2O before 
starting the staining protocol. 
 
3.11.5 Immunohistochemistry (IHC) 
IHC allows to identify a protein on a tissue sample by using antibodies to detect the 
location of proteins and other antigens in tissue sections. The antibody-antigen 
interaction is visualised by adding a secondary antibody conjugated to an enzyme that 
catalyses a reaction to form detectable compounds. That allows to visualize and 
localize specific antigens in a tissue sample. Diaminobenzidine (DAB) was used as a 
substrate because in presence of peroxidase and hydrogen peroxidase it produces a 
brown alcohol-insoluble precipitate at the site of the reaction (where the protein was 
detected by the antibody).  By applying a secondary antibody conjugated with 
horseradish peroxidase (HRP), DAB precipitation can indicate the location of the 
protein of interest. 
After the re-hydration procedure, an antigen retrieval procedure was applied to unmask 
the epitopes of proteins, as the fixation and embedding producer can alter the structure 
of the epitope. A specific protocol was optimised to avoid detachment of the samples. 
Slides were submerged in a solution pre-warmed 10 mM of sodium citrate (Sigma) 
buffer adjusted to pH 6 containing 0.05% Tween. The solution was maintained 
between 70-80 °C by submersion in a heated water bath. Slides were then rinsed for 
10 min in running tap water. 
To block unspecific binding, a blocking buffer 10% goat serum (Vector Laboratories) 
in PBS containing 0.05% Tween20 (PBS-Tween) was added to the slide and left for 
1,5 hours. DACT1 and DACT2 primary antibodies (Table 1) were diluted in TBS-Tween 
1:500 added to the slides and incubated overnight at 4 °C in a humidified chamber. 
After overnight incubation, slides were washed three times 5 minutes with PBS before 
incubation with 3% hydrogen peroxide (Sigma) for 15 minutes. This step ensured that 
endogenous peroxidase activity is blocked so that non-specific or high background 
staining will not occur upon DAB incubation. 
The Rabbit Specific HRP/DAB Detection Kit (Abcam) was used to detect the primary 
antibody (raised in rabbit) using HRP-labelled-streptavidin and a biotinylated anti-rabbit 




left for 10 minutes before it was removed, and the slide washed 3 times with PBS. 
Then the HRP-labelled streptavidin was added and incubated for 10 minutes to allow 
the binding to the secondary antibody. 4 washes with TBS, of 5 minutes each were 
performed on the slides before incubating the slides with DAB. DAB was removed after 
15 seconds by washing the slides with PBS. The incubation time was determined by 
blocking the incubation when the brown coloured deposition at the site of primary 
antibody binding was visible under the microscope. Samples were then counterstained 
with Methylgreen. 
 
3.11.6 Methylgreen counterstain 
Methylgreen is used as a counterstain for the non-matrix structures and cell nuclei 
(Miyaki et al.,1994). Following IHC, slides were washed in dH2O for 5 minutes before 
they were submerged for 5 minutes in methyl green (Sigma) solution pre-heated at 60 
°C. Three washes in tap water were then done before dipping for a few seconds the 
slides in acetone containing  0.05% acetic acid. Sections were de-hydrated through 
95% and 100% Ethanol solutions for 2 minutes each. Two changes in xylene for 5 
minutes were then performed before mounting a glass cover slide with DPX Mountant 
for histology (Sigma) on each slide. 
 
3.11.7 Safranin O/ Fast Green 
Safranin O is a basic dye that stains cartilage matrix in red, at intensity proportional to 
the proteoglycan content in the cartilage tissue (Miyaki et al., 1994). Fast Green is used 
as counterstain for the non-matrix structures and cell nuclei. 
Following rehydration, sections were stained for 10 minutes with Weigert’s iron 
haematoxylin working solution (sigma) and then washed for 10 minutes with running 
tap water. The slides were then stained with 0.1% Fast Green FCF (Sigma) solution 
for 5 minutes and moved to a 1% acetic acid solution for 10 seconds. Finally, samples 
were stained with 0.1% SafraninO (Sigma) solution for 5 minutes, before being de-
hydrated for 5 minutes in 100% EtOH for two times, and then cleared in two steps of 






Thionin is a metachromatic dye that stains in purple/blue glycosaminoglycans to 
visualise the amount of matrix produced by cells. It is particularly used to determine 
the chondrogenic differentiation of MSCs in 3D pellet culture. 
Deparaffinized and rehydrated slides were stained with a 0.5% thionin acetate salt 
(Sigma) solution for 5 minutes before dehydration in a 95% EtOH and two 100% EtOH 
(30 seconds each) changes. Two changes in xylene for 5 minutes were then performed 
before mounting a glass cover slide with DPX. 
3.11.9 Toluidine Blue 
Toluidine Blue is a cationic dye that stains cartilage matrix proteoglycans and nucleic 
acids. The staining properties of Toluidine blue may vary according to the solution pH. 
Like thionin stain, Toluidine Blue is used to determine the chondrogenic differentiation 
of MSCs in 3D pellet culture. 
After submerging the slides in water after deparaffination and re-hydration, slides were 
incubated for 10 minutes in 0.04% Toluidine Blue (Sigma) in 0.1% sodium acetate at 
pH 4. Three 5 seconds washes in dH2O. Slides were then dehydrated in consecutive 
changes in 90%, 95%, and two 100% of EtOH. Two changes in xylene were finally 
performed before a glass coverslip was mounted with DPX. 
3.11.10 Histological Section Imaging 
Stained histological sections were imaged with bright field microscopy using M8 
microscope and scanner (Precipoint) using viewPoint software. 
 
3.12 Data Analysis 
Data analysis was performed with PSAW statistics 20 (SPSS Inc., Chicago, IL, USA) 
and GraphPad Prism8. The normal distribution of the data was determined by the 
Shapiro-Wilk test. Where data followed normal distribution, t-student test or ANOVA 
test was performed, otherwise non-parametric test were applied. Differences were 




For NanoString analysis, (performed by Dr. Rachel Crossland) fold change (FC) 
expression differences between two groups were calculated using nSolver v2.5 
(NanoString Technologies) ratio data, based on normalized count data. Further 
analysis was performed using a pipeline designed by researchers at Newcastle 
University. This integrated a number of “R” (R project) statistical packages in the “R” 
programming language. P-values between the two groups were generated using a two-
tailed t-test. Dendrograms were generated using functions within the “hclust” package, 
and heatmaps were constructed using “gplots” and “RColorBrewer”, based on an 
unsupervised clustering approach of the normalized expression counts, with a 
Euclidean distance measure. 
For RNAseq data analysis (performed by Dr Lila Diamanti), a principal component 
analysis was performed on the data that indicated that the siDACT1 and control 
conditions cluster separately. A 10% false discovery rate threshold set for all the 





4 Results: Chondrocytes from cartilage zones provide different 
signalling to bone marrow-derived MSCs. 
4.1 Background and rationale 
In the context of surgical therapies that deliver exogenous cells (e.g. culture expanded 
mesenchymal stem/stromal cells (MSCs) implantation) or recruit (bone marrow 
stimulation techniques) endogenous cells to the site of chondral damage, resident 
articular chondrocytes (ACs) become spatially adjacent to the MSCs. 
Several studies have investigated the influence of full thickness (non zonally 
separated) ACs on MSCs. ACs are reported to produce factors that can induce 
chondrogenic differentiation of MSCs, as well as reducing markers associated with 
chondrocyte hypertrophy. However, there is only one published study that examines 
this effect using ACs specifically residing in the superficial zone and middle-deep zone. 
Coates and Fisher showed that in adult bovine articular cartilage, cells from the 
superficial zone induced bone marrow-derived MSCs to express hyaline cartilage 
genes in a highly efficient manner compared to those isolated from the middle and 
deeper zones cells (Coates & Fisher, 2014). This was also the case when compared 
to normal chondrogenic induction with TGFβ. Conditioned medium from superficial 
zone explants was not able to induce chondrogenesis. This indicates that MSCs and 
cartilage resident cells establish a positive feedback loop to produce differentiation 
signals. The authors also suggested that progenitor cells residing in the superficial 
zone may be responsible for the effective chondrogenic differentiation of BMSCs 
(Coates & Fisher, 2014). To explore this observation further, the hypothesis that SZ 
cartilage can induce BMSCs to differentiate more efficiently towards the chondrogenic 
lineage, in terms of proteoglycans deposition, than MDZ cartilage, was tested. In 
Coates and Fisher’s work, the mechanism responsible for inducing chondrogenic 
differentiation was attributed to soluble signalling factors.  The question as to which 
soluble factors are specifically responsible for the observed effect was not described. 
Cross-talk between cells is generally mediated by cytokines, growth factors, RNA 
(including mRNA, microRNA and lncRNAs), and other molecules. Recent studies have 
shown that EVs derived from MSCs have regenerative functions in several tissues, 
including kidney, heart, nervous tissues, liver, and lung (S. C. Abreu, Weiss, & Rocco, 




hypothesis in this chapter is that cytokines and EVs produced by both BMSCs and ACs 
would differ when cartilage is sampled from different regions of the knee condyle. To 
evaluate these differences, cytokines that mediate the communication between MSCs 
and ACs were investigated. EVs present in the supernatant of the co-cultures were 
isolated and analysed for their microRNA (miRNA) content. miRNAs importance in 
cartilage has become the centre of many studies and several miRNAs have been 
discovered and proposed as therapeutic targets for OA. miRNAs are on average 21-
25 nt  long RNAs that modulate the translation of targeted mRNAs by modifying their 
stability or translation through interaction with the RNA-induced silencing complex 
(Carthew & Sontheimer, 2009). miRNAs are a fundamental part of the mechanisms 
regulating cell fate determination, cell differentiation, organ development and 
physiology. miRNAs loci are mainly found in non-coding regions in gene transcripts, of 
which 40% are contained in the introns and 10% in the exons and the remaining in the 
introns of coding mRNA transcripts (Y.-K. Kim et al., 2009). Most miRNAs are present 
in clusters within the genome, at a distance of less than 10kb from another miRNA 
(Griffiths-Jones, Saini, van Dongen, & Enright, 2007). A single miRNA can also appear 
at several loci throughout the genome, as reflected by their nomenclature. When 
miRNAs present the same name but a different lettered suffix (e.g. miR-23a and miR 
23b), this indicates that the two miRNAs have a similar sequence and precursors but 
can be found at different loci. Whereas, when miRNAs have identical mature 
sequences at different loci they are identified by a numbered suffix (e.g. hsa-miR-129-
1 and hsa-miR-129-2) (Desvignes et al., 2015). 
miRNAs were found to be selectively sorted into EVs. For example, in prostate cancer, 
specific miRNAs were underrepresented in EVs and sequencing analysis showed that 
some miRNAs were enriched in dendritic cells-derived EVs when compared with the 
cellular miRNAs (Nolte-’t Hoen et al., 2012). However, the mechanisms behind miRNA 
sorting are not well understood. Mechanistically, the loading of miRNAs into EVs may 
rely on factors including the binding motifs of the miRNAs and the miRNA-associated 
proteins. Such specific sorting argues for a specific and important role for miRNA found 
in EVs modulating target cells. A list of miRNAs specifically found in EVs is present on 
the EVs miRNA database (T. Liu et al., 2019). At the time of writing, cartilage derived 
EVs have not been studied. EVsmiRNA content from co-cultured BMSCs and cartilage 
and the comparison of such miRNA from either SZ or MDZ-derived EVs is described 






4.2.1 Method validation for the separation of ACs from human articular 
cartilage SZ, MDZ, and OAZ. 
It has been suggested that different regions of human articular cartilage contain diverse 
cellular subtypes with different critical properties. The hypothesis is that such 
properties can modulate the phenotype of BMSCs that find themselves close to the 
chondrocytes after surgical approaches including bone marrow stimulation techniques. 
To study AC subpopulations a method was optimized to separate three cartilage 
zones. First, cartilage chips of between 200-300 µm from human femoral condyles (fig. 
9A) were separated with a dermatome (fig. 9C). The SZ and MDZ cartilage chips were 
obtained from the non weight-bearing (lateral condyle) condyles that showed intact 
macroscopic and glossy features (fig. 9B). The OAZ cartilage chips were harvested 
from the medial condyle, from the side of visible cartilage damage (fig. 9B). 
 
 
Figure 9 Isolation of chondrocytes from different zones of articular cartilage with 
a dermatome. 
Schematic representation of the knee (A). Samples from lateral and medial condyle 




superficial or middle/deep cartilage are removed with a dermatome from the non-
osteoarthritic part of the later femoral condyle (B, left). Osteoarthritic chips are removed 
from the eburnated medial condyle (B, right). The dermatome is visible in figure C, and 
a 0.200 mm thick cartilage chip removed from the knee condyle is held by forceps in 
figure C.   
 
The average age of patients undergoing total knee replacement who donated the 
samples of cartilage used in the experiments presented in this thesis was 72±5 years. 
Age-related changes in articular cartilage generally include thinning (loss of cartilage 
height) and it has been suggested that the superficial zone may get progressively lost 
(Lotz 2012). To assess the zonal architecture of subjects, cartilage biopsies were taken 
from lateral and medial condyles and histological analysis was performed. Histological 
staining showed (representative sample in fig.10) cartilage thinning in the medial 
condyle and the presence of cell clusters, an OA hallmark. The lateral condyle 
presented in most cases a clear superficial population of cells positioned parallel to the 
surface. In the zone closer to the subchondral bone, ACs were rounder and 







Figure 10 Histology of lateral and medial knee condyle cartilage.  
SafraninO-FastGreen (SafO/FastG) and Toluidine Blue (Tol Blue) stainings on 5 µm 
section of paraffin-embedded human articular cartilage. The different regions are 
indicated as superficial zone (SZ), middle-deep zone (MDZ) and full-thickness. Scale 
bar = 0.5 mm, representative images (N=5). 
 
Following overnight treatment with Collagenase A to obtain single cell suspensions 
from each cartilage zone, the cells were cultured for 4-5 days in normoxic conditions 
and images were taken with a phase-contrast microscope. ACs from the superficial 
zone (fig. 11, left) are elongated, in contrast to the ACs from the middle/deep zone, 
which have a more rounded shape. ACs from the edge of the osteoarthritic damage 






Figure 11 Light Microscopy images of articular chondrocytes from different 
layers. 
Representative images from superficial (SZ), middle/deep (MDZ) and osteoarthritic 
(OAZ) chondrocytes after 3 days of culture in normoxic conditions. N=5,  Scale bar: 
0.05 mm. 
 
To verify that the separation achieved with the dermatome resulted in effectively 
obtaining ACs from different zones, expression of zonal gene expression markers was 
investigated. PRG4 and COMP were expressed in ACs isolated by enzymatic digestion 
from cartilage chips from the SZ, MDZ and OAZ with no statistically significant 
differences (fig.12). COL10 and COL2 are markers of mature cartilage and are 
expressed in the MDZ, but no difference could be detected at gene expression level in 
the analysed samples  (fig. 12).  
 
Figure 12 Gene expression analysis of ACs from SZ, MDZ, or OAZ.  
qPCR was performed on cDNA obtained from the cartilage of patients undergoing total 
knee replacement. ACs were isolated through collagenase digestion and RNA 
harvested without further expansion. Error bars indicate samples standard deviation 
(N=3). (Kruskal-Wallis non-parametric test was run on the data, and there are no 
statistically significant differences). 
 
The superficial origin of cartilage precursors has recently been described in mouse 




















































precursors in human adult cartilage are still elusive. To evaluate the enrichment of 
proliferative chondrocytes in the SZ of mature human knee cartilage, a CFU assay was 
performed on cells from the femoral condyles from four different patients. Compared 
to the number of colonies/plates originating from MDZ ACs, SZ and OAZ ACs resulted 
in a significant increase in cell colonies (fig. 13). 
 
Figure 13 Colony Forming Unit Assay on chondrocytes from the different 
cartilage zones.  
Relative CFU compared to MDZ CFU in a representative experiment from one donor. 
3 to 4 replicates of the CFU assay per donor (N=4) are grouped per zonal derivation 
(Kruskal-Wallis non-parametric test was run on the data (∗∗ = p ≤ .01)). 
 
4.2.2 BMSCs chondrogenic differentiation is differentially affected by the 
zonal regions of cartilage 
ACs are known to drive chondrogenic differentiation of BMSCs when co-cultured. In 
recent work by Coates and Fisher, bovine SZ cartilage seemed to drive 
chondrogenesis and differentiation of BMSCs significantly better than MDZ ACs. We 
hypothesized that a similar result could be observed by co-culturing human BMSCs 
with human ACs from the femoral condyle. To evaluate the effect of secreted factors 
from ACs from different zones on BMSCs chondrogenic differentiation, BMSCs pellets 
were transferred to the co-culture system. A schematic summary of the final co-culture 






Figure 14 Schematic representation of the co-culture experiment of BMSCs and 
cartilage chips from different regions.  
Cartilage chips from different cartilage areas are harvested (samples from 3 different 
donors) and co-cultured in a transwell with BMSCs pellets (from 1 patient) for 21 days. 
Through the experiment, basal medium was used. BMSCs pellets were prepared in 
tube containing basal medium and transferred to co-culture wells after 1 day. Control 
pellets were cultured in basal medium without cartilage chips for 21 days. At day 21, 
pellets were harvested and processed for mRNA analysis or histological assessment. 
The medium in the transwell was changed and stored at – 20 °C twice a week for 
GAGs production analysis by DMMB assay and cytokine proteome array. 
 
A co-culture of cartilage chips and pellets of BMSCs was set up and maintained for 21 
days at the end of which a gene expression analysis of pellets was performed. A third 
condition was included to analyse the effect of ACs from OAZ on BMSC differentiation. 
After 21 days of co-culture, pellets were harvested and processed for histological and 
gene expression analysis. It was noticed that pellets cultured with cartilage chips from 
MDZ and OAZ failed to assume the characteristic pearly white colour of BMSCs 
differentiated into cartilage (data not shown).  
 
The relative fold change in mRNA levels was calculated using the RNA isolated from 
pellets maintained in basal medium for 21 days (fig. 15). The gene expression analysis 
from the three experiments showed large variability and resulted in no significantly 
different expression between the co-cultures, at the gene expression level. It was rare 
to observe gene expression of chondrogenic markers from these conditions higher 
than the positive control (not shown), indicating that the presence of the ACs might 
negatively affect MSC differentiation. The expression of chondrogenic marker SOX9 is 
higher in pellets co-cultured with MDZ chips for all three conditions. Sox9 directly 
regulates transcriptional activation of COL2, which is a marker of chondrogenic 




II. In only one experiment, COL2 was more expressed in the SZ than MDZ condition, 
and in the other conditions, it was less expressed than in the control. Generally, COL1 
expression precedes COL2 expression during chondrogenic differentiation, and should 
decrease progressively during chondrogenesis. In the study presented here, COL1 
expression still appeared in MDZ and OAZ conditions. ACAN is another marker of 
chondrogenic differentiation, encoding for another important matrix protein, aggrecan. 
Overall, chondrogenic markers do  not present statically significant differences 
between conditions . PRG4 expression was not induced in pellets from SZ condition, 
but was expressed by pellets exposed to MDZ cartilage. MMP13 expression appears 
higher in the SZ compared to the other conditions, but was no statistically different. 
 
Figure 15 Gene expression analysis of BMSCs pelleted after 21 days of co-culture 
with cartilage from different regions.  
Control samples are pellets in culture in basal medium only, the same medium added 
to the co-cultures. In SZ, MDZ, and OAZ are pellets co-cultured with cartilage chips 
from SZ, MDZ, or OAZ. The pellets were obtained from passage 5 BMSCs and 3-4 
pellets were pooled per each condition. All expression are relative to the house keeping 
gene HRPT1 expression and SZ condition is set as calibrator, N=3. (Kruskal-Wallis non-
parametric test was run on the data, and there are no statistically significant differences 





To evaluate the matrix protein production within the pellets co-cultured with cartilage 
from different zones, thionin staining on paraffin embedded pellets was performed. 
This method allowed the intensity of staining to be observed, which correlates with the 
amount of GAG present in the ECM produced by the cells. 
The histology in figure 16 shows pellets from each condition, or 2 attached pellets in 
the case of SZ, OAZ and probably MDZ. The pellets were cultured in the same 
transwell and very often they merged. The pellet in co-culture with MDZ chips showed 
the reduced thionine staining indicating limited chondrogenic differentiation and GAGs 
deposition. Similarly, the pellet in co-culture with OAZ cartilage chips also showed 
limited purple colouration indicating little GAG deposition. Both conditions resulted in 
inferior differentiation compared to the control pellet. On the other hand, when co-
cultured with SZ chips, the pellets were bigger (the micrograph in figure 16 probably 
represents a cluster of 2 pellets) and deeper purple stained. The histology seems to 
support more clearly than the gene expression analysis that a co-culture with SZ 
cartilage enhance chondrogenic differentiation of BMSCs.  
 
 
Figure 16  Histology of paraffin embedded pellets at day 21 of co-culture with 
cartilage chips from different zones.  
CTRL are pellets in culture in basal medium, the same medium added to the co-
cultures. In SZ, MDZ, and OAZ are pellets co-cultured with cartilage from SZ, MDZ, or 
OAZ. The pellets were obtained from passage 5 BMSCs. Thionin staining was 
performed on 5 µm thick sections from paraffin embedded samples and all the slides 
were stained at the same time, to allow a fair comparison. The scale bar indicates 1 
mm (N=3). 
 
To assess if there was any difference in GAG production between the different cartilage 
chips and MSCs pellet co-cultures and chips alone, we also performed a DMMB assay 
on the supernatant throughout the 21 days of the experiment. The absorbance 
measured at 545 nm in the DMB assay correlated with the amount of GAG present in 
the supernatant, although it cannot discriminate between the GAG that is newly 




presented in figure 17, the difference at each time point between co-culture and 
controls was not statistically significant, indicating that the presence of MSCs was not 
affecting GAG production or matrix catabolism. As free GAG in the culture 
supernatants did not significantly diminish over 21 days in SZ and MDZ experiments, 
it was concluded that matrix degradation is not a significant factor in this system. For 
both conditions, a gradual reduction in GAGs presence in the supernatant was 
registered in OAZ. The absorbance at day 0 measured at 700-800 nm whereas at day 
21 it reduced to 500-600nm, a much greater reduction compared to SZ and MDZ 
conditions. This observation could be explained by a reduced production of GAGs over 
time, perhaps due to altered physiology of OAZ ACs. 
 
Figure 17 DMMB assay on co-culture supernatant throughout 21 days.  
The absorbance is measured at 545 nm. Black columns indicate the co-culture 
condition, white column the control (only cartilage chips). The error bar indicates the 




4.2.3 Co-culture of BMSCs with SZ cartilage results in less cytokine 
production compared to BMSCs-MDZ or BMSCs-OAZ co-cultures. 
 
Cytokines and chemokines can have synergistic or antagonistic effects on cartilage 
catabolism and anabolism, fundamentally influencing tissue phenotype. Both ACs and 
MSCs produce cytokines and other molecules to communicate with neighbouring cells. 
Whether MSCs and ACs produce different cytokines depending on the zonal origin of 
cartilage, is not known. To explore this, supernatants after 48h of co-culture between 
either SZ-BMSC, MDZ-BMSCs and OAZ-BMSCs were probed for the presence of a 
number of cytokines (fig. 18). 
 
Figure 18 Co-cultures of BMSCs and cartilage from different regions release 
different cytokines in the supernatant.  
The supernatant was harvested after 48h of co-culture and assayed to the array 
membrane. Membranes exposed for 5 min to an X-ray film (left) were quantified with 
ImageJ from the three co-culture conditions (right). Dots at the upper left and right 
corners and bottom left corner represent the internal controls (N=1). 
 
The proteome array profile of BMSCs co-cultured with MDZ and OAZ cartilage appear 




signal quantification with image software ImageJ, IL-6, IL-8 and CXCL1 were found in 
the supernatant of the SZ condition and were all also present in the other two 
conditions (fig. 18). The latter two conditions showed the presence of other cytokines: 
CCL2, MIF, SERPINE1, CXCL12. CXCL10 was found only in the MDZ condition and 
MIP-1a in OAZ. The supernatant analysed was shared between the two cell types and 
therefore did not allow the identification of which cells were expressing a specific 
cytokine. The proteome array analysis was performed with samples from a single 
patient. To assess more patients, co-cultured BMSCs were analysed at gene 
expression level for the genes of the cytokines differentially detected by the array (fig. 
19). A supernatant control containing only cartilage chips from the three zones would 
have offered additional information on the cytokines produced by the cartilage chips 
alone but was not performed due to the scarcity of material and the high cost of the 
assay. RNA was also isolated from the co-cultured cartilage. Because of the low 
amount of material and the difficulty of isolating RNA from the ECM bound cells, gene 
expression analysis from cartilage chips was not possible. 
 
 
Figure 19 Gene expression analysis of BMSCs in co-culture with cartilage from 
different regions.  
Samples were harvested for RNA analysis after 48h of co-culture (n=3). Expression 
fold changes are reported relative to BMSCs only control (culture in the same basal 
medium as the SZ and MDZ conditions). Figure A, B, and C display qPCR data from 
three biological replicates (Mann-Whitney non-parametric test was performed on the 
data,  ∗ = p ≤ 0.05). 
 
CXCL10, SERPINE1, MIF were expressed by BMSCs, but no difference was detected 




culture with SZ cartilage. CXCL12 and CCL2 were more expressed by BMSCs co-
cultured with MDZ (fig. 19).  
 
4.2.4 Extracellular vesicles may be involved in the cross-talk between ACs 
and BMSCs and their miRNA cargo is dependent upon the zonal origin 
of chondrocyte. 
EVs are a well-known cell communication mechanism through which BMSCs and ACs 
signal to other cell types. To describe the communication between BMSCs and 
chondrocytes in the experimental conditions presented here, EVs were isolated from 
the supernatant. The BMSCs used for this co-culture experiment were obtained by 
pooling cells from three different healthy donors and remained constant across all the 
experiments in terms of passage number. The cartilage was obtained from 5 different 
patients using tissue from knee lateral condyles. After 48h from the start of the co-
culture, EVs were isolated from the supernatant and analysed. TEM images showed 
that small EVs were present in the supernatant (fig. 20). The EVs showed specific 






Figure 20 Characterisation of EVs present in the supernatant of BMSC-Cartilage 
co-culture. 







Figure 21 Characterisation of EVs present in the supernatant of BMSC-Cartilage 
co-culture.  
Quantification using Nanosight nanoparticle tracking analysis. Averaged 
Concentration / Size for is reported in the right figure, obtained from 6 measurements 
(left). Error bars indicate + / -1 standard error of the mean. 
 
 
To determine the miRNA cargo of isolated EVs, total RNA was isolated from the EVs. 
As expected, RNA obtained from the EVs was extremely low in concentration and 
required a Bioanalyser analysis to accurately determine the concentration and purity 
level. Figure 22 shows representative electrophoretic charts (electropherograms) of 
two RNA sample pairs out of 5 and includes RNA concentrations and RNA integrity 
Numbers (RIN). The electropherograms illustrate the quality of total RNA samples and 
was performed using the RNA 6000 Pico LabChip kit. 5 ng of RNA samples were 
analysed on the Agilent 2100 bioanalyzer. 18S/28S rRNA peaks are not present 
(generally seen at 40 and 47 seconds). For the downstream application of isolated total 
RNA, RINs are generally accepted when above 8. However, because the calculation 
for RIN is based on ribosomal RNA which is not present in EVs, the RNA was still 





Figure 22 EVs isolated RNA concentration and quality.  
RNA concentrations (A) from control conditions (‘MSCs CTRLA’ and ‘MSCs CTRL B’, 
EVs isolated from the supernatant of BMSCs culture in basal medium) and 
experimental conditions (EVs present in the supernatant of MSCs-SZ or -MDZ co-
cultures) was determined with RNA 6000 Pico LabChip kit. For all the experiments, 
BMSCs were from the same pool of BMSCs from 3 healthy donors at passage 5. 
Experimental conditions are paired as SZ and MDZ cartilage were obtained from the 
same patient. B) 4 representative electropherograms are shown, obtained by loading 
5 ng of RNA in the Agilent 2100 bioanalyzer. 
 
The small amount of RNA isolated from EVs was not a limiting factor for the analysis 
of miRNAs. Using low total RNA concentration is possible thanks to the higher 
accuracy of the NanoString technology over RNA sequencing or other gene expression 
analysis methods. Because techniques like qPCR and RNAseq are reliant on reverse 
transcription of RNA to cDNA, they are also prone to technical bias. NanoString is 
based on direct hybridization of reporter molecules to RNA, thus removing the need 
for reverse transcription. This allows for a direct digital count of tagged labelled 
barcodes that eliminates background noise, as shown by Prokopev et al. (Prokopec et 
al., 2013).  The multiplex assay selected for the experiment includes 799 mature 
miRNA and internal control probes against control transcript sequences. Six of these 
sequences are used as positive hybridization controls: positive controls are used to 
confirm linear response to input amounts and confirm that low input signal is above 
background. Eight of the probes are used as negative controls and are used to 
determine background signal independent of ligation success. This was then used to 
set a threshold for defining expression of miRNA. Despite the low RNA concentration 




100 pg/µl), 10 out of 12 samples passed the initials control analysis performed after 
running a nCounter miRNA expression assay. Two samples from the same donor were 
flagged by the analysis software quality control for ligation issues and were excluded 
from further analysis.  
The mean of the negative controls and positive control was removed from the sample 
readout (background subtraction). Only miRNA with a count ≥ 10 in at least one of the 
samples were included. This step was included to avoid including samples with a low 
transcript count as the minimum amount of counts was set to 10. Despite the high 
specificity of nCounter probes, very low levels of non-specific counting are still inherent 
to any NanoString assay. Thus, very low number of counts for each of the targets in a 
CodeSet would represent false positives. This analysis identified 38 miRNAs present 
in isolated EVs. When the miRNAs clusters from each sample were organised in an 
unsupervised dendrogram (fig.23), patients samples clustered separately following the 
cartilage zones, and the BMSC only samples clustered separately from SZ and MDZ 
conditions. 
 
Figure 23 Unsupervised hierarchical clustering of miRNAs that are present in 
EVs from BMSC-Cartilage co-cultures supernatant.  
Dendrogram of miRNAs clusters from each sample. Samples having similar miRNAs 
profiles are closer in the tree. Dendrogram A compares controls (MSC1 and MSC2) 





Among the top 10 miRNAs (those which had the most counts) present in SZ and MDZ 
conditions, 5 were shared (fig. 24). The top 10 miRNAs for each condition are reported 
in table 3 alongside their biological role and potential targets. Out of the 38 miRNAs 
identified, 5 were significantly differentially expressed in SZ and MDZ condition: mir-
188-5p, miR-199a-3p, miR23a-3p, miR451a, miR-612 (figure 25). miR-23a-3p was the 
only miRNA significantly differentially expressed after applying FDR adjustment. 
 
 
Figure 24 Venn diagram for the top 10 genes found in EVs from SZ and MDZ 
samples. 
miRNA with the highest normalised digital count in co-culture BMSC-SZ or -MDZ 






Figure 25 Heatmap of differentially expressed miRNAs from EVs.  
Heatmap showing hierarchical clustering of significantly differentially expressed 
microRNAs, based on normalized digital expression counts, in supernatant samples of 
co-culture of BMSCs-SZ or MDZ cartilage. Each column represents an individual 
sample. Relative expression changes are indicated by the colour scale (Z-score: red 
2; blue -2). 
 
Table 3 Annotated list of the top 10 miRNAs present in EVs from SZ and MDZ 
conditions. 
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Table 3 Annotated list of the top 10 miRNAs present in EVs from SZ and MDZ 
conditions. 
miRNAs are described in terms of biological role (with precedence given to studies on 
musculoskeletal tissues and cells reported in open access papers, when present) and 




(http://mirtarbase.mbc.nctu.edu.tw). Per each miRNA, the targets that were validated 
with the most different methods (including qPCR, western blot, Reporter assay, NGS.) 
or alternatively, reported by the highest number of papers were chosen to be reported 
on the table. MiRNAs which targets were determined only by NGS are indicated with 
*. 
 
miRNAs obtained from EVs isolated from the supernatant of BMSCs were analysed as 
the control condition. SZ and MDZ cartilage alone EVs were not harvested due to the 
limited number of samples that can be obtained from each patient. Figure 26 shows 
the heatmaps of hierarchical clustering of miRNAs, comparing differentially expressed 
genes from the “BMSCs only” condition to SZ or MDZ conditions. For the BMSCs vs 
SZ comparison, 24 microRNAs were significantly differentially expressed, of which 18 
retained significance following FDR adjustment (fig. 27). 22 microRNAs were 
significantly differentially expressed between BMSC vs. MDZ samples and 20 retained 
significance. The top 10 miRNAs found in EVs of the different co-culture conditions are 






Figure 26 Dendrograms of differentially expressed miRNAs in EVs from BMSC-
SZ and BMSZ-MDZ co-cultures vs BMSCs only.  
Heatmap showing hierarchical clustering of significantly differentially expressed 
microRNAs, based on normalized digital expression counts, in supernatant samples of 




to BMSCs only (B). Each column represents an individual sample. Relative expression 
changes are indicated by the colour scale (red: high; blue: low). 
 
 
Figure 27 Venn diagram for the top 10 genes found in EVs from SZ and MDZ vs 
BMSCs only samples.  
miRNA with the highest normalised digital count in co-cultures BMSC-SZ (A) and 
BMSCs-MDZ (B) conditions compared to miRNA found in EVs from BMSCs only 
cultures are reported in the diagrams. BMSCs used across the experiments are from 
the same donors and passage number. Cartilage from either SZ or MDZ were obtained 




The growing number of people affected by cartilage degeneration and related 
conditions are driving biomedical scientists to find novel approaches for cartilage repair 
or to improve current cartilage repair methods. Bone marrow stimulation techniques to 
treat early-stage chondral defects are currently performed but shows variable 
outcomes in patients regarding the quality of regenerated cartilage. The reasons for 
such inconsistency are largely unknown. In this work, we hypothesize that resident 
ACs play a significant role in directing cartilage repair. The aim was, therefore, to 
describe in more detail which cell populations are present in human articular cartilage 




crosstalk between these ACs and BMSCs. More specifically, the goals of this work 
were to establish a method for isolating articular cartilage cell populations with different 
characteristics dictated or determined by their zonal origin and describe the different 
signalling resulting from co-culturing BMSCs with ACs from either SZ or MDZ. 
 
4.3.1 Chondrocyte populations within human articular cartilage and their 
isolation. 
Other groups have published studies describing the use of a dermatome on bovine 
joint tissue to separate the superficial zone cartilage from the middle and deep zone 
(Coates & Fisher, 2014a). We used a surgical dermatome on human femoral condyles 
and obtained three different population of cells that expressed distinct specific gene 
profiles. Superficial chondrocyte markers such as PRG4 and COMP were more 
expressed in SZ ACs than MDZ or OAZ ACs, while the expression of markers for 
differentiated chondrocytes COL10 and COL2 was higher for OAZ and MDZ ACs, 
although not statistically significant. Given the high inter-patient variability of samples 
isolated from articular cartilage, further patient samples would be needed to confirm or 
refute the findings. These results were in accordance with previously published data 
and confirmed that our method was successful for isolating subpopulations with distinct 
phenotypes. Further substantiating the effectiveness of the method, we observed 
different cell morphologies when ACs from different layers were imaged under the light 
microscope. SZ ACs were observed to have an elongated shape, like fibroblasts, whilst 
MDZ ACs exhibited a rounded morphology more typical of a chondrocyte. ACs are 
generally considered a poorly proliferative cell population and we observed this when 
culturing femoral condyle derived ACs. The increased proliferation rate observed for 
superficial ACs suggests the presence of a subpopulation of more proliferative cells. 
In line with that observation, CFU efficiency of SZ ACs was always higher than for 
MDZ.  The CFU proliferation assay result was in accordance with work by several 
researchers that claimed the presence of cells with stem-like properties or progenitor 
cells in the superficial zone. Although there is evidence of different subpopulations in 
the SZ there is no consensus in the literature about their exact characteristics. A 
number of studies have used different markers to identify these cells but the exact 
identity of this subpopulation remains unknown. The elevated CFU count for OAZ ACs, 
although smaller than for SZ ACs, is of note. The OAZ ACs are harvested at the 




from both fibrillated and non-normal looking cartilage. The superficial layer of cartilage 
is the first that is lost in degenerative joint disease, and it is therefore unlikely that the 
cells with high CFU potential are derived from the SZ of OA cartilage. Fibrillated human 
cartilage displays a morphological OA hallmark, termed cell clusters. Some studies 
have suggested the presence of progenitor or stem cell-like cells within the clusters 
near degenerated cartilage. The high CFU observed in the studies presented here 
could, therefore, be explained by the presence of such cells, contained in cell clusters. 
What is the role of cell clusters and why they contain cells with stem-like markers, is 
currently unknown. One hypothesis is that de-differentiating ACs are presenting stem-
cell markers and that the clusters are the result of ACs whose surrounding matrix is 
degraded in the OA environment. Loss of surrounding matrix could result in the 
removal of signals that maintains chondrocytes in a differentiated phenotype that once 
lost induce cells to dedifferentiate. Cell clusters might form or be recruited to the side 
of degenerated cartilage in the attempt to mediate or contribute to cartilage repair. 
 
4.3.2 Co-culture of cartilage from different zones can affect the 
chondrogenic differentiation of BMSCs. 
Co-culturing with primary ACs has been shown to serve as a chondrogenic inducer for 
MSCs. In this Chapter the hypothesis that human ACs differentially influence 
chondrogenic differentiation of BMSCs depending on their zonal origin was tested. A 
previous study by Coates and Fisher showed how bovine cartilage ACs from the SZ 
can direct more efficiently the differentiation of bovine MSCs compared to those from 
the MDZ (Coates & Fisher, 2014). In addition, we wanted to evaluate how the secreted 
factors from different zonal ACs influenced chondrogenesis in a 3D BMSCs culture, 
which is the more standard method to evaluate MSCs chondrogenic differentiation in 
vitro. To set up a co-culture experiment with cartilage from different zones and BMSCs 
we used a transwell system. In this way, the influence of each cell population on the 
other was determined only by their release of soluble factors. Furthermore, we were 
able to harvest separately BMSCs and ACs for further analysis. A chemically defined 
culture medium was used in order to observe strictly the effect of released factors on 
chondrocyte differentiation. In addition, we decided to use BMSCs from the same 
donor and at the same passage in all experiments in order to reduce the variability. 
Despite this experimental design, we still observed variability, in particular with gene 




that the pellets did not undergo significantly enhanced chondrogenic differentiation 
according to gene expression analysis. Contrary to observations in young bovine 
BMSC, the factors released by either of the zonal ACs populations were not able to 
drive MSC chondrogenic differentiation, as indicated by gene expression of COL2 and 
ACAN (Coates & Fisher, 2014). However, the high expression of COL1 in pellets in co-
culture with MDZ and OAZ ACs indicates their undifferentiated or fibrotic state, 
whereas COL1 expression for SZ condition is low. Lack of correlation between gene 
expression and histological analysis can be explained by the fact that COL2 and COL1 
expression rises and falls within three weeks of chondrogenic induction. It is possible 
that at day 21 when the histology was performed, marker gene expression was falling 
as the deposition of matrix for the SZ condition was already established as illustrated 
by the dark purple thionin staining.  In contrast, MDZ and OAZ co-culture led to an 
alternative pattern of gene expression in the BMSC pellets, with transcripts for matrix 
genes more highly abundant at day 21, perhaps reflecting the early stages of active 
matrix deposition. The expression of the hypertrophic marker MMP13 was the highest 
in SZ, then followed by MDZ and OAZ (fig. 15). Expression of metalloproteinases 
results in cartilage breakdown; however, the histological analysis shows pellet 
breakdown and reduced thionin staining in pellet cultured with MDZ and OAZ cartilage. 
Presence of tissue inhibitor of metalloproteinases (TIMPs) in the co-culture could 
explain this observation (Davidson et al., 2006), which have been shown to act as 
inhibitors of metalloproteinases and aggrecanases, which could be confirmed by 
ELISA immunoassay. 
From the data, MDZ and OAZ ACs prevent and even have a negative effect on initial 
chondrogenic differentiation of BMSCs. In data presented here, the AC samples were 
harvested from the SZ of non-visibly affected cartilage, nonetheless the patients might 
have much fewer SZ ACs, or altered subpopulations, due to the age-related thinning 
of the articular cartilage. The experiments performed aimed at understanding the 
signalling that may underlie the interaction between BMSCs and ACs. It was showed 
that ACs from MDZ and OAZ cartilage regions can have an anti-chondrogenic effect 
on BMSCs. To confirm this observation and to determine if the contribution to BMSCs 
differentiation depends upon the factors released from ACs, cartilage chips could be 
treated to cause cell death by for example cycles of freeze/thaw and the co-culture 
experiment then repeated. The relative contribution of released ECM components 





4.3.3 Signalling between MSCs and cartilage differs in term of miRNAs and 
cytokine production depending on ACs zonal origin. 
MSCs have been injected intra articularly in the knee as a therapeutic strategy to 
alleviate OA and influence cartilage repair. Cell tracking studies suggest that MSCs 
only in part act as cartilage building blocks to replenish lost cartilage with new ACs. It 
is now widely accepted that chondrogenic differentiation is not the main mechanism of 
action of MSCs in cartilage repair when administered therapeutically (De Bari & 
Roelofs, 2018). The current hypothesis by which intra-articularly injected MSCs act as 
a therapy in OA is by modifying the micro-environment through the release of paracrine 
factors that stimulate locally present progenitor cells, attract other progenitors to the 
repair region and/or trophic effects on other cells types including immune cells. The 
work described here showed differences in terms of EV cargo and cytokine production 
by MSCs and ACs, depending on their origin close to the subchondral bone or the 
synovial cavity. 
 
4.3.3.1 Cytokine production in BMSCs-cartilage homeostatic and disease 
conditions. 
A commonly described characteristics of MSCs is their ability to be stimulated to 
produce specific types of cytokines, chemokines, and other factors. For example, 
MSCs respond to inflammatory stimuli, such as tumour necrosis factor alpha (TNFα) 
and interferon gamma (IFNγ), by increasing their immunomodulatory properties. 
Various inflammatory cytokines and growth factors have been proposed to be 
fundamental in the development of OA and have been targeted for therapeutic 
intervention. Several studies have shown that IL-6 is one of the cytokines produced in 
the largest quantities by MSCs (L. Chen, Tredget, Wu, & Wu, 2008). Despite its well 
documented proinflammatory functions, for example, anti–IL-6 therapy is effective in 
some diseases, such as rheumatoid arthritis (RA) (Smolen et al., 2013), IL-6 is a 
pleiotropic cytokine that not only acts on the immune system, but also is involved in 
various physiologic events, including hematopoietic stem cell proliferation and 
differentiation, tumorigenesis, proliferation, and differentiation of neural cells (Naka, 
Nishimoto, & Kishimoto, 2002).  IL-6 produced by MSCs contributes to the 
maintenance of the “stemness” of MSCs and exerts proliferative and antiapoptotic 




negative or positive role in cartilage repair might depend on target cells. MSCs steadily 
produce apparently large quantities of IL-6 even under non-stimulatory conditions and 
it is therefore interesting how, when in the presence of SZ cartilage, its expression is 
significantly higher in our system (fig. 19), although IL-6 was identified in the 
supernatant of all co-cultures conditions. These results suggest two possible 
scenarios: that IL-6 is produced by chondrocytes or that posttranslational regulation 
results in reduced release of IL-6. Cytokines mRNA turnover is regulated by post-
transcriptional mechanisms (White, Brewer, & Wilson, 2013) such as miRNA mediated 
mRNA degradation and post-translational regulator like ReagnaseA. ReagnaseA is a 
post-transcriptional regulator of IL-6 expression in human osteoarthritis chondrocytes 
(Iwasaki et al., 2011; Makki & Haqqi, 2015). miR-9 and miR-139 are an example of 
miRNAs that by regulating the expression of RagnaseA increased the expression of 
IL-6 mRNA in OA chondrocytes (Makki & Haqqi, 2015).  
CCL2 and CXCL12 , were both present in the supernatant of BMSCs-MDZ co-cultures 
and transcript levels were higher (p-values just below significant threshold) in MSCs 
exposed to MDZ cartilage compared to SZ cartilage. CCL2, also referred to as 
monocyte chemotactic protein 1 (MCP1), is one of the main mediators of monocyte 
and macrophage migration in cartilage damage.  CCL2 presence in the synovial fluid 
is associated with radiographic OA progression (Longobardi et al., 2018).  Ccl2 
expression is rapidly (<6 hours) induced in whole joints upon surgical joint 
destabilisation in the mouse (Burleigh et al., 2012) and in vitro upon mechanical injury 
of cartilage (Chong et al., 2013).  The principal role of CCL2 in the joint may be to 
recruit leucocytes following joint injury. However, this role is unlikely to be its only action 
in cartilage, as the tissue is essentially avascular, therefore several other mechanisms 
for chemokine action might take place. C-X-C motif chemokine 12 (CXCL12) codes for 
the protein also known as stromal cell-derived factor 1 (SDF1) and is generally 
expressed by synovial cells and its receptor (CXCR4) is present on ACs (Kanbe, 
Takagishi, & Chen, 2002). CXCL12 was shown to have effects on MSC proliferation 
(X. Liu et al., 2011), on osteogenesis and angiogenesis (Hosogane et al., 2010; Reiter 
et al., 2017; Sundararaman et al., 2011), as well as a role in OA. On MSCs, CXCL12 
prevents apoptosis by protecting from oxidative stress and by activating survival 
molecular pathways (X. Liu et al., 2011). Cxcl12 was shown to be upregulated in 
cartilage and synovial fluid of OA animal models,  and to induce MMP13 in ACs (Wei 




chemoattractant of cells involved in inflammation and stem cell migration (G. W. Kim 
et al., 2015; W. Zhang et al., 2013). By blocking Cxcl2, OA progression was halted in 
a study by Lu et al., in a rat OA model showing direct involvement of this pathway in 
the progression of post-traumatic OA (Lu et al., 2016). Similarly to CXCL12, CCL2 can 
act to blocks chondrogenesis thereby limiting MSCs potential for cartilage repair 
(Harris et al., 2013). The elevated presence of the two cytokines could explain the 
inability of BMSCs to undergo chondrogenic differentiation as observed in figure 16.  
Despite its inability to provide a description of the total protein content of the 
supernatant, the proteome array used in this study allowed the presence or absence 
of a relatively large number of cytokines to be determined. Because of the costly nature 
of the array, the experiment was conceived as an exploratory step to determine which 
cytokines were present and if a difference between conditions could be observed. A 
limitation of the experimental setup is the inability to determine which cell population is 
responsible for the production of the cytokines. It is, however, important to underline 
that whichever cell is responsible for producing a certain cytokine, it might be doing so 
as a result of the dynamic cross talk with to the other cell population. Therefore, whilst 
probing the array with cartilage only or BMSCs only supernatant would have provided 
baseline information it wouldn’t have provided insight into the interplay between the 
cell types that might occur during disease, repair or regeneration. To try and identify 
which cells were principally responsible for the combined cytokine profile, gene 
expression studies for selected transcripts were performed on the co-cultured MSCs 
only. The analysis was not performed on cartilage because of the difficulty in isolating 
enough RNA from the cartilage chips retrieved after the co-culture. Furthermore, it 
should be acknowledged that gene expression does not always directly correlate with 
the total amounts of cytokines eventually present in the supernatant. Transduction and 
export of cytokines outside the cell plasma membrane is a tightly post-transcriptionally 
regulated process (Anderson, 2008).  
According to the more recent hypothesis that BMSCs act as immunomodulators to aid 
cartilage repair when recruited or injected, the fact that CXCL12 and CCL2 diminished 
in BMSCs when in contact with SZ cartilage is of interest. In homeostatic conditions, 
knee articular cartilage is intact and predominantly superficial ACs and their 
extracellular matrix is exposed to the synovial fluid, that contains and acts as a point 
of contact with synovial MSCs. When damage occurs, MDZ cartilage is exposed and 




here, MDZ cartilage in contact with BMSCs results in a greater and more varied 
production of cytokines, including anti-chondrogenic CXCL12 and CCL2. Such an 
effect would be important to start a reparative signalling process but if unchecked could 
perpetuate a catabolic effect on cartilage. MSCs are however releasing trophic factors 
that contribute to promote cartilage repair alongside, therefore the effects observed 
are likely nuanced and influenced in the co-culture. 
 
4.3.3.2 EVs: novel means of communication between cartilage and BMSCs 
As mentioned earlier, MSCs are considered to act through their production of trophic 
factors. EVs have been identified to be one of the principal mechanisms mediating 
MSCs regenerative effects in ischemia and pulmonary hypertension (Lee et al., 2012; 
Timmers et al., 2008). 
EVs have only recently gained attention in the context of joint diseases with synovial 
fibroblast and MSC produced EVs mostly studied (Zhang et al., 2018). EVs released 
in the synovial fluid of inflamed joints (both with OA and rheumatoid arthritis) were 
shown to have a role in disease progression. A few studies have investigated EVs 
derived from synovial fibroblasts. In a study by Domenicis et al., exosomes derived 
from advanced OA synovial fibroblasts were added to macrophages, immune cells 
responsible for cytokine production and involved in inflammatory regulation. After the 
treatment, macrophages produced chemokines including MMP13, CXCL1, IL-1β that 
resulted in inflammation and cartilage catabolism (Domenis et al., 2017). This and 
other studies underline the primary role of EVs as a mean of communication of MSCs 
in the knee articulation (Kolhe et al., 2017).  Vonk et al. recently published a study 
indicating that when BMSCs-derived EVs are added to OA ACs, the TNFɑ mediated 
expression of inflammatory molecules and enzymatic degradation is halted (Vonk et 
al., 2018). In addition, EVs had an anabolic effect on ACs, promoting proteoglycans 
and collagen type II production. The results of these in vitro studies suggest that EVs 
hold great promise as a therapeutic strategy for cartilage repair. The advantages in 
terms of therapeutic usage of EVs over MSCs seem numerous. EVs are easier to 
obtain, have long shelf life and are not damaged by freeze-thaw cycles. The avoidance 
of cells also eliminates the immune related issues of allotransplantation (even if MSCs 
are considered immune privileged), the dangers of ectopic migration and engrafting 




secretome encompasses cytokines and growth factors, in addition to EVs. Protocols 
to obtain sufficient amounts of EVs are not yet been satisfactory due to limitations in 
cell growth and large variations among the donor cell types. Furthermore, using MSCs 
has the advantage that the cell can respond to environmental cues when delivered to 
the site of injury, producing regenerative, trophic and anti-inflammatory factors while 
EVs cargo is stable. Further study of EVs and the cells they are produced by are 
needed to improve their therapeutic potential. The role and mechanism of EVs 
produced by ACs, for examples, is largely understudied. 
 
4.3.3.3 EVs contains different miRNA depending on ACs zonal origin. 
The content of EVs includes proteins, mRNA, lncRNA, miRNA. These elements are 
responsible for modulating gene expression resulting in downstream alteration of 
recipient cell function and consecutively physiological and pathological processes. In 
this study, miRNAs were the only type of EV cargo studied.  
The miRNA content of the EVs was assessed using Nanostring technology that allows 
simultaneous investigation of about 800 miRNAs that were chosen because of their 
known biological significance (according to published studies). 38 miRNAs were 
detected in the EVs isolated in this thesis. The top 10 miRNAs from SZ and MDZ 
conditions that are reported and described in table 3 shows how the MDZ miRNAs are 
not well studied in cartilage tissues and cells. The results reported here link for the first 
time these miRNAs to cartilage and MSCs field of study. 
Five miRNAs were significantly differentially expressed between the SZ and MDZ 
conditions, with mi-R188-5p and miR-612 having significant higher expression in MDZ 
and miR23a-3p, in particular, having high expression in ZS along with miR-199a/b and 
miR-451a (fig. 25) 
miR-188-5p is located on the X chromosome and has been reported to be present in 
synovial tissue from RA patients. Downregulation of this miRNA resulted in migration 
inhibition, and its expression was downregulated by exposure to IL-1β. miR-188 was 
reported to be found in MSCs-derived EVs (Y. Nakamura et al., 2015). It was also 
linked to proliferation, migration and invasion of metastatic prostate cancer cells when 
inhibited (Fang et al., 2015). Targets of miR-188-5p include MMP2 and MMP13: by 
downregulating MMPs, miR-188-5p prevented the participation of BMSCs in neo-




miR-188-5p also target MMPs in cartilage, but such a study would be extremely 
relevant for therapeutic strategies aimed at blocking cartilage degradation during OA. 
miR-612 is located on Chromosome 11 and has been shown to target and regulate the 
Wnt and Naong pathways and has inhibitory effects on cell proliferation, migration, 
invasion, and metastasis of hepatocellular carcinoma (Y. Liu et al., 2016; J. Tang et 
al., 2014) No data are present in the literature on the role on miR-612 in cartilage or 
BMSCs. 
miR-451a is a miRNA located on chromosome 17qll.2 whose expression is  regulated 
by hypoxia, and its activity is linked to the proliferation, migration, differentiation and 
regulation of the haematopoietic system (Altuvia et al., 2005). The target genes of miR-
451a include a calcium-binding protein, eukaryotic translation elongation factor, and 
the F-box protein family, as well as proteins relevant to cartilage degradation (MMP2, 
MMP9, ADAM10) and inflammation (IL6R).  Studies that focus on the role of miR-451a 
in cartilage show a link to OA. In a recent study, miR451 was detected as a plasma 
circulating miRNA and could be used as a biomarker for OA (Coutinho de Almeida et 
al., 2019). miR-451a was also shown to be involved with chondrocyte apoptosis (L. 
Tang, Ding, Zhou, & Liu, 2018). miR-451 was found in MSCs-derived EVs and to act 
as a stimulator of cell proliferation and viability in kidney cells (Zhong et al., 2018).  
miR-199a-3p is another of the listed miRNA that seems to target and modulate Wnt 
signalling. miR-199 acts as an activator/inhibitor of endothelial-to-mesenchymal 
transition, targeting β-catenin in Wnt signalling (Zhao et al., 2014). miR-199a-3p has 
been reported to negatively regulate chondrogenesis (Lin et al. 2009; Akhtar and Haqqi 
2012) and have a role in ACs senescence (Tian, Zhang, & Chen, 2014). miR-199a-3p  
validated targets that have a relevant role in chondrogenic differentiation including 
SMAD1 (Lin, Kong, Bai, Luan, & Liu, 2009), CD44 (Henry et al., 2010) and 
Cyclooxygenase2 (Akhtar & Haqqi, 2012).  
Although both miR-612 and miR-199a-3p would be interesting to study further thanks 
to their role as Wnt pathway modulators, no exhaustive study is available to confirm 
that these miRNAs are also regulating Wnt in ACs or chondroprogenitor cells. 
Finally, miR-23a-3p was identified as differentially expressed between SZ and MDZ 
conditions in this study, showing higher expression in the SZ samples. miR-23a-3p is 
located on chromosome 19 and is involved in different cellular processes, including 
proliferation, senescence and ECM synthesis and is found at increased levels in 




2016). miR-23a-3p targets SMAD3, a TGF-β signalling mediator, which is critical in 
cartilage development, homeostasis, and repair (Kang et al., 2016).  Additionally, miR-
23a-3p act to downregulate the expression of COL2 and ACAN (Kang et al., 2016). 
The suppression of miR-23a-3p in OA ACs enhanced chondrocyte-specific marker 
expression (Prasadam & Xiao, 2018). Runt-related transcription factor 2 (RUNX2) was 
identified as a direct target of miR-23a-3p and showed an up-regulation of RUNX2 
levels after experimental downregulation of miR-23a-3p (He, Meng, Shao, Wang, & 
Yang, 2014; Prasadam & Xiao, 2018).  
 
miRNAs detected in EVs from BMSCs alone in culture, cluster separately from miRNAs 
from either SZ or MDZ conditions, as shown in figure 23. It has been postulated that 
SZ chondrocytes would resemble MSCs, as PRG4 positive chondrocytes are putative 
progenitors of ACs.  Looking at the overlap between the miRNAs in SZ and BMSCs 
conditions, 2 miRNAs are present among the top 10 expressed genes, miR-23a-3p 
and miR-125b-3p. No miRNAs are overlapping between MDZ and BMSCs conditions. 
As discussed above, miR-23a-3p is also significantly differentially expressed and 
higher in SZ compared to MDZ conditions, and an interesting miRNA in cartilage 
homeostasis. miR-125p-5p has recently been reported in different studies to regulate 
inflammation in OA. It was reported to act through IL-1β to induce the expression of 
inflammatory genes and cartilage degradation by regulating ADAM4. miR-125p-5p 
stimulates inflammation in chondrocytes via MIP1α signalling. Interestingly, it was 
found in the supernatant of BMSCs-OAZ co-cultures, but not in the other two co-culture 
conditions (fig. 18).  
Further experiments studying the relations between miR-23a-3p and miR-125p-5p 
would help elucidate the different signalling mechanisms between SZ and MDZ ACs, 
and how this difference is important in term of cartilage repair and OA progression. As 
SZ cartilage favoured chondrogenesis of BMSCs pellets compared to MDZ and OAZ 
cartilage in our experiment, miR-23a-3p and miR-199 could potentially be explored as 
a therapeutic in the contest of cartilage repair and regeneration. A caveat resides in 
using miR-23a-3p in cartilage where inflammation is present, as it seems to respond 
to inflammatory stimuli (IL-1β) and potentially having a catabolic effect in OA cartilage 
(Li et al., 2016). miR-23a-3p could be considered in the context of MSCs differentiation 




199 in regulating the Wnt pathway and blocking senescence, this miRNA could be 
explored as therapeutic. 
Promoting apoptosis of synovial cells, and contributing to inflammation via MIPα 
signalling and aggrecanases expression in OA ACs, miR-125 could be potentially 
explored as a target in disease.  
 
4.3.4 Limitations of the study 
One major limitation of the study is the use of cartilage solely from final stage OA 
patients with different previous treatment interventions. The cartilage obtained from the 
macroscopically intact lateral condyle was considered as a “control” but it should be 
kept in mind that OA is considered a whole joint disease and the tissue from this region 
could also have been exposed to pathological stimuli in the form of soluble mediators 
of altered mechanical load. However, also genomic studies use chondrocytes isolated 
from the lateral condyle as relative control (Tachmazidou et al., 2019). To better 
represent the potential treatment group, it would be most appropriate to study articular 
cartilage from younger donors. However, total knee replacement in patients younger 
than 50 years of age is less common and whilst other orthopaedic procedures may 
have provided access to human cartilage, they would have been more sporadic or 
insufficient in terms of tissue amount to enable appropriate studies to be conducted.  
As an alternative, ovine healthy articular cartilage could be obtained to determine if SZ 
AC characteristics, with respect to their MDZ counterparts, reflect the results presented 
here. However, that would limit the observation to an animal model but would permit 
larger-scale experimentation on tissue more closely matched in terms of age.  
In order to study and compare the EVs present in the co-cultures conditions described 
in this chapter, EVs were isolated with a kit that allowed EVs precipitation. The choice 
of methodology for EVs isolation depends on the downstream functional study 
objective. Ultracentrifugation is an effective isolation method that is more cost-efficient 
and more widely used. However, it is time-consuming and it requires large amounts of 
cells. It also might damage vesicles and affect their downstream analysis. On the other 
hand, the method of choice presented here has limited the ability to fully characterise 
the isolated vesicles. EV characterisation following isolation is generally a necessary 
step to determine which subtypes of EVs are produced. EVs were characterised here 




biomarkers CD9, CD63 and CD81. However, the study of EVs was focusing on miRNA 
content, more than their origin derivation, and therefore the exact characterisation of 
the EVs in this context is secondary. Another limitation is that it is not possible to 
distinguish from which cell type the EVs are derived because of the co-culture set up. 
Similar to what was discussed above, the driving hypothesis is that the EVs would be 
produced by either cell type in response to being exposed to each other. It was 
therefore not possible to study such EVs without mixing the two cell populations. 
Theoretically, it might be possible to determine from which cell a subpopulation of EVs 
is derived. Microvesicles originate from the plasma membrane surface, in contrast to 
exosomes, which are of endosomal origin.  Hence, microvesicles should present 
superficial markers that reflect their cell of origin, which could be exploited in flow 
cytometry approaches to achieve sorting. However, several technical limitations are 
associated with sorting EVs to determine their cell of origin. In addition, markers to 
discriminate between MSCs and ACs are not well defined in the literature.   
Another point to develop further is the characterisation of the EVs studied. MSC-
derived EVs are more widely described in the literature than AC-derived EVs. Very few 
studies have investigated EVs derived from articular ACs either ex vivo or from isolated 
cells in vitro. A full characterisation of EVs isolated from SZ or MDZ cartilage is not 




4.4 Summary and future work. 
Chondrocytes isolated from different zones of articular cartilage have distinct 
phenotypes and properties. The influence of resident ACs on cartilage repair is of great 
relevance not only to surgical techniques like bone marrow recruitment techniques and 
ACI but to better understand cartilage tissue in homeostasis and disease. A further and 
deeper analysis of human cartilage layers is required, as they are in fact made up of 
different cell subpopulations. RNA sequencing or single cell analysis would describe 
at the molecular level the specific cartilage subpopulation. The outcome of such 
studies would potentially be a starting point for identifying new cell and molecular 
mechanisms involved in repair or disease, or for discovering new markers to isolate 




This study further supports the presence of proliferative progenitor cells in the 
superficial zone. Such progenitor cells would be useful for determining the molecular 
and transcriptional signatures that cartilage progenitor should possess. Not only would 
this allow us to pin down which specific subset(s) of cells contribute to cartilage repair 
and could potentially be targeted by therapeutics, but also those cells that could be 
specifically isolated for cell therapy. 
Cytokines and chemokines are homeostatically present in the synovial fluid in contact 
with the SZ of knee cartilage and are produced by the heterogeneous population of 
cells present around the synovial cavity: synovial fibroblast, monocytes and blood-
borne cells present in the highly vascularized synovial tissue, fat pad, cartilage. 
Generally, a low degree of inflammation is considered beneficial and necessary to 
recruit specialised cells and induce tissue repair (Haseeb & Haqqi, 2013). After 
cartilage damage, damage-associated molecular pattern (DAMP) endogenous 
molecules signal to immune and other cells to initiate and contribute to the reparative 
response. Immune cells respond by, among others, releasing cytokines. Prolonged 
DAMP signalling may result in overexpression of particular cytokines and induce a 
catabolic effect in cartilage, instead of promoting its repair. In the study presented here, 
SZ cartilage is responsible for promoting different signalling to MSCs, and possibly 
other cell types present in the knee, compared to the MDZ.  
 
Because of the emerging role of EVs in cartilage homeostasis and disease, it is 
fundamental to improve our understanding of how EVs are involved in the initiation, 
progression and modulation of cells in the joint system. As MSC-derived EVs are 
currently being explored and exploited as a therapeutic, it is paramount that a better 
description of their cargo is available. This study has shown for the first time that 
miRNA obtained from SZ-BMSCs and MDZ-BMSCs co-cultures are different. 
Recently, Chen et al. (Y. Chen, Xue, Zhang, Zheng, & Liu, 2018) reported the use of 
rabbit ACs derived exosomes for promoting in vivo chondrogenic differentiation of 
cartilage precursors. When comparing exosomes derived from ACs to exosomes 
derived from BMSCs, the former induced formation of stable cartilage with limited 
hypertrophic markers, and inhibition of angiogenesis compared to the other condition. 
This study, therefore, suggests that obtaining EVs from ACs for use in cartilage repair 
strategies might be more beneficial for cartilage production than EVs from BMSCs. 




culture might be of interest to target different aspects of early-stage OA. Combining 
inflammatory modulation of EVs from BMSCs and anabolic induction molecules to 
repair cartilage tissues could be an interesting strategy to achieve optimal healing or 
regeneration. In this situation, the miRNA contained in the EVs isolated in the 
experiment could be interesting to study further as these EVs are obtained from a co-
culture of the two cell types. 
 
This work showed for the first time that depending on its proximity to the bone or the 
synovial cavity, cartilage signalling varies in terms of EV cargo and cytokine/chemokine 
production. The different signalling factors produced by these different cartilage 
regions could explain the differences in chondrogenic differentiation of BMSCs in these 
studies. Although the observations presented here are only from an in vitro system it 
does indicate the likelihood of differential contributions of distinct chondrocyte 






5 DACT1 and DACT2 in knee joint tissues 
5.1 Background and rationale 
Further investigation of the events that initiate OA is essential to developing strategies 
to arrest cartilage degradation that leads to the disease. The thinning of superficial 
hyaline cartilage is, among other changes including subchondral bone remodelling, 
one of the identified features of the early stages of OA. The SZ of cartilage has unique 
mechanical properties resulting from its distinct proteoglycan and molecular content 
compared to the deeper regions (D. Archer, 1999). Aligned collagen and elastin fibres 
are arranged parallel to surface, whereas they are perpendicular in the MDZ. The 
proteoglycan content and density are also different from the deeper zones. ACs in the 
SZ have an elongated shape and are parallel to the articular surface unlike the more 
spherical chondrocytes in the deeper zones. MDZ ACs have a lower metabolism, both 
in producing proteins and in responding to load. The causal link between the loss of 
SZ and OA initiation has been suggested to be lubricin. Lubricin is encoded by the 
gene PRG4 and binds onto cartilage surfaces forming a molecular monolayer that 
ensures low friction during joint motion, preventing hard contact of the joint extremities. 
The role of Lubricin was identified by studies that selectively removed by enzymatic 
cleavage several molecules found at the cartilage surface (Chan, et al., 2010). 
Furthermore, it was shown in mouse that cartilage containing collagen II  positive cells 
overexpressing PRG4 is protected from tissue degradation after surgery inducing OA 
(Ruan et al., 2013). Finally, the observation that PRG4 expressing cells in the SZ act 
as chondroprogenitors introduces a new level of complexity in understanding the 
relevance of SZ loss in OA (Decker et al., 2017; Kozhemyakina et al., 2015). Whether 
the SZ is a stem or progenitor cell niche that can supply new chondrocytes during 
adulthood is still unclear.  
Mechanical loading, which is pivotal in PRG4 regulation, regulates Wnt signalling 
(Brunt, Begg, Kague, Cross, & Hammond, 2017; Ogawa, Kozhemyakina, Hung, 
Grodzinsky, & Lassar, 2014; Praxenthaler et al., 2018).  PRG4 has been demonstrated 
to be a transcriptional target of TGFß via activation of Smad3, a transducing protein in 
the TGF-ß pathway (Chavez, Sohn, & Serra, 2019). Stem cell maintenance and 
differentiation are regulated by the Wnt and TGFβ pathways (Cleary, van Osch, Brama, 
Hellingman, & Narcisi, 2015; Narcisi et al., 2015). Because of the close relationship of 




is essential to further our understanding of the part that the SZ plays in cartilage 
homeostasis and to find potential therapeutic targets. 
DACT1, DACT2 and DACT3 are proteins at the intersection of the Wnt and TGFβ 
pathways.  DACTs interact with Dishevelled (Dvl), Casein Kinase δ/ϵ, Vangl, Protein 
Kinase A and C, (important in the various Wnt pathways), or with the Alk4/5 TGFβ 
receptors.  Dact1 seems to accelerate Dishevelled2 degradation by promoting its 
ubiquitination leading to aggregate-induced autophagy. As it can bind and facilitate 
Alk5 degradation, Dact2 has been described to be a suppressor of TGFβ-dependent 
wound healing and Nodal-dependent mesoderm induction (Y. Su et al., 2007; L. Zhang 
et al., 2004). These multi-domain proteins are well conserved among bony vertebrates 
and have been identified in mammals, chicken, frog and zebrafish (Schubert, Sobreira, 
Janousek, Alvares, & Dietrich, 2014), suggesting that their role is fundamental in 
developmental processes. Therefore, Dact proteins can positively or negatively 
regulate the Wnt pathway. In the last few years, a role for DACTs in cartilage has 
emerged. Using laser microdissection of rat articular cartilage, Mori and colleagues 
have reported that the expression of Dact2 is significantly (16.5 fold) higher in the 
superficial zone chondrocytes compared to the articular cartilage (Mori, Chung, 
Tanaka, & Saito, 2014). Shubert and colleagues (Schubert, et al., 2014) reported that 
Dact1 and 2 are involved in limb development by integrating Wnt and TGFβ signalling. 
To date, no thorough study is available on DACT proteins in cartilage homeostasis and 
disease or description of these proteins in the context of human joints DACT proteins 
could be interesting mediators of the cartilage reparative process as they are present 
in the superficial, stem cell/progenitor -enriched zone of articular cartilage in rat.  In this 
chapter, the presence of DACT1 and DACT2 were investigated in mammalian tissues. 
Human macroscopically normal and OA samples were analysed for gene and protein 
expression of DACT1 and DACT2. To investigate the presence of DACT during 








5.2.1 DACT1 and DACT2 are present in healthy and OA cartilage. 
The presence, role and regulation of DACT proteins in human articular cartilage had 
not been previously reported, therefore DACT gene expression in the different femoral 
condyle zones and in osteoarthritic full-thickness cartilage was assessed in samples 
from four different patients (fig. 28). To investigate DACT1 and DACT2 expression, 
primers were designed. Studying DACT2 at gene expression level in human cartilage 
was not performed because of inability to design an optimal primer. Primers were 
tested on the RNA isolated from HEK cells, which express both genes. A ready primer 
was also purchased from but failed when tested. RT-qPCR analysis revealed that 
DACT1 is expressed in human adult cartilage (fig. 28). Matched samples from either 
the lateral (non-OA “control”) or medial (“OA”) side from each patient shows that 
DACT1 expression is reduced in OA cartilage. Overall, DACT1 Ct values were low, 
indicating that these genes are likely expressed at a low level in cartilage tissues 
compared to marker genes such as COL2 or ACAN (data not shown). RNA was 
isolated directly from cartilage tissue, by pulverising the cartilage in liquid nitrogen and 
extracting RNA with TriZol reagent. Initially, the experiment was performed on 
chondrocytes that were isolated from cartilage by overnight collagenase treatment. 
Enzymatic overnight treatment was considered as possibly disruptive to the original 
expression of genes as lowly expressed as DACT1. It was decided to opt for a method 
that would maintain the gene expression profile as close as the (patho)physiological 
one as possible. Samples were therefore harvested within two hours from surgery and 





Figure 28 Gene expression of DACT1 in matched OA and non-OA samples. 
qPCR was performed on cartilage samples from either lateral condyle (“Control”) or 
medial condyle (“OA”), linking line indicates samples from the same patient (N=4). 
 
After observing that DACT1 are present in cartilage tissue, protein expression was 
evaluated by immunohistochemistry on cartilage tissue obtained from end-stage OA 
patients undergoing total knee replacement surgery. Immunohistochemistry does not 
allow permit real quantification of the protein of interest but offers qualitative 
information about which cells of the analysed tissue expressed the protein and if it is 
intracellular or extracellular. DACT1 staining (brown) is mostly localised intracellularly 
in cells present in the SZ of cartilage harvested from the lateral condyles (fig. 29), while 
ACs in the MDZ are green (methyl green counterstaining) and show no DACT1 protein. 
The brown staining region is approximately overlapping to the non-GAG rich SZ 
identified by the SafraninO/FastGreen staining (blue). DACT1 staining was visible in 
some of the cells present in the underlying bone. DACT2 was similarly expressed 
mostly in the SZ of the lateral condyle. Occasionally, brown staining in ACs in the MDZ 






Figure 29 DACT1 is expressed in the superficial zone of human articular cartilage. 
Methylgreen counterstaining and immunohistochemistry with DACT1 antibody 
performed on 5 µm thick section from paraffin-embedded samples, after 2 weeks de-
calcification protocol. Chondrocytes staining for DACT1 are in brown and non-stained 
appear green. Rabbit IgG was used as a negative control and SafraninO/FastGreen 
(red: GAGs; light blue: non GAG-rich tissue, bone) to show histomorphology of the 
non-OA cartilage sample. Representative images are shown, error bars = 0.5 mm. 






Figure 30 DACT2 is expressed in the superficial zone of human articular cartilage. 
Methylgreen counterstaining and immunohistochemistry with DACT1 antibody 
performed on 5 µm thick section from paraffin-embedded samples, after 2 weeks de-
calcification protocol. Chondrocytes staining for DACT1 are in brown and non-stained 
appear green. Refer to fig. 29 for controls. Representative images, error bars = 0.5 
mm. Staining was repeated on samples from different patients (N=5). 
 
Because of the differential expression of DACT1 and DACT2 in the “control” 
(macroscopically non-osteoarthritic) condition compared to OA cartilage, OA tissue 
was also assessed with immunohistochemistry. Both DACT1 and DACT2 show 
staining in the cell clusters present in fibrillated cartilage. As a result of OA, cartilage 







Figure 31 DACT1 and DACT2 are expressed OA cartilage. 
Methylgreen counterstaining and immunohistochemistry with DACT1 and DACT2 
antibody performed on 5 µm thick section from paraffin-embedded samples, after 2 
weeks de-calcification protocol. Chondrocytes staining for DACT1 or DACT2 are in 
brown and non-stained appear green (images on the left, scale bar 0.5 mm). 
Representative images, staining was repeated on samples from different patients 
(N=5). Images on the right for DACT1 and DACT2 show details of cell clusters in higher 
magnification. Scale bar = 0.5 mm). IgG control and SafraninO/Fast Green staining 





To determine the subcellular localisation of DACTs in chondrocytes, ACs were 
enzymatically isolated from the articular cartilage samples and immunohistochemistry 
was performed. Confocal microscopy shows that DACT1 and DACT2  are present 
exclusively in the cell cytoplasm (fig. 32). DACT2 is also highly expressed around the 
nucleus, probably in the endoplasmatic reticulum (ER) the cellular organelle 






Figure 32 DACT1 and DACT2 are expressed in the cytoplasm of human 
chondrocytes.  
Immunohistochemistry was performed on chondrocytes isolated from knee cartilage. 
Fixed cells were stained for COL2, DACT1 and DACT2 with primary antibodies at 
concentrations described in table 2.3. Alexa488 secondary antibody (1:1000) was used 
for all stainings. Imaged by confocal microscopy (40x objective). DACT1/2/COL2, 
green; nuclei, blue. Scale bar indicates 50 µm. 
 
Developmentally, the articular cartilage and the synovium derive from the same cell 




therefore hypothesised that DACT1 and DACT2 could also be expressed in the 
synovium. Sections of the synovial membrane obtained from patients undergoing total 
knee replacement were analysed for the expression of DACT1 and DACT2. Synovial 
samples were isolated from the parapatellar region of the knee joint (fig 33). The 
synovial lining cell layer is enlarged, as expected from a sample isolated from a patient 
with advanced OA. 
 
 
Figure 33 Synovial membrane isolated from parapatellar region of human knee 
joints. 
Section of the fat pad and attached synovial membrane are removed during total knee 
replacement by the orthopaedic surgeon (A). Using tweezers and scalpel, the synovial 
membrane (B) is then separated from the fat tissue and processed for histological 
analysis or treated to isolate SynMSCs. 
 
Figure 34 shows immunohistochemistry for DACT1 and DACT2 on the synovium 
obtained from a patient undergoing total knee replacement. The synovium is rich in 
small blood vessels (indicated by arrows) and the synovial lining, which is the side in 
contact with the joint cavity, is visible at the upper end of the images. DACT1 and 
DACT2 (in brown) are mostly staining the same regions: endothelial cells around blood 






Figure 34 DACT1 and DACT2 are expressed in human synovial tissue. 
Methylgreen counterstaining and immunohistochemistry with DACT1 and DACT2 
antibody performed on 5 µm thick section from paraffin-embedded synovial membrane 
samples. Brown DAB staining indicates DACT1 and DACT2 protein and non-stained 
cells appear green. Representative images, staining was repeated on samples from 
different patients (N=3). Control condition used Rabbit IgG and then DAB was applied 
for 20 seconds, as for the other conditions. Scale bars for images on the left, 500 µm; 
Scale bar for images on the right, 50 µm. 
 
5.2.2 Dact2 is expressed in the developing synovial joints of mouse 
Mesenchymal cell condensation at the site of a future joint is a key step in synovial 
joint formation, which is visible from E13.5 (Shwartz et al., 2016) and proceeds to joint 
cavitation development at E14.5 and E15.5. The cells in the prechondrogenic space 
were shown to be GDF5+, the earliest marker of joint formation (Koyama et al., 2008). 




menisci, ligaments and synovium. Because of this common progenitor and the 
observation that DACT1 and DACT2 are expressed in GDF5 derived adult synovial 
joint tissues, DACT1 and DACT2 expression during limb development was examined. 
Limbs were obtained from mouse embryos at embryonic day (E) 13.5, 14.5, and 15.5 
and analysed by immunohistochemistry to describe the expression of Dact1 and Dact2 
in the developing limbs. 
The interzone is visible at E13.5 at the prospective metacarpal-phalangeal and 
interphalangeal joint sites (fig. 35, large arrows). DACT1 staining is not present on 
E13.5 mouse limbs. DACT2 is present on the endothelial cells around blood vessels 
(fig. 37, black arrow heads), and possibly a very weak signal is detected at the 
Interzone. 
At E14.5 the Interzone is still present and the cavitation phase has not yet started. 
DACT1 is not expressed at the interzone, as well as DACT2, which continues to be 
only present around blood vessels (fig. 36, black arrow heads). 
Staining for DACT2 is clearly visible (fig. 37, black arrows) at day E15.5 when joint 
cavitation has begun, and DACT1 and DACT2 are also present on the endothelial lining 
of vessels around the digits. DACT2 staining is also visible at all three stages in the 






Figure 35 Dact1 and Dact2 expression in developing mouse limb at E13.5. 
Immunohistochemistry with Dact1 and Dact2 antibody performed on 5 µm thick section 
from paraffin-embedded limb of E13.5 C57BL/6J mice. Methylgreen was used as 
counterstain. Brown DAB staining indicates Dact1 and Dact2 protein and non-stained 
cells appear green. Black arrow heads indicate positive staining. Control condition 
used Rabbit IgG and then DAB was applied for 30 seconds, as for the other conditions. 
Images on the left shows the whole embryo limb, images on the right show a higher 
magnification of the phalangeal joint site. Large arrows: interzone sites; arrow heads: 





Figure 36 Dact1 and Dact2 expression in developing mouse limb at E14.5. 
Immunohistochemistry with Dact1 and Dact2 antibody performed on 5 µm thick section 
from paraffin-embedded limb of E14.5 C57BL/6J mice. Methylgreen was used as 
counterstain. Brown DAB staining indicates Dact1 and Dact2 protein and non-stained 
cells appear green. Black arrow heads indicate positive staining. Control condition 
used Rabbit IgG and then DAB was applied for 30 seconds, as for the other conditions. 
Images on the left shows the whole embryo limb, images on the right show a higher 
magnification of the phalangeal joint site. Large arrows: Interzone sites; arrow heads: 





Figure 37 Dact1 and Dact2 expression in developing mouse limb at E15.5. 
Immunohistochemistry with DACT1 and DACT2 antibody performed on 5 µm thick 
section from paraffin embedded limb of E16.5 C57BL/6J mice. Methylgreen was used 
as counterstain. Brown DAB staining indicates Dact1 and Dact2 protein and non-
stained cells appear green. Black arrow heads indicate positive staining. Control 
condition used Rabbit IgG and then DAB was applied for 30 seconds, as for the other 
conditions. Images on the left shows the whole embryo limb, images on the right show 
a higher magnification of the phalangeal joint site. Large arrows: interzone sites; small 
arrows: cells at the cavitation zone; arrow heads: endothelial cells; stars: tendons and 
skeletal muscle. Scale bars = 0.5 mm. 
 
5.2.3 Dact1 and Dact2 are expressed in the mouse knee 
Descriptive studies of Dact1 and Dact2 in mouse adult synovial joints have not been 




mouse limbs were obtained from 2 weeks old C57BL/6J mice and processed for 
immunohistological analysis. Dact1 expression is weakly present at the cartilage 
surface and in bone marrow cells (fig. 38, black arrow heads), synovial lining (fig. 38, 
arrows) and menisci (fig. 38, blue arrow heads). Dact2 expression reflects Dact1, 
although its staining appears more intense. 
 
 
Figure 38 Dact1 and Dact2 are expressed in adult mouse knee.  
Methylgreen counterstaining and immunohistochemistry with Dact1 and Dact2 antibody 
performed on 5 µm thick section from paraffin-embedded knees of 2 weeks old C57BL/6J, 
after decalcification protocol. Brown DAB staining indicates Dact1 and Dact2 protein and non-
stained cells, and cartilage tissue appear green. Black arrow heads indicate positive staining 
in the cartilage tissue, blue arrow heads in the meniscus, black arrow in the synoviual lining. 
Control condition used Rabbit IgG and then DAB was applied for 15 seconds, as for the other 
conditions. Scale bars for images on the left, 200 µm; Scale bar for images on the right, 50 





Immunocytochemistry of ACs isolated from one-week-old mouse femur heads shows 
Dact2 expression in the cytoplasm of the cells (fig. 39). As described for figure 32, 
Dact2 signal is particularly strong on around the nucleus, probably in the ER. Dact1 
showed no expression in mouse chondrocytes. 
 
Figure 39 Dact2, but not Dact1, is expressed in the cytoplasm of mouse 
chondrocytes.  
Immunohistochemistry was performed on mouse chondrocytes isolated from the hip 
cartilage. Fixed cells were stained for Col2, Dact1 and Dact2 with primary antibodies 




used for all stainings. Imaged by confocal microscopy (40x objective). Dact1/2/Col2, 
green; nuclei, blue. Scale bar indicates 50 µm. 
  
 
5.2.4 DACT1 and DACT2 are expressed in Synovial- and Bone Marrow-
derived MSCs. 
Because of the presence of DACT2 in the sites of early synovial joint formation in 
mouse, it was hypothesised that adult mesenchymal MSCs may express DACT 
proteins. Immunocytochemistry of MSCs isolated from the bone marrow of healthy 
donors (purchased from and previously characterised by Lonza) was performed. 
Figures 40 and 41 show DACT1 and DACT2 expression in BMSCs and SynMSCs 
respectively. Both proteins appear mostly expressed in the cytoplasm, which support 
the role in signalling transduction observed in other cell types. DACT1, in particular, 
localises on the side of the nucleus, probably in the ER. 
 
 
Figure 40 DACT2 and DACT1 are expressed in the cytoplasm of human BMSCs. 
Immunohistochemistry was performed on MSCs derived from bone marrow of healthy 
donors, passage 4 (Lonza). Fixed cells were stained for DACT1 and DACT2 with 




secondary antibody (1:1000) and Phalloidin-Alexa555 (1:40,000) was used to stain 
actin filaments. Rabbit IgG used as a negative control (“Control”). Imaged by confocal 
microscopy (40x objective). DACT1/2, green; actin filaments: red; nuclei, blue. Scale 
bar indicates 50 µm. 
 
 
Figure 41 DACT2 and DACT1 are expressed in cytoplasm of human SynMSCs. 
Immunohistochemestry was performed on MSCs derived from MSCs isolated from the 
synovial membrane of patients undergoing knee replacement.bone marrow of healthy 
donors (passage 1). Fixed cells were stained for DACT1 and DACT2 with primary 
antibodyes at concentrations described in table 2.3. Alexa488 secondary antibody 
(1:1000) was used for all stainings. Phalloidin-Alexa555 (1:40,000) was used to stain 
actin filaments. Rabbit IgG used as a negative control (“Control”). Imaged by confocal 
microscopy (40x objective). DACT1/2, green; actin filaments: red; nucles, blue. Scale 







5.3.1 DACT1 and DACT2 are expressed in human and mouse knee joints 
and are modulated in human OA cartilage. 
DACT proteins are known regulators of two of the most important pathways in cartilage 
development and homeostasis, Wnt and TGFβ pathways (C. W. Archer, Dowthwaite, 
& Francis-west, 2003). The involvement of the Wnt pathway in cartilage development 
and the pathogenesis of OA has been investigated and described in many animal 
models. TGFβ signalling is extensively studied for its role in regulating all stages of 
differentiation of chondrocytes, as well as chondrogenic and osteogenic differentiation 
of mesenchymal cells. For example, the potential of BMPs (members of the TGFβ 
superfamily) to induce cartilage formation has been explored in several pre-clinical 
studies (reviewed by (Deng, Li, Gao, Lei, & Huard, 2018). Recent interesting studies 
have begun to recognise how in joint development the two pathways are 
interconnected. When Wnt and BMP signalling are misregulated following lack of 
mechanical stimuli, β-catenin activation is reduced and concomitantly pSMAD1/5/8 
signalling is upregulated and the joint then develops abnormally (Singh et al., 2018). 
The interplay between Wnt and TGFβ pathways seems to regulate the fate decision of 
progenitors to cartilage differentiation: the activation of Wnt/β-catenin signalling is 
concomitant to downregulation of BMP signalling. The two pathways are involved in 
movement-induced development of joints and this regulation is conserved across 
vertebrate species. 
The studies presented here show, for the first time, the expression of DACT1 in human 
articular cartilage, both at gene and protein level. The expression of DACT1 in articular 
cartilage suggests that it may act as a modulator of cartilage homeostasis and 
development. In human articular cartilage, DACT1 and DACT2 are more expressed in 
SZ compared to MDZ (fig. 29 and 30). In the adult mouse knee, Dact2 is also clearly 
expressed in the SZ of articular cartilage. This result mirrors what has been reported 
by Mori and colleagues (Mori et al., 2014) in rat articular cartilage. Data described here 
show that Dact1 expression in mouse chondrocytes (fig. 39) is not conclusive. 
Immunohistochemistry is negative for Dact1 in chondrocytes isolated from 1-week old 
mouse hip cartilage, and the staining in adult knee is weak. The antibody purchased 
for visualising DACT1 recognises both human and mouse (DACT1 is very well 




confirm the expression of Dact1 in mouse cartilage. Another reason for the weak 
staining observed could be low expression of Dact1. According to the online Human 
Protein Atlas website (Uhlén et al., 2015), DACT1 is mostly expressed in the brain and 
only very weak expression is found in other organs, particularly those of mesodermal 
origin (kidney, urogenital and lymphatic tissues). Histological samples reported in the 
atlas, show DACT1 is often clearly visible in endothelial tissues, like the inner layer of 
vessels, which is also clearly observable in figure 34. Similar to that reported in this 
chapter, studies by Sensiate et al. and Shubert et al.  on DACTs during chick embryo 
limb development show that Dact2 appears more expressed than Dact1 in the 
interphalangeal and metacarpal-phalangeal joints (Schubert et al., 2014; Sensiate et 
al., 2014).  
Since the start of this investigation on the presence of DACT1 and DACT2 in human 
cartilage, one paper was published that reported the presence of Dact1 in human 
cartilage. Chou and colleagues (2015) compared gene expression between the medial 
and lateral compartment of OA knees to identify severity associated genes. DACT1 
was identified, both by array and qPCR, to be one of the top down-regulated genes in 
severely damaged cartilage across 42 human samples. However, this study does not 
provide information about the protein expression of DACT1, nor offer a description of 
the molecular mechanism of DACT1 in OA chondrocytes.  
Gene expression data on DACT1 showed a reduction in gene expression of DACT1 
(fig. 28). Post-translational regulation might explain the strong protein expression of 
DACT1 and DACT2 localised to cells in OA cell clusters at the edge of fibrillated 
cartilage (fig. 31). Cell clusters are defined as 6 or more cartilage cells residing in one 
large lacuna and their role or significance is still not fully understood (Lotz et al., 2010). 
This type of cell organization is well described in OA cartilage and it is thought to result 
through cells migrating from degrading matrix and then proliferating (Graverand et al., 
2001; Lee, Paul, Slabaugh, & Kelley, 2000; Pfander, Swoboda, & Kirsch, 2001). The 
phenotype of the cells residing in cartilage clusters have not been thoroughly 
delineated, so it is not known if clusters are composed of clonal cell populations or 
heterogeneous chondrocytes and whether they include cartilage progenitors. As a 
consequence, it is not fully understood if cell clusters are simply the result of cell 
migration in response to damage or if they have a role in cartilage repair (Lotz et al., 
2010). A recent study on human tissue has suggested that cartilage cell clusters 




2015). More studies have since used CD146 as a marker to identify OA-MSCs (X. Su 
et al., 2015). This marker was shown to be expressed on some of the cells contained 
in OA clusters, arguing that OA cell clusters contain both stem and differentiated 
chondrocytes (Jayasuriya et al., 2018). Elucidating further the role of DACT1 and 
DACT2 in ACs biology could extend our understanding of the origin and purpose of 
cell clusters. 
 
5.3.2 Dact2 is found at the Interzone of developing mouse joints. 
Limb development has been studied in mouse and chick embryos to identify the 
molecular pathways governing bone and cartilage formation in joints (Pitsillides & 
Ashhurst, 2008). As previously described, following the formation of the limb bud, a 
condensation of mesenchymal cells start differentiating into chondrocytes and all the 
cells that form the limb (Kronenberg, 2003). The stages of rodent limb embryonic 
development are well characterised with the stages at which joint structure start 
forming well documented (P. Martin, 1990; Mitrovic, 1978). Around day 14.5, the 
cartilaginous template starts to get replaced by bone. Muscle myosin chains are 
present in the limbs from day 11.5, and by day 14.5 muscle and nerves in the limbs 
are mature. From E13.5 the interzone forms, and by E15.5 the distal phalanges are 
also developed. By the later phases of embryogenesis, the interzone begins to 
cavitate, forming two separated articular surfaces joined by synovial fluid (Koyama et 
al., 2008). Cavitation occurs in a proximal to distal fashion as limb joints develop, with 
the most distal phalangeal joints initiating cavitation by late embryogenesis, and 
completed in early postnatal life (Mitrovic, 1978). 
In the data presented here, Dact2 starts to be expressed in the interzone, although 
only weak signal is detected, and this becomes clearer when cavitation starts. Dact1 
signal is not convincingly detected in these stages of the developing joint. To more 
broadly compare these results, the MGI online database was consulted (Bult et al., 
2019). This specific database indicates that Dact1 and Dact2 genes are expressed in 
the mouse, including in the “musculoskeletal system”.  The database also includes 
developmental analysis of genes. In situ hybridisation shows that dact1 is more 
expressed than dact2 in the interdigital joint space and the metacarpal-phalangeal 
joints (fig. 42). In the developing chick however dact2 appears more expressed and 




chick embryo studies were primarily exploring limbs, whereas the mouse embryo 
database reports a whole-mount histology, with limbs not being in the most optimal 
position to investigate gene expression in the limb. For that reason, the chick embryo 
study might be more indicative of gene expression of Dact2. As previously discussed, 
a different antibody for Dact1 should be considered to confirm protein expression in 
the developing joints.  
 
Figure 42 Whole embryo in situ hybridisation of Dact1 and Dact2. 
Figures were obtained from the International Database Resource for the Laboratory 
Mouse. In situ hybridisation was performed for Dact1 and Dact2 mRNA on mouse 
embryos E14.5 (The jackson laboratory, n.d.). 
 
 
Taken together, these studies suggest a link between Dact1 and Dact2 and joint 
development. The data reported in this chapter shows that Dact2 is present at protein 
level in the prospective joint space and might, therefore, be playing a role in the 
regulation of joint formation in the mouse.  
 
5.3.3 DACT1 and DACT2 are expressed in BMSCs and SynMSCs. 
Recent evidence in mouse and humans shows that cells residing in the SZ of cartilage 
are different from the chondrocytes in the MDZ of articular cartilage. Lineage tracing 
studies following the progeny of Gdf5-expressing cells have shown that articular 
cartilage and synovium have a common progenitor as cells that have expressed GDF5 
go on to express PRG4 (Roelofs et al., 2017). Because cells of the progenitor lineage 
are both present in the cartilage SZ and synovial membrane, and both DACT1 and 
DACT2 are present in the SZ, the expression of  DACT1 and DACT2 was investigated 
in the synovium. The knee joint relies on the synovium for nutrients and removal of 
waste product from chondrocytes metabolism and articular matrix turnover. The 
synovium is rich in blood vessels and acts as a semipermeable membrane allowing 
molecular and nutrient exchange with the synovial fluid to maintain the articulation 




particular in the synovial lining layer. Most cells present in the lining layer are of 
fibroblastic and macrophage origin. Macrophages are responsible for removing by 
phagocytosis damaged cells. In a recent paper, Culemann and colleagues showed that 
another role for the macrophages in the synovial lining is to create an immunological 
barrier to between the inflamed joint and the bloodstream (Culemann et al., 2019). 
Whether DACT proteins are also expressed by these tissue-specific macrophages is 
not known.  
As MSCs differentiation potential and maintenance are well known to be regulated by 
Wnt and TGFβ pathways, it was hypothesised that MSCs would express DACT1 and 
DACT2. In addition to bone marrow, the synovium is also a source MSCs. SynMSCs 
display excellent chondrogenic differentiation potential in vitro and are thought to 
participate in cartilage repair (Roelofs et al., 2017). MSCs isolated from the synovium, 
as well as BMSCs, show expression of both DACT1 and DACT2. DACT1 was 
described to be part of Wnt signalling in regulating adipose differentiation and general 
fate determination of C3H10T1/2 (Zhou et al., 2016). There is however no information 
available on the presence and role of DACT1 and DACT2 in primary MSCs. 
 
5.3.4 Limitations of the study. 
Despite having shown that in four different patients DACT1 and DACT2 are modulated 
by OA, more samples are needed to reach a statistically significant result because of 
interpatient variation. In addition, because the control samples are collected from 
patients with end-stage osteoarthritis, proper control would possibly provide a clearer 
difference in expression between OA and normal tissue. To confirm the differential 
gene expression at protein level, further analysis should be performed. Isolating protein 
from cartilage tissues has proven difficult without enzymatic digestion of the matrix to 
obtain single cell chondrocytes. It should be then ensured that the low 
expression/presence of DACT1 and DACT2 in chondrocytes would not be altered by 
such overnight enzymatic digestion and cell culture. Due to inter-patient variability and 
the low amount of sample, it was not possible to isolate RNA from SZ and MDZ chips 
to analyse DACT1 and DACT2 expression in different zones. Histological analysis of 





Information about the expression of DACT1 and DACT2 in cartilage that is not exposed 
to mechanical loading is missing, as samples analysed here were obtained from the 
knee condyles. The Wnt pathway is known to be regulated by mechanical loading and 
a study of DACT1 and DACT2 expression in cartilage from different location would 
shed light on their regulation.  
Despite the obvious limitation of using mouse for modelling and studying genes that 
affect human limb development, mouse embryo histology was able to provide 
information on DACTs expression in limb development. Whereas organoid cultures of 
other organ/tissues (such as intestine and liver) are allowing study of patterning and 
signalling pathways on human tissue, knee osteochondral organoid or cartilage/bone 
differentiated iPSCs technology are not readily available. Human samples to study limb 
development are generally difficult to obtain. DACT genes have a high degree of 
evolutionary conservation, not just in mammals, but in all vertebrates (Schubert et al., 
2014). It therefore likely that DACTs developmental mechanism extrapolated from 
mouse would be similar in human. In support of this claim, data reported in this chapter 
shows parallel expression of both proteins in mouse and human adult cartilage tissues. 
 
 
5.4 Summary and future work. 
The SZ of articular cartilage is believed to host a subpopulation of chondrocyte 
progenitors that regulate tissue homeostasis and might be involved with cartilage 
repair and OA progression. In order to develop therapeutic strategies to heal cartilage 
damage, resident cartilage progenitors were explored by studying the presence of Wnt 
and TGFβ signalling modulators DACT1 and DACT2. Both are present at gene and 
protein level in adult human cartilage and synovium, and in OA their expression is 
altered. Despite the consensus in the literature about DACT1 and DACT2 being part 
of the molecular mechanisms involved in Wnt and TGFβ signalling pathways, upstream 
regulators or signals determining their gene transcription are unknown. One approach 
to investigating what might regulate DACT1 and DACT2 during OA progression could 
be to understand if inflammatory cytokines influence either MSC or chondrocyte 
expression of these genes.  
It was also shown in this chapter that DACT1 and DACT2 are present in mouse 




are also present in human SynMSCs and BMSCs. The implications of a link between 
progenitors (either during development or in adult tissues) and DACT proteins are a 
strong motivation to continue investigating the role of DACT in articular cartilage. 
Although the role of DACT1 and DACT2 has been described in the literature, 
particularly in cancer cells, no information about the specific role in chondrocytes or 
MSCs is available. Shedding light on the role of DACT1 and DACT2 would be 
advantageous to cartilage repair and regeneration strategies. DACTs role in cartilage 
could also help to define the molecular mechanisms underlying osteoarthritis (OA). 
Notably, activation of β-catenin in ACs in adult mice led to the development of an OA-
like phenotype (Zhu et al., 2009). β-catenin levels are increased in human OA sample 
and variants of the FRZB gene are associated with OA (Loughlin et al., 2004). Initial 






6 Investigating the role and mechanism of DACT1 and DACT2 in 
MSCs. 
6.1 Background and rationale 
Canonical Wnt signalling is believed to play a central role in the progression of OA and 
is involved in many aspects of cartilage development and homeostasis. In parallel, the 
TGFβ pathway has been shown to actively contribute to the regulation of joint 
maintenance and to be deregulated in various tissues suffering from OA.   
Depending on the receptor activated and intracellular signalling molecules, different 
Wnt signalling pathways can be activated: the planar cell polarity (PCP) and Wnt/β-
catenin pathways often referred to as ‘canonical’, are the best described. DACTs 
proteins are primarily known to bind to DVL, which is the first signal transduction protein 
of the three Wnt pathways. In the canonical pathway, DVL causes the disruption of the 
GSK3β-Axin-β-catenin complex by inhibiting GSK3β. β-catenin is then not 
phosphorylated, and therefore destroyed, but can accumulate and be transported to 
the nucleus where it activates target gene expression (fig. 43). The PCP pathway is 
less well characterized than the canonical pathway and also relies on DVL interaction 
with downstream effectors after Wnt binding to the FZD receptor. In the PCP pathway, 
downstream effectors of DVL include the small GTPases RHO and RAC (fig. 43). At 
the same time, DVL also influences the degradation of the alternative receptor to FZD, 
Pk. DVL binds to the ubiquitin ligase SMURF to promote the ubiquitination of Pk that 
gets then degraded (Narimatsu et al., 2009). How the common FZD-DVL distinguishes 
among different Wnt pathways is unclear.  
The TGFβ signalling pathway relies on transmembrane type I and type II 
serine/threonine kinase receptors to transmit signals to the intracellular effector SMAD 
proteins. Seven different receptors, activin receptor‐like kinases (ALKs) exist that 
selectively phosphorylate different complexes of SMADs.  Upon BMP binding to ALK 
1, 2, 3 and 6, SMAD 1/5/8 are phosphorylated. In contrast, TGFβ binds ALK 4, 5, and 
7 which signals through activation of SMAD 2/3. BMPs are regulated by different 
inhibitors that by competitively interacting with them blocks their binding to the 
receptor. These inhibitors include Noggin, inhibitory SMADs (SMAD6 and SMAD7), 




The cross-talk between the Wnt and TGFβ pathways has been reported in several 
cartilage studies. For examples, BMP-2 enhanced mesenchymal differentiation to the 
cartilage lineage through upregulation of master regulator of chondrogenesis SOX9 
(Jin et al., 2006). This is achieved by downregulating Wnt/β-catenin expression as 
overexpression of β-catenin results in proteasome degradation of Sox9 via 
ubiquitination. Another example of the interconnection of the two pathways is the 
number of shared receptors and ligands such as sclerostin (Wnt antagonist that 
competitively binds to LRP5/6 receptor and modulates BMP signalling (Xiaofeng Li et 
al., 2005; Winkler et al., 2005)) and CTGF (regulated by WNT3a and BMP-9, and can 
bind to BMP-4 and TGFβ (J. G. Abreu, Ketpura, Reversade, & De Robertis, 2002). A 
third example is the complex interaction of cytoplasmic proteins belonging to each 
pathway. Synergistic signalling between Wnt and TGFβ pathway proteins results in 
enhanced chondrogenic differentiation (Im & Quan, 2010; Narcisi et al., 2015; Shuanhu 
Zhou, Eid, & Glowacki, 2004).  Due to the complex interactions of Wnt and TGFβ 
pathways, the exact underlying molecular mechanisms linking the two pathways 
remains elusive, but its relevance to better understanding cartilage disorders and its 
regeneration appears clear. 
DACT1 and DACT2 act on both Wnt and TGFβ pathways (Y. Su et al., 2007). The 
cytoplasmic form of DACT1 can induce DVL degradation via a lysosome-dependent 
mechanism. In the nucleus, DACT1 can prevent the formation of LEF1:β-catenin 
complexes at target gene promoters (X. Gao et al., 2008). In both these cases DACT1 
acts as a Wnt signalling antagonist. DACT2 has also been shown to have a negative 
effect on Wnt canonical pathway (S. Wang et al., 2015). DACT2 overexpression 
negatively regulates TGFβ signalling by binding and targeting ALK4 and ALK5 for 
degradation (Y. Su et al., 2007; L. Zhang et al., 2004). Other studies report DACT1 
and DACT2 as positive regulators of the Wnt pathway (Waxman, Hocking, Stoick, & 
Moon, 2004). DACT1 was proposed to inhibit GSK3β, which results in increased 
intracellular β-catenin levels ensuring activation of target genes (Yuan et al., 2012). 
The double regulation has been clear since the earliest reports of DACTs (Cheyette et 
al., 2002). The ability to act both as positive and negative regulator seems to be 
dependent on the phosphorylation state of DACT1: DACT1 take on an inhibitory role 
when unphosphorylated, and promotes Wnt signalling when phosphorylated (Teran, 
Branscomb, & Seeling, 2009). As previously discussed, which pathways DACT1 and 




Biochemical studies have shown that the PCP pathways is regulated by DACT1 by its 
binding to DVL, as it is disrupted in the developing tissues of mouse Dact1 KO 
(Suriben, Kivimäe, Fisher, Moon, & Cheyette, 2009; Wen et al., 2010). 
 
Figure 43 DACT1 modulates Wnt and TGFβ pathways. 
In the canonical Wnt pathway (A) and PCP/Wnt pathway (B) DACT1 can activate gene 
expression by either binding to DVL, that results in the degradation of GSK3β-Axin- β-
catenin complex, or by inhibiting GSK3β. β-catenin is then not phosphorylated but can 
accumulate and be transported to the nucleus where it activates target gene 
expression. In the TGFβ pathway (C), DACT2 targets ALK4/5 for degradation blocking 
SMAD2/3 activation. Original work. 
 
Because of the relevance of Wnt and TGFβ pathways in both MSCs and chondrocytes, 
it was hypothesised that DACT1 and DACT2 would act as a mediator in these 
pathways. In this chapter, DACT1 and DACT2 silencing through RNAi were performed 
on MSCs and ACs to investigate their role. After observing a clear effect of DACT1 
knockdown on cell survival, Wnt target genes upon DACT1 silencing were tested. 
WNT3a and inhGSK3β were then used to determine if the phenotype of DACT1 
silenced MSCs could be rescued. Finally, an RNA sequencing study on DACT1 
silenced MSCs was performed in the attempt to determine DACT1 targets molecules 




6.2.1 DACT1 knockdown in MSCs and ACs results in cell death. 
To investigate the role of DACT1 and DACT2 on MSC in vitro, RNAi was performed. 
RNAi on BMSCs, SynMSCs and ACs, was optimised using GAPDH siRNA as a 




determine the optimal RNA interference conditions (data not shown). Despite the use 
of primary cells, effective silencing (>75%) was achieved in all cells (figure 44). Control 
cells were included in all silencing experiments, transfected with negative control 
siRNA (siCTRL). The conditions that were used throughout this chapter were 10 µM 
siRNA mixed with 2.55 μL of lipofectamine per mL of media, and a seeding density of 
MSCs 8000 cells/cm2, such that cells were around 50–60% confluent upon transfection  
applied on the following day. Seeding conditions for chondrocytes were about 10,000 
cells/cm2. In order to determine the efficiency of the knockdown performed with RNAi, 
qPCR primers were designed for DACT1 and DACT2. DACT1 primers were identified 
and successfully tested for efficiency on RNA from isolated chondrocytes. DACT2 
primers were designed or taken from publications but failed to prove efficient for RT-
qPCR analysis. It was then decided to continue the study primarily on DACT1. 
MSCs were incubated with either a negative control siRNA or target siRNA (siDACT1) 
for 1 day or 5 days before mRNA was harvested and amplified by RT-qPCR (fig. 44). 
Images of the cells were taken each day with a light microscope to assess the effect 
of the silencing on cell morphology. The results show that after normalising to the 
housekeeping gene HPRT1, there was a significant reduction in DACT1 mRNA 
expression levels (81±18 % after 24 hours and 93±3 % after 5 days) relative to the 
control conditions.  
The silencing was also performed on chondrocytes isolated from knee condyle tissue 
by enzymatic digestion (passage 1). Although tested on only one patient sample, 
silencing showed high efficiency both after one day following silencing, as well as 5 
days after. Due to larger inter-patient variability and inconsistent accessibility to donor 
tissue, as well as a consequence difficulty in performing parallel and relative 
experiments on passage one ACs, further studies on DACT1 were conducted in 







Figure 44 Silencing efficiency of DACT1 in MSCs and ACs.   
qPCR was performed on A) patient derived MSCs (N=7 for Day1, N=3 for day 5) and 
B) ACs (N=1, error bars indicate the SD of technical replicates). Silencing was 
performed on ACs at passage one, and BMScs at passage 4-5. Relative expression 
was calculated with 2^-ΔΔCt method. (Mann-Whitney non-parametric test was 
performed on the data, ** indicates p < 0.01). 
 
Light microscopy of silenced BMSCs and SynMSCs did not show detectable 
morphological differences at day 1 after silencing (fig.45 and 46). The siCTRL condition 
shows after 5 days an expected level of proliferation and cells appear fibroblastic and 
healthy, without evident morphological differences to normal untreated cells. That 
indicates that the amount of lipofectamine used was not toxic to the cells. siGAPDH 
showed similar results. 5 days after transfecting with siDACT1, both BMSCs and 
SynMSCs showed not only lack of proliferation, but fewer cells were present in the 
wells. Few cells remained attached to the well and floating (rounder cells) cells were 
visible in the media. The siDACT2 condition showed no evident differences in 
morphology and proliferation and was comparable to the control condition. 
 
Figure 45 BMSCs silencing of DACT1 affects cell proliferation and survival.  
Light microscopy pictures of BMSCs passage 4-5, isolated from BM healthy donors 
(Lonza). Silencing was applied the day following seeding at 60-70% confluence (N=4). 
In siCTRL condition a scrambled miRNA was transfected as a negative control, 






Figure 46 SynMSCs silencing of DACT1 affects cell proliferation and survival. 
Light microscopy pictures of SynMSCs passage 1, isolated from the synovium of 
patients undergoing total knee replacement. Silencing was performed on the day 
following seeding at 60-70% confluence (N=3). In siCTRL condition a scrambled 
miRNA was transfected as a negative control, siGAPDH was transfected as a positive 
control. Scale bar = 200 µm. 
 
Plated chondrocytes were smaller and rounder in morphology two days after plating 
(fig. 47, day 1).  Proliferation after 7 days was limited, as expected for slow cycling 
chondrocytes. After one day from applying the silencing, cells show no visible 
morphological differences. To clearly observe the same anti-proliferative effect and 
reduction of cells, more time was needed in comparison to the more metabolically 
active MSCs. Similarly to that observed in BMSCs and SynMSCs, the siDACT2 







Figure 47 ACs silencing of DACT1 affects cell proliferation and survival.  
Light microscopy pictures of ACs passage 1, isolated from lateral knee condyle 
cartilage of patients undergoing total knee replacement. Silencing was performed on 
the day following seeding 80% confluence (N=2). In the siCTRL condition, a scrambled 
miRNA was transfected as a negative control, siGAPDH was transfected as a positive 
control. Scale bar = 200 µm. 
 
The effect on proliferation and survival of BMSCs was further investigated with two 
different assays. The proliferation of cells was observed 72 hours from silencing and 
showed that by 48 hours from silencing, the cells were still attached to the well were 
fewer than at the time of silencing (fig. 48). Treatment with siDACT2, on the other hand, 
showed an identical trend in proliferation to the control condition. 
 
 
Figure 48 Real-time effect of DACT1 silencing on BMSCs proliferation and 
survival over 72 hours.  
BMSCs from healthy donors (Lonza) were seeded in XCELLigence E-plates and their 
impendence measured every 15 minutes by XCELLigence RTCA (N=4). Cell Index 
measurements were normalised to the time of silencing. The control condition was 
transfected with a scrambled miRNA (Non-parametric Kruskal-Wallis test was 




To determine if the observed effect of siDACT1 was, in fact, caused by cell death, the 
CyQUANT® Direct assay was performed on silenced cells 48 hours after silencing. 
The assay uses a cell-permeable dye that binds to DNA to quantify the cells present 
in a well. The reagent was added to the well without removing the media (where cells 
affected by the DACT1 silencing were by then potentially floating). The added reagent 
includes a masking dye that blocks staining of dead cells or cells with compromised 
cell membranes resulting in only healthy cells being stained. The masking dye allows 
a measure of cell death. The significant reduction registered in the siDACT1 condition 
is clearly the result of cell death (fig. 49). siDACT2 showed no significant difference 
from the control condition (fig.49). 
 
Figure 49 CyQuant assay shows reduced BMSCs 48 hours after DACT1 silencing. 
BMSCs from healthy donors (Lonza) were transfected with siDACT1 or siDACT2. The 
control condition was transfected with a scrambled miRNA (siCTRL). The assay was 
performed at 48 hours after silencing. CyQUANT® Direct 2X detection reagent was 
added to adherent cells in culture media, and the fluorescence was read 30 minutes  
after reagent addition. (Non-parametric Mann-Whitney test was performed, *** = 
p<0.001, N=3). 
 
Morphological changes of the dying cell are similar across all cell types and display 
specific hallmark features (Hacker, 2000).  Cell shrinkage is probably one of the earliest 
and easiest to observe changes. Confocal fluorescence imaging of 
immunocytochemistry for DACT1 and actin filaments shows cell shrinkage after 16h of 
DACT1 silencing. Normally elongated and fibroblastic-like BMSC morphology is lost 
and the nuclei show initial pyknosis (nuclear shrinkage due to DNA condensation in 
preparation for nuclear fragmentation) (fig. 50). DACT1 silencing at the protein level is 
















































death assessment of DNA laddering by agarose gel electrophoresis could be used as 
a semiquantitative method to detect apoptosis. 
 
 
Figure 50 Protein knockdown of DACT1 result in BMSCs death.  
immunohistochemistry was performed on BMSCs passage 5-6 isolated from healthy 
donor bone marrow (Lonza). Fixed cells were stained DACT1 (1:500) and Alexa488 
secondary antibody (1:1000). Phalloidin-Alexa555 (1:40,000) was used to stain actin 
filaments. Imaged by confocal microscopy (40x objective). The control condition was 
transfected with a scrambled miRNA (siCTRL). Representative images from one of 
four independent experiments with BMSCs and SynMSCs are shown.   DACT1 green; 
actin: red, nucleus, blue. Scale bar indicates 50 µm. 
 
6.2.2 Transcriptomic analysis to identify DACT1 targets in BMSCs. 
As described here, the influence of DACT1 and its likely mechanism of action is highly 
dependent on the cell type where it is expressed and largely undescribed in cartilage 
and mesenchymal progenitors. After observing a very clear phenotype upon 
knockdown of DACT1, an RNAseq study was performed on BMSCs from 4 different 
healthy and young patients that were silenced for DACT1. As can be observed in figure 
48, at about 20 hours cell death starts, which suggests an upstream and early effect 
of DACT1 silencing on cell homeostasis. A time point of 16 hours after silencing was 
then chosen to harvest RNA to observe which genes are affected by DACT1 
knockdown. 
Before submitting for sequencing, the harvested RNA was retrotranscribed to cDNA 
determine if DACT1 had been significantly silenced and illustrate if the RNA quality 
was sufficient to perform the deep sequencing. The average DACT1 knockdown was 




assessed with a Bioanalyzer. For 3 of the 8 samples, the RIN numbers were not 
available. Electropherograms samples with RIN = 10 were comparable to those with 
RIN N/A (fig. 51B and C), therefore, it was concluded that RNA quality was for all 
samples of a high standard to continue the experiment. 
 
Figure 51 RNA of DACT1 silenced BMSCs concentration and quality for RNA 
sequencing.  
RNA was isolated from BMSCs after 16 hours from siDACT1 transfection. The control 
condition was transfected with a scrambled miRNA (siCTRL).  A) qPCR was performed 
to verify DACT1 silencing. Relative expression was calculated with 2^-ΔΔCt method. 
Agilent 2100 bioanalyzer was used to determine RNA quality B) RNA concentration 
and RIN of experimental conditions are reported. C) Two representative 
electropherograms and overall results from two of the samples are shown. 
 
RNA sequencing detected 5624 differentially expressed genes between DACT1 
knockdown and control BMSCs, of which 1330 were significant using <10 % FDR 
threshold set for all the differentially expressed and < 0.05% p-value (figure 52).  
Tables 4 and 5 report respectively the top 10 up (A) and down (B) regulated genes and 
their biological role following DACT1 knockdown. Unsurprisingly, the pre-apoptotic 
gene ATP-dependent RNA helicase (AIF4A1) is among the top upregulated ones. 
DACT1 is the top hit of the downregulated genes, confirming the qRT-PCR result in 
fig. 53A. Several of the top downregulated proteins are associated with the Wnt/PCP 




involved in the regulation of apoptosis and signal transduction. Another protein that is 
known for its role in the Wnt/PCP pathway, as well as SMAD regulator, is SMURF2. 
Ring Finger Protein 130 (RNF130), another ubiquitin ligase like SMURF, is also among 
the top downregulated genes. Ubiquitin Specific Peptidase 46 (USP46), which is part 
of ubiquitin-proteasome system, is responsible for dynamic cellular processes such as 
the regulation of cell cycle and proliferation. USP46 might also be a protein involved in 
Wnt signalling (X. Li et al., 2013; Shi et al., 2015). In general, several proteins involved 
in ubiquitination (LON Peptidase N-Terminal Domain And Ring Finger 1 - LONRF1, 
SMURF2, RNF130, USP46) are represented in the top affected genes. Another 
pathway seems to frequently appear in the biological functions of the top differentially 
expressed genes reported in the tables is apoptosis (AIF4A1, RNF130, Cyclin 
Dependent Kinase 6 - CDK6, RASSF3). 
 
 
Figure 52 Volcano plot of the fold change of differentially expressed genes in 
DACT1 silenced BMSCs.  
5624 genes were differentially expressed, 1330 of which were significant. Each gene 
is represented by one point on the graph, in grey are plotted non statistically significant 




downregulated genes. The horizontal axis is the log2 fold change between siDACT1 
and siCTRL conditions. The negative log10 of the p-value is plotted on the vertical axis. 
The control condition was transfected with a scrambled miRNA (siCTRL) (N=4) 
 
 
Table 4 List of the top 10 up-regulated genes siDACT1 vs siCTRL BMSCs. 
Fold 
Change 






Wnt-protein binding participates in wound 
healing as well as organ regeneration and 
tissue remodelling. May regulate cortical 
bone osteogenesis. 






Primary cilia formation. Downstream effector 
of HOXC8 transmitting extracellular 
information for axial skeletal patterning. 













Lipid phosphatase, biosynthetic pathway of 













Essential for bone resorption and osteoclast 






Neutral amino acid/proton symporter. 











Table 5 List of the top 10 down-regulated genes siDACT1 vs siCTRL BMSCs. 
Fold 
Change 





Regulation of intracellular signalling pathways 
during development: canonical and/or non-





Involved in base excision repair of DNA 









Protein polyubiquitination. Involved in 











Fusion of retrograde transport vesicles 
derived from an endocytic compartment with 





GTPase-activating protein for RAB5A and 
RAB43. Receptor trafficking. In complex with 





Serine/threonine-protein controlling cell cycle 






SNARE involved in vesicular transport from 





protein ligase 2 






Acts as an E3 ubiquitin-protein ligase. 
Involved in programmed cell death of 
hematopoietic cells. 
 
To confirm the RNAseq results, primers for 4 of the top up- and down-regulated genes 
were designed and tested. The expression of the genes of interested was quantified 
on RNA isolated from BMSCs after 24 hours of silencing. The 24 hours and not 16 
hours time point was selected to confirm continued patterns of differentialexpression 
(as a quick confirmation of the sequencing data). The genes tested show consistent 




DACT1, USP6, CDK6 and SMURF2 show decreased expression in DACT1 
knockdown BMSCs (fig. 53). At 24 hours after silencing, the selected genes showed 
increased fold change compared to 16 hours, further confirmation that their differential 
expression is caused by DACT1 silencing. 
 
Figure 53 RNAseq data validation by RT-qPCR.  
5 genes among the top up and downregulated from the RNA sequencing analysis were 
validated in a sample after 24 hours from silencing. Relative expression was calculated 
with the formula 2^-ΔΔCt. The control condition was transfected with a scrambled 
miRNA (siCTRL). Error bars indicated the standard deviation of the mean of technical 
replicates, N=1. 
 
Top 300 differentially expressed genes were analysed with Ingenuity Pathway Analysis 
(IPA, Qiagen), a bioinformatics software for the analysis and integration of ‘omics data. 
The software analysis identified canonical pathways (fig. 54), diseases and biological 
functions (fig. 55), and gene networks and regulators (fig. 56) that are most significant 
to the uploaded data. 
Figure 54 shows the known biological pathways that appear most significantly affected 
by the genes in the uploaded data set. As expected, “Cell Cycle G1/S checkpoint 
regulation”, in white, meaning that the pathway is activated upon DACT1 knockdown, 
and “GADD45 signalling” (grey, activation unknown) are highlighted, as they are both 
linked to cell cycle control and apoptosis. Growth arrest and DNA-damage-inducible, 
alpha (GADD45) encodes for a protein induced by DNA damage and other stress 
signals associated with growth arrest and apoptosis (Salvador, Brown-Clay, & 




reported to affect DACT1 expression in BMSCs (Zhou et al., 2016). The Sirtuin 
pathway shows a negative z-score. This would indicate that DACT1 knockdown inhibits 
the transcriptional activation of the Sirtuin pathway. Most of the reported pathways, 
however, are not obviously relevant to musculoskeletal tissues, such as “hereditary 
breast cancer signalling”, “oleate biosynthesis” or “Estrogen receptor signalling”.  
 
Figure 54 Top enriched canonical pathways following DACT1 silencing in 
BMSCs.  
The pathway that shows significant enrichment for a set of top 300 genes from the 
RNA sequencing analysis is reported. The x-axis reports the top function as calculated 
by IPA based on the 300 differentially expressed genes uploaded from the RNA 
sequencing analysis siDACT1 vs siCTRL. The y-axis represents the ratio of the 
number of genes from the dataset that map the to the pathway and the number of all 
genes ascribed to that pathway. The vertical yellow line represents the threshold p-
value (calculated by Fisher’s test). According to the expression value of each gene, 
IPA determines per each reported pathway if they are activated or not (z-score). In 
yellow are activated pathways, in blue non activated, in white could be either and in 
grey are pathways for which data activity pattern is not available. 
 
Differentially expressed genes were also categorized to diseases and functions (fig. 
55). Consistent with the results of canonical pathway analysis following DACT1 
silencing, cancer, reproductive system disease, endocrine system disorders appear 
linked to the 300 genes updated that were differentially expressed after DACT1 
knockdown. “Cell growth and proliferation”, “cell movement”, “embryonic 
development”, “organ development” are all biological functions that fit in with the 





Figure 55 Summary of key biological processes and diseases influenced by 
differentially expressed genes.  
The top 5 “disease and disorders”, “molecular and cellular functions” and “physiological 
system development and functions” associated with the top 300 differentially 
expressed genes resulting from DACT1 silencing. Y-axis reports the negative 
logarithm of the p-value calculated by IPA. 
 
Besides the predominant pathways and cellular functions, gene networks were built to 
connect genes and enriched categories of diseases and functions based on the 
correlation between differentially expressed genes. It is worth noting that WNT3a 
appeared among the top regulators of the networks. That is consistent with its role in 
cell cycle progression and the link between DACT1 and Wnt pathways, of which 
WNT3a is a prime ligand and signalling molecule. WNT3a activates both canonical and 
non-canonical Wnt pathways in BMSCs (Qiu, Chen, & Kassem, 2011), and has been 
shown to sustain BMSCs proliferation and chondrogenic potential (Narcisi et al., 2015). 
Again, the network function relates back to developmental disorders and embryonic 
development, cell cycle and cellular growth and proliferation (fig. 56). The networks 
linking different genes further highlighted interesting links between certain proteins of 
interest such as SMURF2, miR-221, RUNX1, ID4. 
In network 4 “Cellular development, cell growth and proliferation, cell cycle” miR-221 
(in red, upregulated) is present, forming links with MAPK1/2, MET (also upregulated, 
and a top hit of upregulated genes) and PDF. MAP kinases in WNT signal transduction 
bind to AXIN and E3 ligases to regulate β-catenin activity. Mir-221 was reported to 
behave as an anti-chondrogenic regulator in MSCs. Upon silencing of miR-221, MSCs 





RUNX1 Partner Transcriptional Co-Repressor 1 (RUNX1T1) is an important protein in 
BMSCs fate determination present in one of the networks (number 5, “Embryonic 
development, Nervous System Development and Function, Organ Development”) 
displayed in figure 56. RUNX1T1 is reported to act as a negative regulator of 
adipogenesis and is downregulated alongside DACT1 silencing. In the network, it is 
connected to inhibitor of DNA binding protein 4 (ID4), a gene encoding for a member 
of the inhibitor of DNA binding (ID) protein family. Downregulation of ID proteins, 
orchestrated by SMAD proteins, is a pathway by which TGF- signalling could arrest 
the cell cycle (Kowanetz, Valcourt, Bergström, Heldin, & Moustakas, 2004). These 
networks collectively provide a valuable list of proteins that are known to be important 
in MSCs regulation and chondrogenesis. The identified networks also provide putative 
proteins and molecules which effects have not been investigated in the 
















Figure 56 List of top regulators and networks of siDACT1 300 genes.  
Reported upstream regulators can elicit the gene expression changes observed in the 
provided data set. To build the networks, IPA uses the upstream regulator and 
computationally seek pairs of regulators predicted to affect the expression of a similar 
set of genes and repeats it. The genes shaded in red are upregulated, and the genes 
shaded green are downregulated. Legend at the lower right explains the relationship 









6.2.3 DACT1 could be involved in the canonical Wnt pathway in BMSCs. 
Wnt pathways are known for their role in regulating MSCs proliferation. Wnt signalling 
target genes include CMYC and CCND1, important for cell proliferation. Several Wnt 
pathway proteins were identified to be linked to DACT1 from the data resulting from 
the sequencing of DACT1 silenced cells. Wnt gene targets were selected and their 
expression was studied after DACT1 silencing to establish if they were modulated by 
DACT1 loss. siDACT1 was applied to SynMSCs from three different patients and after 
24 hours the expression of Wnt target genes CCND1, JAG1, ID1, SOX9 and FZD was 
determined by RT-qPCR. Cyclin-dependent kinase D1 (CCND1) is a protein that 
integrates Shh and Wnt activities and is a cell cycle regulator. CCND1 is a direct target 
gene of the Wnt canonical pathway: TCF consensus binding sites are present in 
the CCND promoter. Jagged 1 (JAG1) is β-catenin target gene that acts as a ligand 
for the NOTCH pathway (Estrach, Ambler, Lo Celso, Hozumi, & Watt, 2006).  NOTCH 
signalling has an important role in cell growth and differentiation (Artavanis-Tsakonas, 
Rand, & Lake, 1999; Fortini, 2009). ID1 is a protein regulating both Wnt and TGFβ 
pathways (Järvinen, Shimomura-Kuroki, Balic, Jussila, & Thesleff, 2018; Nakashima, 
Katagiri, & Tamura, 2005). FRZB is a Wnt receptor that transmits the signalling in the 
PCP and canonical Wnt pathway, as previously described. 
Firstly, DACT1 was consistently silenced in all SynMSCs after 24 hours. JAG1 and 
SOX9 showed up-regulation following DACT1 silencing and CCND1 expression was 
also increased, around 2-fold in all samples. ID1 expression was concomitantly 
reduced alongside DACT1. FZD expression was not consistent across the samples 
and therefore difficult to interpret (fig. 57). The data suggest that DACT1 acts as an 






Figure 57 WNT target genes affected by DACT1 silencing in BMSCs.  
Expression of 5 targets gene of the canonical WNT pathway was determined by RT-
qPCR after 24 hours DACT1 silencing of SYnMSCs. Relative expression was 
calculated with the formula 2^-ΔΔCt. The control condition was transfected with a 
scrambled miRNA (siCTRL) (N=3). Error bars refer to the standard deviation of 
technical replicates. 
 
WNT3a was suggested to be an upstream network regulator according to IPA analysis 
and the expression of SOX9, CCND1 and JAG1 canonical Wnt target genes were 
upregulated following DACT1 silencing. It was hypothesised that by adding a Wnt 
pathway activator such as CHIR-99021 (which is a potent GSK3β inhibitor, 
subsequently referred to as inhGSK3β), we would be able to mimic all or part of the 
DACT1 silencing effects in MSCs and gain an insight into the balance that DACT1 may 
have on canonical and non-canonical Wnt signalling in DACT1 silenced cells. 
Because of cell death resulting from DACT1 silencing, it was not possible to test if 
DACT1 silencing causes an increase or a reduction of nuclear β-catenin. GSK3β 
phosphorylates highly conserved serine (Ser) and threonine (Thr) residues (Ser 33, 
Ser 37, Thr 41, and Ser 45) at the N-terminus of β-catenin and targets β-catenin for 
degradation. Different antibodies were used to identify unphosphorylated β-catenin 
(ABC, in red), and a different antibody that binds to phosphorylated β-catenin was also 
used (in green, Alexa488). In the presence of Wnt signalling, the destruction complex 
is inactivated resulting in the cytoplasmic accumulation of β-catenin and its subsequent 
translocation to the nucleus. Similar nuclear localisation of active-β-catenin (ABC) was 
expected in both conditions where WNT3a and inhGSK3β were added to the cells, or 
when the two were both added to the BMSCs. After overnight serum starvation, 
BMSCs were treated with WNT3a, inhGSK3β or both overnight. In figure 58 




ABC localisation in the nucleus. Limited phosphorylated β-catenin is present in the 
plasma membrane. BMSCs treated with canonical Wnt activators WNT3a and 
inhGSK3β show nuclear localisation of ABC. 
 
 
Figure 58 WNT3a and GSK3b inhibitor treatments cause nuclear localisation of 
active-β-catenin.  
Anti-β-catenin (in green, Alexa488) and anti-ABC (in red, Alexa555) antibodies (1:500) 




2.5 µM inhGSK3β or both overnight before fixation. In the IgG CTRL condition, 
phalloidin-Alexa555 was used to show cytoskeletal actin filaments. Representative 
images from one of two independent experiments with BMSCs are shown (N=2).  β-
catenin: green; red: active-β-catenin; nucleus: blue Scale bar: 50 µm. 
 
After ensuring that WNT3a and inhGSK3β acted on BMSCs as expected, the two 
molecules were added before treatment with siDACT1.  
First, GSK3β inhibitor (Wnt activator) was tested alone and in combination with 
siDACT1, and compared to the siDACT1 alone condition, on BMSCs (fig. 59). The 
experimental hypothesis was that GSK3β inhibitor would mimic the effect of DACT1 
silencing if DACT1 was modulating only the Wnt pathway. After one day from applying 
the silencing, siDACT1 and inhGSK3β conditions showed no significant difference in 
cell index values. At day 2 and 3 statistically significant differences arose between the 
two conditions. In addition, siDACT1 alone had a similar effect to what observed in the 
GSK3β+siDACT1 condition. At day 2 and day 3 the difference between 
GSK3β+siDACT1 and the control was not statistically significant, whereas with 
siDACT1 there continued to be have significant influence. The experiment showed that 
DACT1 silencing was not exactly mimicked by adding a Wnt pathway activator. 
 
Figure 59 Real-time effect of inhGSK3β on siDACT1 BMSCs over 72 hours. 
BMSCs from healthy donors (Lonza) were seeded in XCELLigence E-plates and their 
impendence measured every 15 minutes by XCELLigence RTCA. Cell Index 
measurements were normalised to the time of silencing. The control condition was 
transfected with a scrambled miRNA. 2.5 µM GSK3β inhibitor was added to cells 5 
hours before applying the silencing (Kruskal-Wallis non-parametric test was performed 
on the measurements at 24, 48, and 72 hours, *= p<0.05, ** = p<0.01, N=3). 
 
The CyQUANT® Direct assay was performed after 48 hours to determine the effect of 
































































































































previously determined, siDACT1 caused a significant reduction in cell numbers 
compared to the control conditions after 48 hours. The addition of inhGSK3β to the 
cells did not have a significant effect on cell numbers compared to untreated control. 
By adding WNT3a or inhGSK3β to the cells before transfecting with siDACT1, a similar 
resulted to siDACT1 condition was observed. siDACT1, Wnt3a and nhGSK3β 
conditions showed no statistically significant difference. Treatment with inhGSKb or 
Wnt3a reproduces siDACT1 results partially, which indicate that potentially DACT1 
impact Wnt pathway. However, given the results obtained in figure 59, a more plausible 
explanation would be that DACT1 impact on other pathways (non-canonical & TGFb) 
that support cell survival (as well as canonical Wnt signalling). Further study are 
however necessary to confirm these observations. 
 
 
Figure 60  Effect of WNT3a and inhGSK3β on DACT1 silenced cell survival and 
proliferation.  
CyQUANT® Direct assay was performed after 48 hours of DACT1 silencing. BMSCs 
from three healthy donors (Lonza) were transfected with siDACT1 5 hours after 
administering WNT3a, or 2.5 µM inhGSK3β or both. The control condition was 
transfected with a scrambled miRNA (siCTRL) (Kruskal-Wallis non-parametric test was 





6.2.4 Preliminary work suggests a role for DACT1 in regulating protein 
ubiquitination. 
The RNAseq data suggested that several genes encoding for proteins involved in 
ubiquitination are affected by DACT1 silencing in BMSCs. Ubiquitination is a simple 
and versatile protein modification that can impart different signalling consequences. 
Ubiquitin is a small protein that is covalently attached to target protein by a process 
involving three different enzymes E1, E2 and E3 and can also be conjugated to other 
substrate proteins. Ubiquitin modification controls signalling pathways by influencing 
both proteolytic and nonproteolytic functions, such as control of protein activity and 
subcellular localisation. Because several ubiquitin-related genes are downregulated 
after DACT1 knockdown, it was hypothesised that ubiquitinated protein levels in 
silenced cells would be higher than the control condition. Western blot analysis probing 
for ubiquitin in the protein lysate obtained from BMSCs after 6 h or 24 h following 
DACT1 silencing was performed. After 6 h no ubiquitination was detectable and no 
difference between the two conditions was visible. After 24h, siDACT1 showed bands 
at several heights suggesting a higher number of ubiquitinated proteins than in siCTRL 
condition at the same time point. This result supports the hypothesis that DACT1 may 
be involved in regulating protein ubiquitination 
 
Figure 61  DACT1 knockdown increases ubiquitination in BMSCs.  
BMSCs from healthy donor (Lonza) were transfected with siDACT1 or scramble 
miRNA (siCTRL) and harvested for protein analysis at 6 hours or 24 hours after 
silencing. Total protein was quantified, and the same amount was loaded in each lane. 








6.3.1 DACT1 knockdown influences BMSC survival by activating apoptotic 
and cell cycle pathways. 
siDACT1 transfection has been performed previously in colon cancer cell lines without 
resulting in the apoptosis of the silenced cells. In three cancer cell line cells, siDACT1 
reduced migratory potential and downregulated protein levels of β-catenin, cyclin D1 
and c-Myc (Yuan et al., 2012). The same study reports that overexpression of DACT1 
enhances cell proliferation. This results from DACT1 inhibiting GSK3β  and consequent 
resulting in β-catenin stabilisation (Yuan et al., 2012).   
Two other studies investigating DACT1 in different cancer cell lines reported opposite 
observations relative to cell growth and proliferation, but still describe DACT1 
regulation of these proliferative and apoptotic pathways through WNT signalling. Yin 
et al. showed that in breast cancer cells, DACT1 overexpression results in apoptosis 
by negative regulation of the canonical Wnt pathway -by decreasing β-catenin activity 
(Yin et al., 2013). Analogous to what was described in breast cancer cells, in a 
leukaemia cell line, DACT1 was reported to influence not only cell growth and 
proliferation but also apoptosis. DACT1 overexpression arrested leukaemia cells in 
G0/G1 and induced apoptosis (K. Zhu, Jiang, Yang, Hu, & Liu, 2017). 
In this chapter, silencing of DACT1 by RNAi suggests that in response BMSCs and 
SynMSCs undergo cell death. Transcriptome analysis showed that the apoptotic 
pathway was activated following DACT1 downregulation, corroborating what was 
observed morphologically (fig. 50) and functionally (fig. 48 and 49). To support this 
observation, a TUNEL assay or an agarose gel electrophoresis showing DNA 
laddering should be performed. In order to exclude the possibility that the specific 
sequence of miRNA used in these experiments had unforeseen off-target toxic effects, 
a different siDACT1 (with different miRNA sequence that still targets DACT1 mRNA) 
was purchased and tested. The same cell phenotype was observed in silenced MSCs 
with the different siDACT1 molecules, suggesting that effects are specific to DACT1 
knockdown. 
A similar apoptotic effect following DACT1 silencing was observed in cultured ACs 
although further studies need to be performed to confirm that the same pathways are 





6.3.2 Transcriptome analysis of DACT1 silenced cells reveals an interesting 
connection to ubiquitination and Wnt pathways. 
Transcriptome analysis of DACT1 silenced cells was performed and the list of genes 
identified by the RNA sequencing highlighted several interesting genes that are linked 
to DACT1 in BMSCs. 
This is the first report of a link between DACT1 and SMURF2. SMURF2 
downregulation following DACT1 knockdown was significant after 24 hours, as shown 
by RT-qPCR (fig. 44). SMURF2 is an E3 ubiquitin ligase that selectively interacts with 
SMADs and is known to target SMAD1 for ubiquitination, determining its degradation 
by the proteome. Vertebrates express two SMURF genes: SMURF1 and SMURF2. 
The two genes possess similar expression patterns, and probably have partially 
redundant functions as double Smurf1−/−; Smurf2−/− (Smurf DKO) mice are 
embryonic lethal at around E12.5 (Narimatsu et al., 2009). If only one of the two genes 
is knockout, mice survive. Both proteins are expressed by osteoblasts and proliferating 
chondrocytes (Wu et al., 2009; Yamashita et al., 2005). In chondrocytes, SMURF2 
mediates GSK3β ubiquitination and its degradation by the proteome, resulting in 
upregulation of β-catenin.  It has been suggested that this is possibly a starting 
signalling that contributes to the initiation of OA (Wu et al., 2009). Recently, Huang et 
al. reported that when SMURF2 is overexpressed under the COL2 promoter, it starts 
a signalling cascade that initiates OA development (H. Huang, Veien, Zhang, Ayers, & 
Song, 2016). TGFβ signalling can elicit cell proliferation, differentiation and apoptosis 
through SMAD mediators. SMAD3 can be targeted for phosphorylation by GSK3β that 
results in ubiquitin-mediated degradation of SMAD3 (Xing Guo et al., 2008). DACT1 
knockdown affected genes regulating both ubiquitination and phosphorylation, 
indicating that DACT1 might act to integrate the TGFβ and WNT pathways by 
regulating the stability of central mediators of these pathways such as GSK3β and 
SMADs. 
LONRF1, RNF130, and USP46 are genes identified by RNA sequencing linked with 
ubiquitination, as pointed out in tables 4 and 5. The downregulation of these genes 
alongside DACT1 suggests a role for DACT1 as a signal mediator in the pathways 
where it is involved through ubiquitination. To support this hypothesis, a preliminary 
experiment showed increased protein ubiquitination 24 hours after DACT1 silencing of 




Among the top upregulated genes, TAPT1 has never before been associated with 
DACT1 and would make an interesting gene to further investigate because of its link 
to cartilage. In the mouse embryo, TAPT1 is involved in the development of the axial 
skeleton, and mutation in this gene leads to a complex lethal osteochondrodysplasia 
(Howell et al., 2007; Symoens et al., 2015). TAPT1 is a positive regulator of cartilage 
development. 
MET, which encodes for the receptor of the hepatocyte growth factor (HGF), is the top 
upregulated gene following DACT1 silencing. Although no previous work has been 
reported that links DACT1 and MET, DACT1 is downregulated in hepatocellular 
carcinoma (Yau et al., 2005). HGF was shown to have a role in the proliferation of 
mesenchymal cells and to regulate limb dub development. The protein expression 
pattern of MET is however very interesting and relevant to the consideration of the data 
presented in Chapter 5 and 6. Immunohistochemistry shows the presence of MET in 
the deep zone of normal cartilage. In addition, only a small number of chondrocytes in 
the superficial and intermediate zone showed MET staining. Additionally, in OA 
cartilage, and in contrast to normal cartilage, MET was identified using 
immunohistochemistry in all OA chondrocytes (Pfander et al., 1999). From the 
immunohistochemical pictures reported by Pfander and colleagues, MET seems to 
have exactly the opposite expression pattern to DACT1 (Chapter 5). Further analysis 
is needed to determine if the gradient formed by these two proteins is instrumental in 
maintaining cell phenotype in either zone of articular cartilage. 
 
6.3.3 DACT1 as a modulator of the WNT signalling in BMSCs. 
The data described in this thesis does not unambiguously clarify whether the canonical 
Wnt pathways is the only one where DACT1 is involved. On one hand, DACT1 
knockdown alters the expression of known Wnt targets such as CCND1, SOX9, and 
JAG1. However, the addition of WNT3a and GSK3b inhibitor is not able to completely 
reproduce the siDACT1 phenotype. WNT3a signals via the canonical WNT pathway 
and inhibits hypertrophic differentiation of BMSCs, as well as maintaining proliferation 
and chondrogenic potential (Narcisi et al., 2015). Recently, a paper reported that 
WNT3a did not affect DACT1 expression in intestinal epithelial cells and that TGFβ 
instead can regulate DACT1 expression  (Wang et al., 2018). The combination of both 




fig. 60). As the presence of WNT3a and inhGSK3β result in increased MSCs 
proliferation, it is possible that the “rescue” effect was determined by the proliferation 
of non silenced cells. Further analysis is necessary to determine the percentage of 
DACT1 which is effectively knockdown after 48 hours in that condition. However, 
because of the high silencing efficiency already at 24 hours (fig. 44), it is unlikely that 
the proliferation of a few cells can determine the partial rescue effect detected. More 
likely, DACT1 regulates Wnt canonical pathway in BMSCs, but that is not the only 
pathways where is has regulatory effects.  
If the canonical Wnt pathway is only one of the signalling networks in which DACT1 is 
involved, the genes detected by the RNA sequencing can be instrumental in identifying 
other candidates. Top downregulated genes SMURF2 and RASSF3 code for proteins 
that are involved in the regulation of the PCP signalling pathway. 
PCP regulates the polarisation of cells in tissue and their migration. PCP proteins in 
embryos have important roles in epithelial cells, mesenchymal cells, and neurons. In 
adults, Wnt regulation of RHO and other PCP pathway proteins respond to and 
transduce mechanical stimuli (Abuammah et al., 2018). The Wnt co-receptor LRP5, for 
example, is required for strain-induced mechanotransduction in osteoblasts and is 
involved in both canonical and PCP pathways (Bryja et al., 2009). Mechanical signals 
that regulate cartilage repair remain poorly understood but may well share similar 
pathways and relevant molecules to osteoblasts. A study on the effect of PCP pathway 
inhibitors such as Y-67632, a ROCK inhibitor, might be a possible avenue to further 
elucidate which pathway is influenced by DACT1 
Among the top pathways suggested by IPA analysis, Sirtuin is of interest because of 
its link to OA and cartilage. Sirtuins are a family of proteins that regulate longevity and 
ageing in several tissues, including cartilage, and are associated to cellular functions 
such as inflammation, senescence, autophagy and apoptosis (Kida & Goligorsky, 
2016; Yacoub, Lee, & He, 2014). Sirtuins are deacetylases that act on histones to 
modulate transcription but were shown to have a general role to modify protein stability, 
catalytic activity and binding properties. SIRT1 is expressed in chondrocytes and 
downregulated in OA cartilage. SIRT1 knockdown results in ACAN downregulation and 
upregulation of OA marker genes such as COL10 and ADAMTS-5 (Fujita et al., 2011). 
In a cartilage-specific conditional Sirt1-knockdown, OA was surgically induced and loss 
of Sirt1 in chondrocytes led to the accelerated development of OA, suggesting that 




In agreement with the study published by Matsuzaki et al. intra-articular injections of 
SIRT1 activator, resveratrol, were able to preserve cartilage from developing OA in 
mice (W. Li, Cai, Zhang, Cui, & Shen, 2015). Zhou et al., suggest in their study on 
MSCs that resveratrol treatment increases DACT1 expression. They proposed that 
SIRT1 acts as an adipogenesis inhibitor in MSCs by inhibiting DACT1 (Zhou et al., 
2016). Taken together these studies show that SIRT1 has an important role in 
regulating survival and senescence of chondrocytes and its function is lost in OA.  
 
6.3.4 Limitations of the study 
The transcriptome analysis described in this Chapter was performed on DACT1 
silenced BMSCs obtained from 4 young and healthy donors. The time point selected 
for the study was 16 hours after silencing based upon the observation that a clear 
phenotypic effect (cell death) was initiated on average around 20 hours from silencing. 
In each of the different donors, the decline in cell number started between 15 hours 
and 20 hours after silencing.  Despite the small number of samples and the apparent 
differences in time of response to silencing, 1330 genes showed statistically significant 
differential expression following DACT1 knockdown. Indeed, it is expected that more 
statistically significant genes might be detected by increasing the number of biological 
samples 
The analysis performed by IPA on the top 300 genes differentially expressed following 
DACT1 knockdown has some limitations. IPA interprets the patterns of differentially 
expressed genes by grouping them into functional categories and pathways and then 
scores them with statistical analysis. The statistical analysis indicates the likelihood 
that the pathways are not detected by chance. Due to the small number of samples, 
and the low fold change, the pathways suggested by IPA should be confirmed by 
independent experiments. The genes uploaded were also filtered: only the top 150 
upregulated and the top 150 downregulated (fold change) genes were selected. This 
limited selection assumes that only changes resulting in high fold change expression 
are relevant, so nuanced responses may be lost in this analysis. 
Another imitation of the IPA analysis is the bias due to its reliance on published and 
available material on the uploaded genes. Because the information on DACT1 is 
limited in the literature, it is likely that many connections to this protein have not been 




among the genes connected to DACT1 in the manually updated database in the IPA 
software. IPA results should, therefore, be considered as an explorative tool to be 
confirmed by other experiments. 
 
 
6.4 Summary and future studies 
The results presented and discussed in this chapter represent the first study on the 
function of DACT1 in human primary MSCs and the first transcriptome analysis on 
DACT1 silenced cells. The RNA sequencing study provides a list of potential target 
genes influenced by DACT1 and interacting pathways. A few genes give a glimpse of 
the potential molecular mechanisms of DACT1. SMURF2 acts on both WNT and TGFβ 
pathways in close relation to DVL. SMURF2 is expressed in cartilage and involved in 
early OA development. This study links for the first time DACT1 with SMURF2 which 
could help dissect the double role of DACT1 in WNT and TGFβ pathways. SMURF2 
and three more downregulated genes (LONRF1, RNF130, and USP46) are involved 
in protein ubiquitination, suggesting a role of DACT1 in ubiquitin signalling. Another 
interesting identified target gene is MET. Coding for the receptor of HGF, MET has a 
mutually exclusive expression pattern with DACT1 in articular cartilage, as described 
in chapter 5, and is overexpressed in OA cartilage. A follow-up analysis of modulated 
genes found in this study might be useful for acquiring a deeper understanding of 
pathological changes in OA.   
It was demonstrated with different experiments that DACT1 knockdown leads to 
apoptosis of BMSCs. The data presented in this chapter suggests that WNT pathways 
(canonical and perhaps PCP) might be regulated by DACT1. The DACT1 link to the 
WNT/β-catenin pathway was assessed by administering a Wnt3a or a GSK3β inhibitor 
to investigate their potential to mimic the effect of siDACT1 on  BMSC apoptosis. Partial 
but not complete reproduction of the phenotype was observed, which may indicate that 
DACT1 knockdown triggers apoptotic signals through multiple different pathways and 
not just canonical/non-canonical Wnt signalling. An overexpression of DACT1 study is 
necessary to further determine its role in BMSCs and ACs. DACT1 overexpression 
could have a protective effect on BMSCs. In support of this hypothesis are the recent 
data from phase 3 WNT inhibitor drug developed by Samumed. In the work published 




of BMSCs and when injected into a rat OA model showed cartilage regeneration 
(Deshmukh, Seo, Swearingen, & Yazici, 2018). SM04690 was also showed to help 
cartilage regeneration and reduce synovial inflammation. The Wnt pathway inhibitor 
SM04690 acts by targeting two kinases, CLK2 and DYRK1A, which result in the 
upregulation of DACT1 (Deshmukh, Seo, Swearingen, & Yazici, 2018). These data 
suggest that a higher expression of DACT1 can be beneficial for cartilage repair and 
block the progression of OA. 
The results reported here have led to other questions on the role of DACTs. It was 
shown in chapter 5 that DACT1 expression is reduced in OA cartilage samples (data 
reported also in another study (Chou et al., 2015)), which suggest that this intracellular 
signalling modulator may have an important role in cartilage homeostasis. To further 
explore the role of DACT1 in vivo, mouse models could be used. If DACT1 expression 
is important for repair, a cell-specific DACT1 knockout in chondrocytes or MSCs should 
affect repair after chondral damage or its ability to prevent synovial joint tissue damage 
development in an OA model.  
Another interesting question is what molecules regulate DACT1. The sirtuin pathway 
was identified by IPA analysis and was reported to modulate DACT1 expression in 
MSCs. Sirtuin has a role in cell senescence and not only shows downregulation in 
cartilage (like DACT1) but, when silenced, initiates OA development in the mouse. 
Further studies to investigate DACT1 regulation by SIRT1 could improve our 
understanding of OA progression. 
Although limited experiments were performed with DACT2 knockdown cells, we 
observed that DACT2 knockdown had no effect on apoptosis or cell proliferation, in 
complete contrast to DACT1 knockdown. Further studies on DACT2 could give an 
interesting insight into the regulation of TGFβ signalling. A mouse Dact2 knockout 
model is available (Sanger Institute, UK) and although it shows no abnormal 
musculoskeletal features, no studies have been performed on adult and older mice. 
Histological analysis in older mice could unveil the effect of DACT2 knockdown on 
cartilage tissue. Alternatively, a cartilage damage model with this knockdown would 
inform us of the importance of DACT2 on osteochondral repair. 
To conclude, it can be hypothesised, that DACT1 acts on cell survival and proliferation 
by modulating phosphorylation and ubiquitination of proteins of both WNT and TGFβ 





Figure 62 DACT1 act on BMSCs survival and proliferation by modulating TGFβ 
and WNT pathways.  
DACT1 knockdown results in BMSCs apoptosis through downregulation of CDK6, 
RASSF3 and RNF130, and by upregulating AIF4A1 (A). DACT1 might integrate the 
two pathways through modulating phosphorylation and ubiquitination through 





7 Summary and conclusion 
The aim of this body of work has been to extend our knowledge of the phenotypic 
differences between chondrocytes from different regions of articular cartilage. The 
existence of chondrogenic stem progenitor cells in the superficial zone of articular cartilage 
has been suggested (by others and by the data presented in this thesis and by others) 
based on their adhesion properties, expression of stem-cell markers, CFU potential, and 
ability to differentiate into chondrocytes in vitro. Recent murine genetic lineage tracing 
experiments have been able to confirm in vivo the presence of progenitors in the SZ of 
articular cartilage (Decker et al., 2017; Kozhemyakina et al., 2015; L. Li et al., 2017). The 
identified SZ cartilage progenitors form the entire adult articular cartilage in vivo and might 
take part in the healing of small cartilage defects. Questions remain on whether this cell 
population is present in adult human tissue and how it may take part in repairing cartilage 
damage during injury and disease. To further our understanding of how distinct 
chondrocyte populations might contribute during cartilage repair and regeneration, this 
thesis explored the signalling between the different regions of articular cartilage in terms 
of cytokine production and EVs-miRNA content. Understanding the differences between 
different subpopulations were also investigated in terms of DACT1 expression. DACT1 
has been reported to be a modulator of both WNT and TGFβ pathways, but its role has 
not been explored extensively in cartilage.  
 
7.1 Summary of the key findings 
7.1.1 Bi-directional signalling between BMSCs and cartilage differs  
The influence of resident ACs on cartilage repair is of great relevance not only to surgical 
techniques like microfracture and ACI but also to better understand cartilage tissue in 
homeostasis and disease. To study what determines a difference in modulating MSCs 
trophic and immunomodulatory action, a deeper analysis of human cartilage layers is 
required. In chapter 4, the crosstalk in terms of cytokine production and miRNA present in 
EVs was shown to be different when BMSCs are co-cultures with SZ or MDZ cartilage. 
MDZ-BMSCs co-cultures resulted in a larger array of cytokine production compared to SZ-
BMSC condition. EVs isolated from either BMSCs-SZ cartilage or BMSCs-MDZ cartilage 
co-cultures carried different miRNAs. 38 miRNAs were identified in EVs obtained from co-
culture supernatants, 5 were significantly differentially expressed in SZ and MDZ 




the only miRNA significantly differentially expressed after applying FDR (multiple testing 
correction) adjustments. miR-23a-3p is present in significantly higher quantities in EVs 
from the BMSCs-SZ condition. Targeting SMAD3 and RUNX2, and downregulating the 
expression of COL2 and ACAN, miR-23a-3p is a well-known regulator of cartilage. When 
compared the miRNAs carried by EVs obtained from BMSC not co-cultured with cartilage 
to BMSCs-SZ conditions, miR23a-3p and miR-125b-5p were present in both. That might 
suggest that BMSCs produce more miR23a-3p and miR-125b-5p when in contact with SZ, 
or that both cell types produce these miRNAs when in the presence of each other. miR-
125p-5p regulates inflammation in OA by acting through IL-1β to induce the expression of 
inflammatory genes and cartilage degradation by regulating ADAMTS4. On the other 
hand, no overlapping in miRNAs was detected between BMSCs only and BMSCs-MDZ 
conditions.  
Although the data presented here is obtained from in vitro experiments, it is indicative of 
the large differences in AC phenotype within cartilage tissue.  What the data also suggest 
is that the signalling of superficial zone chondrocytes to surrounding cells in the knee joint 
might be an interesting avenue to explore with the aim of identifying novel mechanisms 
and targets for cartilage repair.  
 
7.1.2 DACTs are found in human joints and regulate BMSC apoptosis and 
proliferation through the canonical Wnt pathway.  
DACT1 was found to be expressed in the SZ of articular cartilage, which has been shown 
to host a subpopulation of chondrocyte progenitors that regulate tissue homeostasis and 
might be involved in cartilage repair and OA progression. It was shown here and by others 
that DACT1 is downregulated in OA. DACT1 and DACT2 are present at gene and protein 
level in adult human cartilage and synovium.  DACT2 was identified in adult cartilage and 
during development, specifically in the Interzone, a region of condensed mesenchymal 
cells that give rise to the joint. Both proteins are also present in human SynMSCs and 
BMSCs. DACT1 knockdown in BMSCs induces apoptosis, as confirmed by the differential 
expression detected by transcriptomic analysis of genes involved in apoptosis. As DACT1 
is almost exclusively expressed in the SZ and downregulated in OA, and its knockdown in 
MSCs results in cell death, it can be hypothesised that a loss of superficial chondrocytes 
is linked to OA development. When SZ cartilage loses its stable state, it would be expected 
that response to mechanical loading is altered resulting in cartilage and subchondral bone 




and fluid, OA changes are initiated. miR-125b-5p is one of the miRNAs identified in EVs 
isolated from BMSCs alone and when cultured with SZ cartilage, which has been reported 
to have an inhibitory effect on DACT1 expression. miR-125b-5p downregulation of DACT1 
resulted in inhibition of cell proliferation and promoted cell apoptosis (Yu, Yang, & Rui, 
2019). Further studies to dissect the regulation of DACT1 expression could give valuable 
insight to OA development. 
 
7.2 Conclusion 
OA is a musculoskeletal disease that affects millions of people across the world and is a 
leading cause of disability, heavily affecting the quality of life and wellbeing. 
Understanding cartilage progenitors both in terms of how they are regulated and how they 
communicate with other cell types in the joint, is paramount to understand and develop 
novel therapies to treat early cartilage defects and so help slow or prevent the 
development of OA. The articular surface is home to cartilage progenitors.  Elucidating 
the signalling between SZ cartilage and BMSCs would be beneficial to improve our 
drug/biomolecule treatment, cell therapy and surgical intervention for cartilage repair. 
This study shows how the interaction between BMSCs and SZ cartilage produces a 
specific cytokine response. The crosstalk between cartilage and BMSCs may also be 
based on signalling through EVs. In experiments presented here, EVs were found to have 
different miRNA profiles depending on whether BMSCs were cocultured alone or with SZ 
or MDZ cartilage. A list of differentially expressed EV-derived miRNA was identified and 
could be further investigated to understand how resident chondrocytes might interact to 
repair cartilage in MSC therapy. This thesis presents a novel study on a Wnt regulator, 
DACT1, in cartilage and MSCs. Collectively, the data suggest a role in apoptosis and 
senescence for DACT1 in BMSCs. Further study on DACT1 and its downregulation could 
help provide a possible link between senescence of SZ progenitors and OA development. 
Overexpression of DACT1 could potentially have a protective role in cartilage and should 
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Table 7 Top300 up- and down-regulated genes siDACT1 vs siCTRL 
Top 150 up-regulated genes Top 150 down-regulated genes 
Gene ID Fold Change Gene ID Fold Change 
MET 0.9196 DACT1 -2.078 
LINC00894 0.8375 NEIL2 -1.276 
TAPT1 0.8302 RP11-175O19.4 -1.253 
SLC26A10 0.7952 LONRF1 -1.226 
PTPMT1 0.7809 RASSF3 -1.175 
ANKRD20A5P 0.7604 SFT2D2 -1.114 
RP11-449J21.3 0.7461 USP46 -1.024 
RP11-159D12.6 0.7342 CDK6 -1.023 
CA2 0.7327 VAMP3 -0.977 
RP11-96D1.8 0.7268 SMURF2 -0.956 
SLC36A1 0.7095 RNF130 -0.920 
RP11-340I6.6 0.6940 KAZN -0.905 
AC011893.3 0.6849 SLC25A22 -0.893 
RP11-84A19.3 0.6805 AMMECR1 -0.891 
FAM49B 0.6719 TBPL1 -0.879 
EIF4A1 0.6677 LYRM7 -0.866 
RPS26 0.6648 TNFRSF10B -0.866 
SNORD104 0.6641 DIXDC1 -0.862 




IL11 0.6475 DICER1 -0.861 
CTD-2574D22.3 0.6414 FAM160B1 -0.848 
GNB3 0.6370 MTO1 -0.842 
MIR222HG 0.6369 C1orf198 -0.826 
HERC2P3 0.6356 AP4E1 -0.820 
C10orf90 0.6346 SLC2A10 -0.813 
AC027601.1 0.6332 PDE8B -0.810 
AGER 0.6323 EIF2S3L -0.801 
SNHG3 0.6317 TBC1D16 -0.788 
NNAT 0.6315 CAPN5 -0.787 
DDX10 0.6267 RP11-38O23.4 -0.777 
H3F3A 0.6201 C7orf60 -0.767 
AC010761.8 0.6201 ATXN1 -0.765 
OGFOD2 0.6145 AVL9 -0.755 
MT-TE 0.6098 AF196972.4 -0.744 
RP11-644F5.10 0.6093 TMEM109 -0.744 
STARD4-AS1 0.6087 ZFHX3 -0.742 
CTD-3035K23.3 0.6083 DCP2 -0.737 
RP11-696N14.1 0.6073 RP11-767N6.7 -0.735 
RP11-708J19.1 0.6068 RFESD -0.734 
INE1 0.6065 EIF2S3 -0.734 
ESR1 0.6050 CBX5 -0.729 
SMAP1 0.6046 LINC00619 -0.727 
BOD1 0.6031 TBC1D2B -0.723 
LINC01125 0.6030 SYPL1 -0.722 
TMEM256-
PLSCR3 
0.5946 TUG1 -0.719 
GOPC 0.5939 DPY30 -0.713 
MTATP6P1 0.5934 DDI2 -0.709 
EGFL8 0.5913 EFCAB14P1 -0.705 
LINC00106 0.5910 DENND5B -0.699 
RP11-540B6.6 0.5883 EFCAB14 -0.693 




AC018766.4 0.5875 ZNF442 -0.685 
RP11-1391J7.1 0.5873 AC240274.1 -0.684 
KRTCAP2 0.5867 PANK1 -0.680 
RP1-152L7.8 0.5862 TDGP1 -0.680 
PTPN1 0.5858 RP3-452M16.1 -0.679 
PRSS53 0.5852 UBE4A -0.678 
CCDC39 0.5833 TTC1 -0.677 
ZNF692 0.5831 MAGI1 -0.674 
RP11-573D15.9 0.5805 PLK2 -0.672 
AC007191.4 0.5800 MED20 -0.672 
CTD-2545G14.4 0.5798 SLC43A2 -0.671 
RP11-755F10.3 0.5756 STX17 -0.668 
AARSD1 0.5747 PLEKHA1 -0.667 
SLC25A25-AS1 0.5709 CDKL5 -0.664 
ZCCHC3 0.5695 HLTF -0.663 
KCNAB3 0.5693 CTD-2554C21.1 -0.662 
PIF1 0.5661 WDR41 -0.662 
RP5-1159O4.1 0.5648 ARPP19 -0.661 
RP11-235E17.6 0.5635 SFXN2 -0.657 
ERCC5 0.5634 OTUD4 -0.653 
DDX39B 0.5595 SCD -0.652 
LPAR2 0.5588 ASAP1 -0.651 
AC005253.2 0.5580 NEK6 -0.651 
RP11-395G23.3 0.5563 FAM63B -0.640 
PDXDC2P 0.5558 ZDHHC7 -0.640 
SNHG25 0.5554 ARHGAP5 -0.638 
PDCD6 0.5551 TTPAL -0.638 
RP11-158L12.4 0.5550 FAM46B -0.635 
SNHG4 0.5535 ELAC1 -0.634 
ASGR1 0.5534 AHNAK -0.633 
RP11-
1348G14.8 
0.5526 ANKRD33B -0.632 




RP1-181J22.1 0.5509 RP11-566E18.1 -0.627 
VGLL4 0.5494 HSDL1 -0.626 
RP11-264B17.2 0.5493 FAT4 -0.626 
AGAP6 0.5485 NCOA2 -0.626 
DDX10P2 0.5484 TDG -0.624 
MSRB3 0.5475 RP11-680G24.4 -0.624 
RP11-
1334A24.5 
0.5449 BVES -0.623 
TOMM20 0.5418 PAQR8 -0.621 
ID4 0.5406 IST1 -0.619 
E2F5 0.5357 DENND1B -0.619 
MTND2P28 0.5353 DCUN1D3 -0.619 
NAP1L5 0.5345 B4GALT4 -0.618 
RP11-395N3.1 0.5338 LDB2 -0.616 
MT-CO2 0.5337 GADD45B -0.615 
AC009506.1 0.5336 KATNAL1 -0.615 
EME2 0.5310 SLC9A6 -0.614 
MT-ATP8 0.5310 CYR61 -0.613 
SAMD15 0.5263 RP1-172N19.4 -0.612 
LL0XNC01-
7P3.1 
0.5261 ATXN1L -0.609 
AC016722.4 0.5261 LAMC1 -0.606 
PRICKLE4 0.5258 C2CD5 -0.605 
RFXAP 0.5254 NARF -0.604 
RFK 0.5240 MRAS -0.604 
RP13-
516M14.10 
0.5240 CTDSPL -0.602 
ELMO3 0.5228 TP53INP2 -0.600 
PI4KAP1 0.5225 FNIP2 -0.600 
CTA-29F11.1 0.5216 ARHGAP19 -0.594 
CSPG4P10 0.5191 ENO2 -0.593 
MEG3 0.5182 PAG1 -0.591 




RP5-1142A6.9 0.5159 GLMP -0.590 
RP11-802E16.3 0.5136 PRKAA2 -0.589 
DNM3OS 0.5125 NT5DC3 -0.589 
HOXC-AS3 0.5123 KLHL12 -0.588 
BRICD5 0.5116 TSPAN17 -0.588 
RP11-264I13.2 0.5115 ISCA2 -0.587 
LZTFL1 0.5090 CAPZA1 -0.585 
MAPK8IP3 0.5089 IL15RA -0.584 
CCND3 0.5087 ABHD8 -0.583 
GABPA 0.5078 ARID1A -0.581 
ATG4A 0.5069 PKI55 -0.579 
TSSK4 0.5053 CHST15 -0.579 
MPP3 0.5050 LRRC32 -0.579 
TBX2-AS1 0.5035 TMEM230 -0.578 
KIAA0895L 0.5033 TUFT1 -0.578 
LUC7L3 0.5032 TMEM2 -0.576 
RP11-320M2.1 0.5030 DENND6A -0.574 
MAT2A 0.5026 HEG1 -0.568 
PNISR 0.5026 TANC1 -0.567 
RAD54L2 0.5012 CCL2 -0.567 
AHSA2 0.5011 ENSAP2 -0.566 
AC007383.3 0.5007 LMOD1 -0.566 
MT-ND4 0.5001 MTMR9 -0.565 
CTD-2270P14.1 0.4996 KBTBD7 -0.565 
MT-ND6 0.4996 SLC35B4 -0.565 
MT-RNR1 0.4992 NUAK2 -0.561 
TTC14 0.4991 ARL6IP1P3 -0.561 
SLC25A5-AS1 0.4987 FYCO1 -0.560 
ATXN7L2 0.4970 LBH -0.557 
GPC2 0.4969 LRIG3 -0.556 
CREM 0.4968 ALX4 -0.555 
DNMT3B 0.4960 RPTN -0.553 




PILRB 0.4943 RNPEPL1 -0.552 
ATP6V1B1 0.4933 RASSF5 -0.551 
CTC-479C5.12 0.4922 FADS2 -0.551 
SPRY4 0.4909 TENM4 -0.550 
 
